Goldman Sachs BDC, Inc 8-K, filed Nov 19, 2020
Goldman Sachs BDC, Inc. (GSBD)
About this 8-K
Goldman Sachs BDC, Inc filed this 8-K on November 19, 2020.
Items reported
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 19, 2020
GOLDMAN SACHS BDC, INC.
(Exact name of registrant as specified in charter)
| Delaware | 814-00998 | 46-2176593 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 200 West Street, New York, New York | 10282 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (212) 902-0300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Common Stock, par value $0.001 per share |
GSBD | The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 – Other Events.
As previously disclosed, on October 12, 2020, Goldman Sachs BDC, Inc., a Delaware corporation (“GSBD”), completed its previously announced merger with Goldman Sachs Middle Market Lending Corp. (“MMLC”) pursuant to that certain Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 11, 2020, by and among GSBD, MMLC, Evergreen Merger Sub Inc., a wholly owned subsidiary of GSBD (“Merger Sub”), and Goldman Sachs Asset Management, L.P. (“GSAM”), investment adviser to each of GSBD and MMLC. Pursuant to the Merger Agreement, Merger Sub was first merged with and into MMLC, with MMLC as the surviving corporation (the “First Merger”), and, immediately following the First Merger, MMLC was then merged with and into GSBD, with GSBD as the surviving company (the First Merger and the subsequent merger, collectively, the “Merger”).
Filed with this Current Report on Form 8-K as Exhibit 99.1 are the unaudited consolidated financial statements of MMLC for the periods described in Item 9.01(a) below and the notes related thereto.
Filed with this Current Report on Form 8-K as Exhibit 99.2 are the unaudited pro forma condensed consolidated financial statements for the periods described in Item 9.01(b) below and the notes related thereto.
Item 9.01 – Financial Statements and Exhibits.
(a) Financial statements.
The historical unaudited consolidated financial statements of MMLC as of September 30, 2020 and December 31, 2019 and for the three and nine months ended September 30, 2020 and 2019, are filed herewith as Exhibit 99.1 and incorporated herein by reference.
(b) Pro forma financial information.
The unaudited pro forma condensed consolidated financial statements of GSBD, giving effect to the Merger, as of and for the nine months ended September 30, 2020 and for the year ended December 31, 2019, are filed herewith as Exhibit 99.2 and incorporated herein by reference.
(d) Exhibits.
Forward-Looking Statements
This Current Report on Form 8-K may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this Current Report on Form 8-K may constitute forward-looking statements and are not guarantees of future performance or results of GSBD and involve a number of risks and uncertainties. Such forward-looking statements may include statements preceded by, followed by or that otherwise include the words “may,” “might,” “will,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “anticipate,” “predict,” “potential,” “plan” or similar words. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings made by GSBD with the Securities and Exchange Commission (the “SEC”), including those contained in the joint proxy statement and prospectus that forms part of a registration statement on Form N-14 filed with the SEC on August 4, 2020. Certain factors could cause actual results to differ materially from those projected in these forward-looking statements. Factors that could cause actual results to differ materially include: the ability to realize the anticipated benefits of the Merger, effects of disruption on the business of GSBD from the Merger; GSBD’s plans, expectations, objectives and intentions as a result of the Merger, future operating results of GSBD, the business prospects of GSBD and the prospects of its portfolio companies, actual and potential conflicts of interests with GSAM and other affiliates of GSAM, general economic and political trends and other factors, the dependence of GSBD’s future success on the general economy and its effect on the industries in which it invests; and future changes in laws or regulations and interpretations thereof. GSBD does not undertake any duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this Current Report on Form 8-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GOLDMAN SACHS BDC, INC. (Registrant) | ||||||
| Date: November 19, 2020 | By: | /s/ Jonathan Lamm | ||||
| Name: Jonathan Lamm | ||||||
| Title: Chief Financial Officer and Treasurer | ||||||
Exhibit 99.1
GOLDMAN SACHS MIDDLE MARKET LENDING CORP.
| INDEX |
PAGE | |||
| FINANCIAL INFORMATION | ||||
| Financial Statements |
||||
| Consolidated Statements of Assets and Liabilities as of September 30, 2020 (Unaudited) and December 31, 2019 |
2 | |||
| Consolidated Statements of Operations for the three and nine months ended September 30, 2020 (Unaudited) and 2019 (Unaudited) |
3 | |||
| Consolidated Statements of Changes in Net Assets for the three and nine months ended September 30, 2020 (Unaudited) and 2019 (Unaudited) |
4 | |||
| Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 (Unaudited) and 2019 (Unaudited) |
5 | |||
| Consolidated Schedules of Investments as of September 30, 2020 (Unaudited) and December 31, 2019 |
6 | |||
| Notes to the Consolidated Financial Statements (Unaudited) |
19 | |||
Goldman Sachs Middle Market Lending Corp.
Consolidated Statements of Assets and Liabilities
(in thousands, except share and per share amounts)
| September 30, 2020 (Unaudited) |
December 31, 2019 |
|||||||
| Assets |
||||||||
| Investments, at fair value |
||||||||
|
Non-controlled/non-affiliated investments (cost of $1,693,771 and $1,656,685) |
$ | 1,637,716 | $ | 1,633,562 | ||||
| Non-controlled affiliated investments (cost of $45,801 and $45,702) |
50,826 | 49,598 | ||||||
| Investments in affiliated money market fund (cost of $160,798 and $-) |
160,798 | — | ||||||
| Cash |
16,911 | 13,393 | ||||||
| Receivable for investments sold |
426 | 41 | ||||||
| Interest and dividends receivable |
11,496 | 7,022 | ||||||
| Deferred financing costs |
1,988 | 2,617 | ||||||
| Unrealized appreciation on foreign currency forward contracts |
— | 46 | ||||||
| Other assets |
824 | 96 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 1,880,985 | $ | 1,706,375 | ||||
|
|
|
|
|
|||||
| Liabilities |
||||||||
| Debt |
$ | 843,219 | $ | 729,986 | ||||
| Interest and other debt expenses payable |
378 | 713 | ||||||
| Management fees payable |
3,714 | 3,520 | ||||||
| Incentive fees payable |
6,456 | 3,419 | ||||||
| Distribution payable |
— | 21,272 | ||||||
| Unrealized depreciation on foreign currency forward contracts |
134 | — | ||||||
| Directors’ fees payable |
100 | — | ||||||
| Accrued expenses and other liabilities |
3,884 | 2,676 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
$ | 857,885 | $ | 761,586 | ||||
|
|
|
|
|
|||||
| Commitments and Contingencies (Note 8) |
||||||||
| Net Assets |
||||||||
| Preferred stock, par value $0.001 per share (1,000,000 shares authorized, no shares issued and outstanding) |
$ | — | $ | — | ||||
| Common stock, par value $0.001 per share (200,000,000 shares authorized, 53,844,947 and 50,562,483 shares issued and outstanding as of September 30, 2020 and December 31, 2019) |
54 | 51 | ||||||
| Paid-in capital in excess of par |
1,034,279 | 972,476 | ||||||
| Distributable earnings |
(11,233 | ) | (27,738 | ) | ||||
|
|
|
|
|
|||||
| TOTAL NET ASSETS |
$ | 1,023,100 | $ | 944,789 | ||||
|
|
|
|
|
|||||
| TOTAL LIABILITIES AND NET ASSETS |
$ | 1,880,985 | $ | 1,706,375 | ||||
|
|
|
|
|
|||||
| Net asset value per share |
$ | 19.00 | $ | 18.69 | ||||
The accompanying notes are part of these unaudited consolidated financial statements.
2
Goldman Sachs Middle Market Lending Corp.
Consolidated Statements of Operations
(in thousands, except share and per share amounts)
(Unaudited)
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2020 |
September 30, 2019 |
September 30, 2020 |
September 30, 2019 |
|||||||||||||
| Investment Income: |
||||||||||||||||
| From non-controlled/non-affiliated investments: |
||||||||||||||||
| Interest income |
$ | 36,520 | $ | 37,135 | $ | 111,906 | $ | 101,019 | ||||||||
| Other income |
1,505 | 535 | 2,113 | 1,502 | ||||||||||||
| From non-controlled affiliated investments: |
||||||||||||||||
| Interest income |
751 | 654 | 2,319 | 1,986 | ||||||||||||
| Dividend income |
48 | 58 | 106 | 149 | ||||||||||||
| Other income |
7 | 7 | 73 | 20 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total investment income |
$ | 38,831 | $ | 38,389 | $ | 116,517 | $ | 104,676 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Expenses: |
||||||||||||||||
| Interest and other debt expenses |
$ | 5,562 | $ | 7,001 | $ | 19,162 | $ | 16,469 | ||||||||
| Management fees |
3,714 | 3,489 | 10,739 | 10,145 | ||||||||||||
| Incentive fees |
6,456 | 3,265 | 6,456 | 14,605 | ||||||||||||
| Professional fees |
1,341 | 517 | 3,358 | 1,252 | ||||||||||||
| Directors’ fees |
107 | 114 | 320 | 327 | ||||||||||||
| Other General and Administrative Expenses |
928 | 905 | 2,753 | 2,488 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total expenses |
$ | 18,108 | $ | 15,291 | $ | 42,788 | $ | 45,286 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| NET INVESTMENT INCOME |
$ | 20,723 | $ | 23,098 | $ | 73,729 | $ | 59,390 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net realized and unrealized gains (losses): |
||||||||||||||||
| Net realized gain (loss) from: |
||||||||||||||||
|
Non-controlled/non-affiliated investments |
$ | — | $ | (7 | ) | $ | 226 | $ | (10,568 | ) | ||||||
| Foreign currency forward contracts |
40 | 53 | 150 | 65 | ||||||||||||
| Foreign currency transactions |
47 | (19 | ) | 20 | 19 | |||||||||||
| Net change in unrealized appreciation (depreciation) from: |
||||||||||||||||
|
Non-controlled/non-affiliated investments |
27,126 | (7,236 | ) | (32,932 | ) | (11,424 | ) | |||||||||
| Non-controlled affiliated investments |
401 | 479 | 1,129 | 2,016 | ||||||||||||
| Foreign currency forward contracts |
(179 | ) | 78 | (180 | ) | 123 | ||||||||||
| Foreign currency translations |
(2,334 | ) | 2,225 | (2,411 | ) | 2,642 | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net realized and unrealized gains (losses) |
$ | 25,101 | $ | (4,427 | ) | $ | (33,998 | ) | $ | (17,127 | ) | |||||
|
|
|
|
|
|
|
|
|
|||||||||
| (Provision) benefit for taxes on realized gain/loss on investments |
$ | — | $ | — | $ | — | $ | 100 | ||||||||
| (Provision) benefit for taxes on unrealized appreciation/depreciation on investments |
(89 | ) | (171 | ) | (73 | ) | (614 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| NET INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS |
$ | 45,735 | $ | 18,500 | $ | 39,658 | $ | 41,749 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Weighted average shares outstanding |
53,844,947 | 49,470,258 | 53,198,038 | 46,754,248 | ||||||||||||
| Net investment income per share (basic and diluted) |
$ | 0.38 | $ | 0.47 | $ | 1.39 | $ | 1.27 | ||||||||
| Earnings (loss) per share (basic and diluted) |
$ | 0.85 | $ | 0.37 | $ | 0.75 | $ | 0.89 | ||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
3
Goldman Sachs Middle Market Lending Corp.
Consolidated Statements of Changes in Net Assets
(in thousands, except share and per share amounts)
(Unaudited)
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2020 |
September 30, 2019 |
September 30, 2020 |
September 30, 2019 |
|||||||||||||
| Net assets at beginning of period |
$ | 977,365 | $ | 928,731 | $ | 944,789 | $ | 820,154 | ||||||||
| Increase (decrease) in net assets from operations: |
||||||||||||||||
| Net investment income |
$ | 20,723 | $ | 23,098 | $ | 73,729 | $ | 59,390 | ||||||||
| Net realized gain (loss) |
87 | 27 | 396 | (10,484 | ) | |||||||||||
| Net change in unrealized appreciation (depreciation) |
25,014 | (4,454 | ) | (34,394 | ) | (6,643 | ) | |||||||||
| (Provision) benefit for taxes on realized gain/loss on investments |
— | — | — | 100 | ||||||||||||
| (Provision) benefit for taxes on unrealized appreciation/depreciation on investments |
(89 | ) | (171 | ) | (73 | ) | (614 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net increase (decrease) in net assets from operations |
$ | 45,735 | $ | 18,500 | $ | 39,658 | $ | 41,749 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Distributions to stockholders from: |
||||||||||||||||
| Distributable earnings |
$ | — | $ | (21,272 | ) | $ | (23,153 | ) | $ | (60,099 | ) | |||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total distributions to stockholders |
$ | — | $ | (21,272 | ) | $ | (23,153 | ) | $ | (60,099 | ) | |||||
|
|
|
|
|
|
|
|
|
|||||||||
| Capital transactions: |
||||||||||||||||
| Issuance of common shares |
$ | — | $ | — | $ | 61,806 | $ | 124,155 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net increase (decrease) in net assets from capital transactions |
$ | — | $ | — | $ | 61,806 | $ | 124,155 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| TOTAL INCREASE (DECREASE) IN NET ASSETS |
$ | 45,735 | $ | (2,772 | ) | $ | 78,311 | $ | 105,805 | |||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net assets at end of period |
$ | 1,023,100 | $ | 925,959 | $ | 1,023,100 | $ | 925,959 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Distributions declared per share |
$ | — | $ | 0.43 | $ | 0.43 | $ | 1.29 | ||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
4
Goldman Sachs Middle Market Lending Corp.
Consolidated Statements of Cash Flows
(in thousands, except share and per share amounts)
(Unaudited)
| For the Nine Months Ended | ||||||||
| September 30, 2020 |
September 30, 2019 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net increase (decrease) in net assets from operations: |
$ | 39,658 | $ | 41,749 | ||||
| Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used for) operating activities: |
||||||||
| Purchases of investments |
(171,954 | ) | (643,023 | ) | ||||
| Payment-in-kind interest capitalized |
(1,462 | ) | (794 | ) | ||||
| Investments in affiliated money market fund, net |
(160,798 | ) | — | |||||
| Proceeds from sales of investments and principal repayments |
142,064 | 146,770 | ||||||
| Net realized (gain) loss |
(220 | ) | 10,575 | |||||
| Net change in unrealized (appreciation) depreciation on investments |
31,803 | 9,408 | ||||||
| Net change in unrealized (appreciation) depreciation on foreign currency forward contracts and transactions |
158 | (89 | ) | |||||
| Amortization of premium and accretion of discount, net |
(5,613 | ) | (5,063 | ) | ||||
| Amortization of deferred financing costs |
1,059 | 974 | ||||||
| Change in operating assets and liabilities: |
||||||||
| (Increase) decrease in receivable for investments sold |
(385 | ) | (11 | ) | ||||
| (Increase) decrease in interest and dividends receivable |
(4,474 | ) | (2,525 | ) | ||||
| (Increase) decrease in other assets |
(728 | ) | 125 | |||||
| Increase (decrease) in interest and other debt expenses payable |
(335 | ) | 38 | |||||
| Increase (decrease) in management fees payable |
194 | 590 | ||||||
| Increase (decrease) in incentive fees payable |
3,037 | (247 | ) | |||||
| Increase (decrease) in investments purchased payable |
— | 15,868 | ||||||
| Increase (decrease) in directors’ fees payable |
100 | 99 | ||||||
| Increase (decrease) in accrued expenses and other liabilities |
1,208 | 131 | ||||||
|
|
|
|
|
|||||
| Net cash provided by (used for) operating activities |
$ | (126,688 | ) | $ | (425,425 | ) | ||
|
|
|
|
|
|||||
| Cash flows from financing activities: |
||||||||
| Proceeds from issuance of common stock |
$ | 61,806 | $ | 124,155 | ||||
| Distributions paid |
(44,425 | ) | (55,017 | ) | ||||
| Financing costs paid |
(430 | ) | (745 | ) | ||||
| Borrowings on debt |
240,433 | 586,924 | ||||||
| Repayments of debt |
(127,200 | ) | (233,550 | ) | ||||
|
|
|
|
|
|||||
| Net cash provided by (used for) financing activities |
$ | 130,184 | $ | 421,767 | ||||
|
|
|
|
|
|||||
| Net increase (decrease) in cash |
3,496 | (3,658 | ) | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents |
22 | (35 | ) | |||||
| Cash, beginning of period |
13,393 | 15,010 | ||||||
|
|
|
|
|
|||||
| Cash, end of period |
$ | 16,911 | $ | 11,317 | ||||
|
|
|
|
|
|||||
| Supplemental and non-cash activities |
||||||||
| Interest expense paid |
$ | 18,127 | $ | 14,745 | ||||
| Accrued but unpaid excise tax expense |
$ | — | $ | 8 | ||||
| Accrued but unpaid distributions |
$ | — | $ | 21,272 | ||||
| Exchange of investments |
$ | 13,019 | $ | 1,054 | ||||
The accompanying notes are part of these unaudited consolidated financial statements.
5
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and Spread (+) |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| 1st Lien/Senior Secured Debt # - 126.17% |
||||||||||||||||||||||||
| 3SI Security Systems, Inc.(1) |
Commercial Services & Supplies | 6.75 | % | L + 5.75%; 1.00% Floor | 06/16/2023 | $ | 2,216 | $ | 2,193 | $ | 2,166 | |||||||||||||
| Accuity Delivery Systems, LLC^ (1) (2) |
Health Care Providers & Services | 8.00 | % | L + 7.00%; 1.00% Floor | 06/13/2023 | 14,480 | 14,222 | 14,842 | ||||||||||||||||
| Acquia, Inc.(1) (2) |
Software | 8.00 | % | L + 7.00%; 1.00% Floor | 10/31/2025 | 18,197 | 17,877 | 17,651 | ||||||||||||||||
| Acquia, Inc.(1) (2) (3) |
Software | L + 7.00%; 1.00% Floor | 10/31/2025 | 1,946 | (33 | ) | (58 | ) | ||||||||||||||||
| Apptio, Inc.(1) (2) |
IT Services | 8.25 | % | L + 7.25%; 1.00% Floor | 01/10/2025 | 46,452 | 45,735 | 45,755 | ||||||||||||||||
| Apptio, Inc.(1) (2) (3) |
IT Services | L + 7.25%; 1.00% Floor | 01/10/2025 | 3,160 | (45 | ) | (47 | ) | ||||||||||||||||
| Associations, Inc.(1) (2) |
Real Estate Management & Development | 8.00 | % | L + 7.00% (incl. 3.00% PIK); 1.00% Floor | 07/30/2024 | 19,744 | 19,582 | 18,954 | ||||||||||||||||
| Associations, Inc.(1) (2) (3) |
Real Estate Management & Development | 8.23 | % | L + 7.00% (incl. 3.00% PIK); 1.00% Floor | 07/30/2024 | 4,322 | 4,224 | 4,086 | ||||||||||||||||
| Associations, Inc.(1) (2) |
Real Estate Management & Development | 7.00 | % | L + 6.00%; 1.00% Floor | 07/30/2024 | 836 | 829 | 802 | ||||||||||||||||
| BJH Holdings III Corp. (dba Jack’s Family Restaurants)(2) |
Hotels, Restaurants & Leisure | 6.50 | % | L + 5.50%; 1.00% Floor | 08/19/2025 | 9,028 | 8,952 | 8,667 | ||||||||||||||||
| Brillio, LLC(1) (2) |
IT Services | 5.75 | % | L + 4.75%; 1.00% Floor | 02/06/2025 | 6,518 | 6,468 | 6,371 | ||||||||||||||||
| Brillio, LLC(1) (2) (3) |
IT Services | 5.75 | % | L + 4.75%; 1.00% Floor | 02/06/2025 | 2,200 | 1,100 | 1,050 | ||||||||||||||||
| Bullhorn, Inc.(2) |
Professional Services | 6.75 | % | L + 5.75%; 1.00% Floor | 09/30/2026 | 15,988 | 15,702 | 15,749 | ||||||||||||||||
| Bullhorn, Inc.(2) |
Professional Services | 6.75 | % | L + 5.75%; 1.00% Floor | 09/30/2026 | 332 | 326 | 327 | ||||||||||||||||
| Bullhorn, Inc.(2) |
Professional Services | 6.75 | % | L + 5.75%; 1.00% Floor | 09/30/2026 | 264 | 260 | 260 | ||||||||||||||||
| Bullhorn, Inc.(2) (3) |
Professional Services | L + 5.75%; 1.00% Floor | 09/30/2026 | 732 | (13 | ) | (11 | ) | ||||||||||||||||
| Bullhorn, Inc.(2) (3) |
Professional Services | L + 5.75%; 1.00% Floor | 09/30/2026 | 799 | (14 | ) | (12 | ) | ||||||||||||||||
| Businessolver.com, Inc.(1) (2) |
Health Care Technology | 8.50 | % | L + 7.50%; 1.00% Floor | 05/15/2023 | 30,076 | 29,726 | 29,324 | ||||||||||||||||
| Businessolver.com, Inc.(1) (2) |
Health Care Technology | 8.50 | % | L + 7.50%; 1.00% Floor | 05/15/2023 | 4,511 | 4,455 | 4,399 | ||||||||||||||||
| Businessolver.com, Inc.(1) (2) (3) |
Health Care Technology | L + 7.50%; 1.00% Floor | 05/15/2023 | 3,760 | (40 | ) | (94 | ) | ||||||||||||||||
| CFS Management, LLC (dba Center for Sight Management)(1) (2) |
Health Care Providers & Services | 6.75 | % | L + 5.75%; 1.00% Floor | 07/01/2024 | 6,940 | 6,884 | 6,697 | ||||||||||||||||
| CFS Management, LLC (dba Center for Sight Management)(1) (2) |
Health Care Providers & Services | 6.75 | % | L + 5.75%; 1.00% Floor | 07/01/2024 | 2,067 | 2,051 | 1,995 | ||||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas)(1) (2) |
Professional Services | 6.75 | % | L + 5.75%; 1.00% Floor | 11/14/2025 | 10,223 | 10,043 | 9,916 | ||||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas)(1) (2) |
Professional Services | 6.75 | % | L + 5.75%; 1.00% Floor | 11/14/2025 | 4,307 | 4,230 | 4,178 | ||||||||||||||||
| Chronicle Bidco Inc. (dba |
Professional Services | L + 5.75%; 1.00% Floor | 11/14/2025 | 1,300 | (22 | ) | (39 | ) | ||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates)^^^ (1) (2) |
Health Care Providers & Services | 7.50 | % | L + 6.50%; 1.00% Floor | 03/28/2025 | 12,700 | 12,566 | 12,319 | ||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates)^^^ (1) (2) |
Health Care Providers & Services | 7.50 | % | L + 6.50%; 1.00% Floor | 03/28/2025 | 9,673 | 9,550 | 9,383 | ||||||||||||||||
| ConnectWise, LLC(1) (2) |
IT Services | 7.00 | % | L + 6.00%; 1.00% Floor | 02/28/2025 | 19,806 | 19,464 | 19,608 | ||||||||||||||||
| ConnectWise, LLC(1) (2) (3) |
IT Services | L + 6.00%; 1.00% Floor | 02/28/2025 | 1,524 | (26 | ) | (15 | ) | ||||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene)(1) (2) |
Real Estate Management & Development | 9.00 | % | L + 7.50%; 1.50% Floor | 08/30/2024 | 31,000 | 30,492 | 26,350 | ||||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene)(1) (2) |
Real Estate Management & Development | 9.00 | % | L + 7.50%; 1.50% Floor | 08/30/2024 | 9,120 | 8,962 | 7,752 | ||||||||||||||||
| CorePower Yoga LLC(2) |
Diversified Consumer Services | 7.00 | % | L + 6.00% (incl. 1.25% PIK); 1.00% Floor | 05/14/2025 | 14,400 | 14,214 | 12,240 | ||||||||||||||||
| CorePower Yoga LLC(2) (3) |
Diversified Consumer Services | 7.00 | % | L + 6.00% (incl. 1.25% PIK); 1.00% Floor | 05/14/2025 | 1,010 | 189 | 50 | ||||||||||||||||
| CST Buyer Company (dba |
Diversified Consumer Services | 6.25 | % | L + 5.25%; 1.00% Floor | 10/03/2025 | 16,870 | 16,684 | 16,870 | ||||||||||||||||
| CST Buyer Company (dba |
Diversified Consumer Services | L + 5.25%; 1.00% Floor | 10/03/2025 | 1,294 | (14 | ) | — | |||||||||||||||||
| DDS USA Holding, Inc.(1) (2) |
Health Care Equipment & Supplies | 6.75 | % | L + 5.75%; 1.00% Floor | 06/30/2022 | 5,364 | 5,350 | 5,310 | ||||||||||||||||
| DDS USA Holding, Inc.(1) (2) |
Health Care Equipment & Supplies | 6.75 | % | L + 5.75%; 1.00% Floor | 06/30/2022 | 5,069 | 5,056 | 5,018 | ||||||||||||||||
| DDS USA Holding, Inc.(1) (2) (3) |
Health Care Equipment & Supplies | 6.75 | % | L + 5.75%; 1.00% Floor | 06/30/2022 | 1,533 | 763 | 751 | ||||||||||||||||
| Diligent Corporation(2) |
Professional Services | 7.25 | % | L + 6.25%; 1.00% Floor | 08/04/2025 | € | 22,650 | 25,860 | 25,892 | |||||||||||||||
| Diligent Corporation(2) |
Professional Services | 7.25 | % | L + 6.25%; 1.00% Floor | 08/04/2025 | 14,645 | 14,438 | 14,279 | ||||||||||||||||
| Diligent Corporation(2) (3) |
Professional Services | L + 6.25%; 1.00% Floor | 08/04/2025 | 1,800 | (34 | ) | (45 | ) | ||||||||||||||||
| DocuTAP, Inc.(1) (2) |
Health Care Technology | 6.50 | % | L + 5.50%; 1.00% Floor | 05/12/2025 | 34,802 | 34,102 | 33,845 | ||||||||||||||||
| E2open, LLC(2) |
Software | 6.75 | % | L + 5.75%; 1.00% Floor | 11/26/2024 | 24,057 | 23,864 | 23,095 | ||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
6
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and Spread (+) |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| Elemica Parent, Inc.(1) (2) |
Chemicals | 5.73 | % | L + 5.50% | 09/18/2025 | $ | 4,225 | $ | 4,135 | $ | 3,930 | |||||||||||||
| Elemica Parent, Inc.(1) (2) (3) |
Chemicals | 5.72 | % | L + 5.50% | 09/18/2025 | 550 | 406 | 379 | ||||||||||||||||
| Elemica Parent, Inc.(1) (2) (3) |
Chemicals | L + 5.50% | 09/18/2025 | 830 | (9 | ) | (58 | ) | ||||||||||||||||
| Empirix, Inc.(1) (2) |
Diversified Telecommunication Services | 7.25 | % | L + 6.25%; 1.00% Floor | 09/25/2024 | 31,261 | 30,870 | 30,323 | ||||||||||||||||
| Empirix, Inc.(1) (2) (3) |
Diversified Telecommunication Services | L + 6.25%; 1.00% Floor | 09/25/2023 | 1,800 | (19 | ) | (54 | ) | ||||||||||||||||
| Eptam Plastics, Ltd.(1) (2) |
Health Care Equipment & Supplies | 6.50 | % | L + 5.50%; 1.00% Floor | 12/06/2025 | 6,331 | 6,247 | 6,157 | ||||||||||||||||
| Eptam Plastics, Ltd.(1) (2) |
Health Care Equipment & Supplies | 6.50 | % | L + 5.50%; 1.00% Floor | 12/06/2025 | 1,354 | 1,336 | 1,317 | ||||||||||||||||
| Eptam Plastics, Ltd.(1) (2) (3) |
Health Care Equipment & Supplies | L + 5.50%; 1.00% Floor | 12/06/2025 | 2,708 | (18 | ) | (74 | ) | ||||||||||||||||
| Fenergo Finance 3 |
Diversified Financial Services | 7.00 | % | L + 6.00%; 1.00% Floor | 09/05/2024 | € | 25,300 | 29,040 | 29,292 | |||||||||||||||
| Fenergo Finance 3 |
Diversified Financial Services | L + 6.00%; 1.00% Floor | 09/05/2024 | 1,683 | (19 | ) | (21 | ) | ||||||||||||||||
| Fenergo Finance 3 |
Diversified Financial Services | L + 6.00%; 1.00% Floor | 09/05/2024 | € | 2,200 | (30 | ) | (32 | ) | |||||||||||||||
| Foundation Software(2) |
Construction & Engineering | 10.25 | % | P + 7.00%; 2.00% Floor | 08/31/2027 | 428 | 418 | 418 | ||||||||||||||||
| Foundation Software(2) (3) |
Construction & Engineering | P + 7.00%; 2.00% Floor | 08/31/2026 | 61 | (2 | ) | (2 | ) | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) (3) |
Hotels, Restaurants & Leisure | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 96 | — | (3 | ) | |||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 8.00 | % | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 4,004 | 3,977 | 3,864 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 8.00 | % | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 3,011 | 2,991 | 2,905 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 8.00 | % | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 2,995 | 2,975 | 2,891 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 8.00 | % | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 11,297 | 11,145 | 10,901 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 8.00 | % | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 2,257 | 2,228 | 2,178 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 8.00 | % | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 1,427 | 1,408 | 1,377 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) (3) |
Hotels, Restaurants & Leisure | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 08/21/2023 | 1,506 | (19 | ) | (53 | ) | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) |
Health Care Providers & Services | 7.02 | % | L + 6.00%; 1.00% Floor | 09/04/2024 | 13,795 | 13,600 | 13,209 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) |
Health Care Providers & Services | 7.00 | % | L + 6.00%; 1.00% Floor | 09/04/2024 | 7,123 | 7,020 | 6,820 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) |
Health Care Providers & Services | 7.01 | % | L + 6.00%; 1.00% Floor | 09/04/2024 | 6,886 | 6,801 | 6,593 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) (3) |
Health Care Providers & Services | L + 6.00%; 1.00% Floor | 09/04/2023 | 2,900 | (34 | ) | (123 | ) | ||||||||||||||||
| GlobalTranz Enterprises, Inc.(2) |
Road & Rail | 5.16 | % | L + 5.00% | 05/15/2026 | 11,358 | 11,167 | 9,569 | ||||||||||||||||
| Governmentjobs.com, Inc. (dba NeoGov)(1) (2) |
Software | 7.50 | % | L + 6.50%; 1.00% Floor | 02/05/2026 | 29,153 | 28,621 | 28,643 | ||||||||||||||||
| Governmentjobs.com, Inc. (dba NeoGov)(1) (2) (3) |
Software | 7.50 | % | L + 6.50%; 1.00% Floor | 02/05/2026 | 3,887 | 222 | 224 | ||||||||||||||||
| Granicus, Inc.(2) |
Software | 8.00 | % | L + 7.00%; 1.00% Floor | 08/21/2026 | 13,560 | 13,226 | 13,221 | ||||||||||||||||
| Granicus, Inc.(2) (3) |
Software | L + 7.00%; 1.00% Floor | 08/21/2026 | 929 | (23 | ) | (23 | ) | ||||||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)(1) (2) |
Hotels, Restaurants & Leisure | 7.75 | % | L + 6.75%; 1.00% Floor | 07/09/2025 | 34,501 | 34,072 | 32,000 | ||||||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)(1) (2) (3) |
Hotels, Restaurants & Leisure | L + 6.75%; 1.00% Floor | 07/09/2025 | 2,805 | (34 | ) | (203 | ) | ||||||||||||||||
| Hygiena Borrower LLC |
Life Sciences Tools & Services | 5.00 | % | L + 4.00%; 1.00% Floor | 08/26/2022 | 5,122 | 5,084 | 5,019 | ||||||||||||||||
| Hygiena Borrower LLC(3) |
Life Sciences Tools & Services | L + 4.00%; 1.00% Floor | 08/26/2022 | 550 | (4 | ) | (11 | ) | ||||||||||||||||
| iCIMS, Inc.(1) (2) |
Software | 7.50 | % | L + 6.50%; 1.00% Floor | 09/12/2024 | 42,594 | 41,988 | 41,849 | ||||||||||||||||
| iCIMS, Inc.(1) (2) |
Software | 7.50 | % | L + 6.50%; 1.00% Floor | 09/12/2024 | 7,844 | 7,720 | 7,707 | ||||||||||||||||
| iCIMS, Inc.(1) (2) (3) |
Software | L + 6.50%; 1.00% Floor | 09/12/2024 | 2,662 | (35 | ) | (47 | ) | ||||||||||||||||
| Instructure Holdings(1) (2) |
Diversified Consumer Services | 8.00 | % | L + 7.00%; 1.00% Floor | 03/24/2026 | 38,591 | 38,142 | 38,206 | ||||||||||||||||
| Instructure Holdings(1) (2) (3) |
Diversified Consumer Services | L + 7.00%; 1.00% Floor | 03/24/2026 | 3,000 | (34 | ) | (30 | ) | ||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
7
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and Spread (+) |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| Integral Ad Science, Inc.(1) (2) |
Interactive Media & Services | 8.25 | % | L + 7.25% (incl. 1.25% PIK); 1.00% Floor | 07/19/2024 | $ | 36,902 | $ | 36,403 | $ | 35,519 | |||||||||||||
| Integral Ad Science, Inc.(1) (2) (3) |
Interactive Media & Services | L + 6.00%; 1.00% Floor | 07/19/2023 | 2,586 | (29 | ) | (97 | ) | ||||||||||||||||
| Internet Truckstop Group, LLC (dba Truckstop)(1) (2) |
Transportation Infrastructure | 6.50 | % | L + 5.50%; 1.00% Floor | 04/02/2025 | 32,133 | 31,500 | 31,491 | ||||||||||||||||
| Internet Truckstop Group, LLC (dba Truckstop)(1) (2) (3) |
Transportation Infrastructure | L + 5.50%; 1.00% Floor | 04/02/2025 | 2,600 | (49 | ) | (52 | ) | ||||||||||||||||
| Lithium Technologies, Inc.(1) (2) |
Interactive Media & Services | 9.00 | % | L + 8.00%; 1.00% Floor | 10/03/2022 | 50,047 | 49,473 | 47,920 | ||||||||||||||||
| Lithium Technologies, Inc.(1) (2) (3) |
Interactive Media & Services | 9.21 | % | L + 8.00%; 1.00% Floor | 10/03/2022 | 3,448 | 539 | 428 | ||||||||||||||||
| Mailgun Technologies, Inc.(1) (2) |
Interactive Media & Services | 6.00 | % | L + 5.00%; 1.00% Floor | 03/26/2025 | 22,995 | 22,628 | 22,995 | ||||||||||||||||
| Mailgun Technologies, Inc.(1) (2) (3) |
Interactive Media & Services | L + 5.00%; 1.00% Floor | 03/26/2025 | 1,448 | — | — | ||||||||||||||||||
| MedeAnalytics, Inc.(2) (3) |
Health Care Technology | L + 6.50%; 1.00% Floor | 10/09/2026 | 479 | — | — | ||||||||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & |
Health Care Technology | 6.50 | % | L + 5.50%; 1.00% Floor | 11/15/2024 | 29,507 | 29,059 | 29,064 | ||||||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & |
Health Care Technology | 6.50 | % | L + 5.50%; 1.00% Floor | 11/15/2024 | 4,525 | 2,651 | 2,647 | ||||||||||||||||
| MRI Software LLC |
Real Estate Management & Development | 6.50 | % | L + 5.50%; 1.00% Floor | 02/10/2026 | 14,025 | 13,901 | 13,534 | ||||||||||||||||
| MRI Software LLC(3) |
Real Estate Management & Development | L + 5.50%; 1.00% Floor | 02/10/2026 | 565 | (7 | ) | (20 | ) | ||||||||||||||||
| MRI Software LLC(3) |
Real Estate Management & Development | L + 5.50%; 1.00% Floor | 02/10/2026 | 990 | (9 | ) | (35 | ) | ||||||||||||||||
| Netvoyage Corporation (dba NetDocuments)(1) (2) |
Software | 8.75 | % | L + 7.75%; 1.00% Floor | 03/22/2024 | 7,876 | 7,787 | 7,620 | ||||||||||||||||
| Netvoyage Corporation (dba NetDocuments)(1) (2) |
Software | 8.75 | % | L + 7.75%; 1.00% Floor | 03/22/2024 | 5,940 | 5,842 | 5,747 | ||||||||||||||||
| Netvoyage Corporation (dba NetDocuments)(1) (2) |
Software | 8.75 | % | L + 7.75%; 1.00% Floor | 03/22/2024 | 880 | 867 | 851 | ||||||||||||||||
| Netvoyage Corporation (dba NetDocuments)(1) (2) (3) |
Software | L + 7.75%; 1.00% Floor | 03/24/2022 | 610 | (4 | ) | (20 | ) | ||||||||||||||||
| Picture Head Midco LLC(1) (2) |
Entertainment | 8.25 | % | L + 7.25% (incl. 0.50% PIK); 1.00% Floor | 08/31/2023 | 27,467 | 27,004 | 24,995 | ||||||||||||||||
| PlanSource Holdings, Inc.(1) (2) |
Health Care Technology | 7.25 | % | L + 6.25%; 1.00% Floor | 04/22/2025 | 33,940 | 33,396 | 32,752 | ||||||||||||||||
| PlanSource Holdings, Inc.(1) (2) (3) |
Health Care Technology | L + 6.25%; 1.00% Floor | 04/22/2025 | 4,681 | (72 | ) | (164 | ) | ||||||||||||||||
| Power Stop, LLC(2) |
Auto Components | 4.65 | % | L + 4.50% | 10/19/2025 | 10,709 | 10,689 | 10,174 | ||||||||||||||||
| Premier Imaging, LLC (dba Lucid Health)(1) (2) |
Health Care Providers & Services | 6.75 | % | L + 5.75%; 1.00% Floor | 01/02/2025 | 17,127 | 16,906 | 16,356 | ||||||||||||||||
| Project Eagle Holdings, LLC(2) |
Aerospace & Defense | 9.25 | % | L + 8.25%; 1.00% Floor | 07/06/2026 | 452 | 441 | 441 | ||||||||||||||||
| Project Eagle Holdings, LLC(2) (3) |
Aerospace & Defense | L + 8.25%; 1.00% Floor | 07/06/2026 | 38 | (1 | ) | (1 | ) | ||||||||||||||||
| PT Intermediate Holdings III, LLC (dba Parts Town)(2) |
Trading Companies & Distributors | 6.50 | % | L + 5.50%; 1.00% Floor | 10/15/2025 | 17,190 | 17,115 | 15,901 | ||||||||||||||||
| Purfoods, LLC(2) |
Health Care Providers & Services | 7.25 | % | L + 6.25%; 1.00% Floor | 08/12/2026 | 300 | 293 | 293 | ||||||||||||||||
| Purfoods, LLC(2) (3) |
Health Care Providers & Services | L + 6.25%; 1.00% Floor | 08/12/2026 | 200 | (2 | ) | (3 | ) | ||||||||||||||||
| Riverpoint Medical, LLC(1) (2) |
Health Care Equipment & Supplies | 5.50 | % | L + 4.50%; 1.00% Floor | 06/21/2025 | 13,305 | 13,250 | 12,806 | ||||||||||||||||
| Riverpoint Medical, LLC(1) (2) (3) |
Health Care Equipment & Supplies | L + 4.50%; 1.00% Floor | 06/21/2025 | 2,450 | (10 | ) | (92 | ) | ||||||||||||||||
| Selectquote, Inc.(2) |
Insurance | 7.00 | % | L + 6.00%; 1.00% Floor | 11/05/2024 | 12,082 | 11,878 | 12,082 | ||||||||||||||||
| SF Home Décor, LLC (dba SureFit Home Décor)(1) (2) |
Household Products | 10.75 | % | L + 9.75%; 1.00% Floor | 07/13/2022 | 23,517 | 23,142 | 21,224 | ||||||||||||||||
| Shopatron, LLC (dba Kibo)(1) (2) |
Internet & Direct Marketing Retail | 9.00 | % | L + 8.00%; 1.00% Floor | 12/18/2020 | 8,879 | 8,845 | 8,813 | ||||||||||||||||
| Shopatron, LLC (dba Kibo)(1) (2) (5) |
Internet & Direct Marketing Retail | 9.00 | % | L + 8.00%; 1.00% Floor | 12/18/2020 | 2,737 | 2,743 | 2,729 | ||||||||||||||||
| SPay, Inc. (dba Stack Sports)(1) (2) |
Interactive Media & Services | 8.75 | % | L + 7.75% (incl. 2.00% PIK); 1.00% Floor | 06/17/2024 | 15,146 | 14,950 | 13,329 | ||||||||||||||||
| SPay, Inc. (dba Stack Sports)(1) (2) |
Interactive Media & Services | 8.84 | % | L + 7.75% (incl. 2.00% PIK); 1.00% Floor | 06/17/2024 | 1,101 | 1,087 | 969 | ||||||||||||||||
| SPay, Inc. (dba Stack Sports)(1) (2) |
Interactive Media & Services | 8.97 | % | L + 7.75% (incl. 2.00% PIK); 1.00% Floor | 06/17/2024 | 550 | 546 | 484 | ||||||||||||||||
| Syntellis Performance Solutions, |
Health Care Technology | 9.00 | % | L + 8.00%; 1.00% Floor | 08/02/2027 | 419 | 407 | 407 | ||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
8
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and Spread (+) |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)(1) (2) |
Health Care Providers & Services | 6.25 | % | L + 5.25%; 1.00% Floor | 08/15/2025 | $ | 15,814 | $ | 15,615 | $ | 15,261 | |||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)(1) (2) (3) |
Health Care Providers & Services | L + 5.25%; 1.00% Floor | 08/15/2025 | 2,707 | (33 | ) | (95 | ) | ||||||||||||||||
| Viant Medical Holdings, Inc.(2) |
Health Care Equipment & Supplies | 7.25 | % | L + 6.25%; 1.00% Floor | 07/02/2025 | 18,973 | 18,693 | 18,025 | ||||||||||||||||
| Villa Bidco Inc (dba Authority |
Diversified Consumer Services | 6.75 | % | L + 5.75%; 1.00% Floor | 03/21/2025 | 16,092 | 15,764 | 15,770 | ||||||||||||||||
| Villa Bidco Inc (dba Authority |
Diversified Consumer Services | 8.00 | % | P + 4.75%; 2.00% Floor | 03/21/2025 | 1,297 | 153 | 153 | ||||||||||||||||
| VRC Companies, LLC (dba Vital Records Control)(1) |
Commercial Services & Supplies | 7.50 | % | L + 6.50%; 1.00% Floor | 03/31/2023 | 9,926 | 9,867 | 9,851 | ||||||||||||||||
| VRC Companies, LLC (dba Vital Records Control)(1) (3) |
Commercial Services & Supplies | L + 6.50%; 1.00% Floor | 03/31/2022 | 249 | (1 | ) | (2 | ) | ||||||||||||||||
| WebPT, Inc.(1) (2) |
Health Care Technology | 7.75 | % | L + 6.75%; 1.00% Floor | 08/28/2024 | 14,933 | 14,690 | 14,336 | ||||||||||||||||
| WebPT, Inc.(1) (2) (3) |
Health Care Technology | 7.75 | % | L + 6.75%; 1.00% Floor | 08/28/2024 | 1,556 | 753 | 716 | ||||||||||||||||
| WebPT, Inc.(1) (2) (3) |
Health Care Technology | L + 6.75%; 1.00% Floor | 08/28/2024 | 1,867 | (15 | ) | (75 | ) | ||||||||||||||||
| Wine.com, LLC(1) (2) |
Beverages | 8.00 | % | L + 7.00%; 1.00% Floor | 11/14/2024 | 9,000 | 8,866 | 8,977 | ||||||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies)(1) (2) (4) |
Real Estate Management & Development | 7.00 | % | L + 6.00%; 1.00% Floor | 06/13/2025 | 47,220 | 46,445 | 46,748 | ||||||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies)(1) (2) (3) (4) |
Real Estate Management & Development | L + 6.00%; 1.00% Floor | 06/13/2025 | 4,722 | (74 | ) | (47 | ) | ||||||||||||||||
| WorkForce Software, LLC(1) (2) |
Software | 7.50 | % | L + 6.50%; 1.00% Floor | 07/31/2025 | 12,796 | 12,582 | 12,477 | ||||||||||||||||
| WorkForce Software, LLC(1) (2) (3) |
Software | L + 6.50%; 1.00% Floor | 07/31/2025 | 1,123 | (18 | ) | (28 | ) | ||||||||||||||||
| Wrike, Inc.(1) (2) |
Professional Services | 7.75 | % | L + 6.75%; 1.00% Floor | 12/31/2024 | 32,260 | 31,744 | 32,260 | ||||||||||||||||
| Wrike, Inc.(1) (2) (3) |
Professional Services | L + 6.75%; 1.00% Floor | 12/31/2024 | 2,300 | (33 | ) | — | |||||||||||||||||
| Xactly Corporation(1) (2) |
IT Services | 8.25 | % | L + 7.25%; 1.00% Floor | 07/29/2022 | 34,852 | 34,533 | 34,242 | ||||||||||||||||
| Xactly Corporation(1) (2) (3) |
IT Services | L + 7.25%; 1.00% Floor | 07/29/2022 | 2,177 | (16 | ) | (38 | ) | ||||||||||||||||
| Yasso, Inc.(1) (2) |
Food Products | 8.75 | % | L + 7.75%; 1.00% Floor | 03/23/2022 | 7,348 | 7,297 | 7,348 | ||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total 1st Lien/Senior Secured Debt |
1,320,702 | 1,290,854 | ||||||||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
9
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and Spread (+) |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| 1st Lien/Last-Out Unitranche (6) - 9.78% |
||||||||||||||||||||||||
| Doxim, Inc.(1) (2) |
Diversified Financial Services | 7.00 | % | L + 6.00%; 1.00% Floor | 02/28/2024 | $ | 27,300 | $ | 26,741 | $ | 26,618 | |||||||||||||
| Doxim, Inc.(1) (2) |
Diversified Financial Services | 7.00 | % | L + 6.00%; 1.00% Floor | 02/28/2024 | 22,376 | 21,930 | 21,816 | ||||||||||||||||
| RugsUSA, LLC(1) (2) |
Household Products | 7.00 | % | L + 6.00%; 1.00% Floor | 04/30/2023 | 8,314 | 8,267 | 8,272 | ||||||||||||||||
| Smarsh, Inc.(1) (2) |
Interactive Media & Services | 8.88 | % | L + 7.88%; 1.00% Floor | 03/31/2021 | 43,750 | 43,607 | 43,313 | ||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total 1st Lien/Last-Out Unitranche |
100,545 | 100,019 | ||||||||||||||||||||||
| 2nd Lien/Senior Secured Debt - 26.17% |
||||||||||||||||||||||||
| American Dental Partners, Inc.(1) (2) |
Health Care Providers & Services | 9.50 | % | L + 8.50%; 1.00% Floor | 09/25/2023 | $ | 5,333 | $ | 5,261 | $ | 4,906 | |||||||||||||
| Chase Industries, Inc. (dba Senneca Holdings)(1) (2) (7) |
Building Products | 11.00% PIK | 05/11/2026 | 12,150 | 11,847 | — | ||||||||||||||||||
| Chase Industries, Inc. (dba Senneca Holdings)(1) (2) |
Building Products | 10.00 | % PIK | 10.00% PIK | 11/11/2025 | 12,150 | 10,750 | 9,933 | ||||||||||||||||
| ERC Finance, LLC (dba Eating Recovery Center)(1) (2) |
Health Care Providers & Services | 9.22 | % | L + 8.22%; 1.00% Floor | 09/22/2025 | 25,400 | 24,994 | 24,511 | ||||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software)(1) (2) |
Diversified Financial Services | 7.80 | % | L + 7.50% | 07/31/2025 | 10,000 | 9,811 | 9,050 | ||||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software)(1) (2) |
Diversified Financial Services | 7.80 | % | L + 7.50% | 07/31/2025 | 2,500 | 2,448 | 2,263 | ||||||||||||||||
| Hygiena Borrower LLC(1) |
Life Sciences Tools & Services | 8.75 | % | L + 7.75%; 1.00% Floor | 08/26/2023 | 2,650 | 2,617 | 2,557 | ||||||||||||||||
| Hygiena Borrower LLC(1) |
Life Sciences Tools & Services | 8.75 | % | L + 7.75%; 1.00% Floor | 08/26/2023 | 139 | 137 | 134 | ||||||||||||||||
| ICP Industrial, Inc.(1) (2) |
Chemicals | 9.25 | % | L + 8.25%; 1.00% Floor | 05/03/2024 | 28,900 | 28,447 | 27,888 | ||||||||||||||||
| Intelligent Medical Objects, Inc.(1) (2) |
Health Care Technology | 9.50 | % | L + 8.50%; 1.00% Floor | 12/22/2024 | 21,900 | 21,514 | 21,298 | ||||||||||||||||
| Market Track, LLC(1) (2) |
Media | 8.75 | % | L + 7.75%; 1.00% Floor | 06/05/2025 | 20,000 | 19,595 | 19,100 | ||||||||||||||||
| National Spine and Pain Centers, |
Health Care Providers & Services | 9.25 | % | L + 8.25%; 1.00% Floor | 12/02/2024 | 17,400 | 17,063 | 16,660 | ||||||||||||||||
| Odyssey Logistics & Technology Corporation(2) |
Road & Rail | 9.00 | % | L + 8.00%; 1.00% Floor | 10/12/2025 | 26,626 | 26,191 | 22,100 | ||||||||||||||||
| SMB Shipping Logistics, LLC (dba Worldwide Express)(1) (2) |
Air Freight & Logistics | 9.00 | % | L + 8.00%; 1.00% Floor | 02/03/2025 | 25,000 | 24,704 | 23,437 | ||||||||||||||||
| Spectrum Plastics Group, Inc.(2) |
Containers & Packaging | 8.00 | % | L + 7.00%; 1.00% Floor | 01/31/2026 | 6,278 | 6,255 | 5,160 | ||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners)(1) (2) |
Insurance | 9.75 | % | L + 8.75%; 1.00% Floor | 09/29/2025 | 9,700 | 9,609 | 9,166 | ||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners)(1) (2) |
Insurance | 9.75 | % | L + 8.75%; 1.00% Floor | 09/29/2025 | 1,584 | 1,570 | 1,497 | ||||||||||||||||
| Xcellence, Inc. (dba Xact Data |
IT Services | 9.75 | % | L + 8.75%; 1.00% Floor | 06/22/2024 | 26,100 | 25,641 | 24,860 | ||||||||||||||||
| YI, LLC (dba Young Innovations)(1) (2) |
Health Care Equipment & Supplies | 8.75 | % | L + 7.75%; 1.00% Floor | 11/07/2025 | 21,608 | 21,140 | 19,448 | ||||||||||||||||
| Zep Inc.(2) |
Chemicals | 9.25 | % | L + 8.25%; 1.00% Floor | 08/11/2025 | 30,500 | 29,963 | 23,828 | ||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total 2nd Lien/Senior Secured Debt |
299,557 | 267,796 | ||||||||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
10
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| Investment * |
Industry |
Interest Rate |
Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||
| Preferred Stock - 1.52% |
||||||||||||||||
| Accuity Delivery Systems, LLC^ (1) (2) (8) (9) |
Health Care Providers & Services | 136,589 | $ | 4,500 | $ | 8,878 | ||||||||||
| Exostar LLC - Class A(2) (9) (8) |
Aerospace & Defense |
10 | 10 | 10 | ||||||||||||
| Foundation Software(2) (9) (8) |
Construction & Engineering |
11 | 11 | 11 | ||||||||||||
| Wine.com, LLC(1) (2) (8) (9) |
Beverages |
314,154 | 2,700 | 6,657 | ||||||||||||
|
|
|
|
|
|||||||||||||
| Total Preferred Stock |
7,221 | 15,556 | ||||||||||||||
| Common Stock - 1.40% |
||||||||||||||||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B^^^ (1) (2) (9) |
Health Care Providers & Services | 11,719 | $ | 1,580 | $ | 1,868 | ||||||||||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) -
Performance |
Health Care Providers & Services | 11,060 | 220 | 374 | ||||||||||||
| Country Fresh Holding Company Inc.(1) (2) (8) (9) |
Food Products |
843 | 1,053 | 52 | ||||||||||||
| Elah Holdings, Inc.^ (1) (2) (8) (9) |
Capital Markets |
65,436 | 3,163 | 3,162 | ||||||||||||
| Exostar LLC - Class B(2) (9) (8) |
Aerospace & Defense |
15,704 | — | — | ||||||||||||
| Foundation Software - Class B(2) (9) (8) |
Construction & Engineering |
5,913 | — | — | ||||||||||||
| National Spine and Pain Centers, LLC(1) (2) (8) (9) |
Health Care Providers & Services | 500 | 500 | 298 | ||||||||||||
| Wrike, Inc.(1) (2) (8) (9) |
Professional Services |
4,949,520 | 3,075 | 8,018 | ||||||||||||
| Yasso, Inc.(1) (2) (8) (9) |
Food Products |
790 | 790 | 545 | ||||||||||||
|
|
|
|
|
|||||||||||||
| Total Common Stock |
10,381 | 14,317 | ||||||||||||||
| Warrants - 0.00% |
||||||||||||||||
| KDOR Holdings Inc. (dba Senneca |
Building Products |
1,000 | $ | 1,036 | $ | — | ||||||||||
| KDOR Holdings Inc. (dba Senneca |
Building Products |
— | 108 | — | ||||||||||||
| KDOR Holdings Inc. (dba Senneca |
Building Products |
— | 22 | — | ||||||||||||
|
|
|
|
|
|||||||||||||
| Total Warrants |
1,166 | — | ||||||||||||||
| Investments in Affiliated Money Market Fund - 15.72% |
||||||||||||||||
| Goldman Sachs Financial Square Government Fund - Institutional Shares^^^ (10) |
160,797,948 | $ | 160,798 | $ | 160,798 | |||||||||||
|
|
|
|
|
|||||||||||||
| Total Investments in Affiliated Money Market Fund |
160,798 | 160,798 | ||||||||||||||
|
|
|
|
|
|||||||||||||
| TOTAL INVESTMENTS - 180.76% |
$ | 1,900,370 | $ | 1,849,340 | ||||||||||||
|
|
|
|
|
|||||||||||||
| LIABILITIES IN EXCESS OF OTHER ASSETS - (80.76%) |
$ | (826,240 | ) | |||||||||||||
|
|
|
|||||||||||||||
| NET ASSETS - 100.00% |
$ | 1,023,100 | ||||||||||||||
|
|
|
|||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
11
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of September 30, 2020
(in thousands, except share and per share amounts)
(Unaudited)
| * | Assets are pledged as collateral for the Truist Revolving Credit Facility. See Note 6 “Debt”. |
| # | Percentages are based on net assets. |
| (+) | Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR (“L”) or alternate base rate (commonly based on the Prime Rate (“P”)), at the borrower’s option, which reset periodically based on the terms of the credit agreement. L loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L rates. As of September 30, 2020, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 0.36%, 0.26%, 0.23%, 0.19%, 0.15% and 0.10%, respectively. As of September 30, 2020, P was 3.25%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at September 30, 2020. |
| (++) | The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars (“$”) unless otherwise noted, Euro (“€”). |
| ^ | As defined in the Investment Company Act of 1940, the portfolio company is deemed to be an “affiliated person” of the Company because the Company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. See Note 3 “Significant Agreements and Related Party Transactions”. |
| ^^^ | The portfolio company is otherwise deemed to be an “affiliated person” of the Company under the Investment Company Act of 1940. See Note 3 “Significant Agreements and Related Party Transactions”. |
| (1) | The fair value of the investment was determined using significant unobservable inputs. See Note 5 “Fair Value Measurement”. |
| (2) | Represent co-investments made with certain funds managed by the Investment Adviser in accordance with the terms of the exemptive relief that the Company received from the U.S. Securities and Exchange Commission. See Note 3 “Significant Agreements and Related Party Transactions”. |
| (3) | Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. See Note 8 “Commitments and Contingencies”. |
| (4) | The investment is not a qualifying asset under Section 55(a) of the Investment Company Act of 1940. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company’s total assets. As of September 30, 2020 the aggregate fair value of these securities is $76,314 or 4.06% of the Company’s total assets. |
| (5) | The investment includes an exit fee that is receivable upon repayment of the loan. See Note 2 “Significant Accounting Policies”. |
| (6) | In exchange for the greater risk of loss, the “last-out” portion of the Company’s unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion that the Company would continue to hold. |
| (7) | The investment is on non-accrual status as of September 30, 2020. |
| (8) | Non-income producing security. |
| (9) | Securities exempt from registration under the Securities Act of 1933 (the “Securities Act”), and may be deemed to be “restricted securities” under the Securities Act. As of September 30, 2020, the aggregate fair value of these securities is $29,873 or 2.92% of the Company’s net assets. The acquisition dates of the restricted securities are as follows: |
| Investment |
Acquisition Date | |||
| Accuity Delivery Systems, LLC - Preferred Stock |
06/13/2018 | |||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B - Common Stock |
03/30/2018 | |||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units - Common Stock |
03/30/2018 | |||
| Country Fresh Holding Company Inc. - Common Stock |
04/29/2019 | |||
| Elah Holdings, Inc. - Common Stock |
05/09/2018 | |||
| Exostar LLC - Class A - Common Stock |
07/06/2020 | |||
| Exostar LLC - Class B - Common Stock |
07/06/2020 | |||
| Foundation Software - Common Stock |
08/31/2020 | |||
| Foundation Software - Class B - Common Stock |
08/31/2020 | |||
| KDOR Holdings Inc. (dba Senneca Holdings) - Warrants |
05/29/2020 | |||
| KDOR Holdings Inc. (dba Senneca Holdings) - Warrants |
05/29/2020 | |||
| KDOR Holdings Inc. (dba Senneca Holdings) - Warrants |
06/22/2020 | |||
| National Spine and Pain Centers, LLC - Common Stock |
06/02/2017 | |||
| Wine.com, LLC - Preferred Stock |
11/14/2018 | |||
| Wrike, Inc. - Common Stock |
12/31/2018 | |||
| Yasso, Inc. - Common Stock |
03/23/2017 | |||
| (10) | The annualized seven-day yield as of September 30, 2020 is 0.00%. |
| PIK | – Payment-In-Kind |
ADDITIONAL INFORMATION
Foreign currency forward contracts
| Counterparty |
Currency Purchased | Currency Sold | Settlement | Unrealized Appreciation (Depreciation) |
||||||||||||
| Bank of America, N.A. |
USD 729 | EUR 650 | 10/05/2020 | $ | (34 | ) | ||||||||||
| Bank of America, N.A. |
USD 716 | EUR 635 | 01/05/2021 | (31 | ) | |||||||||||
| Bank of America, N.A. |
USD 702 | EUR 620 | 04/06/2021 | (28 | ) | |||||||||||
| Bank of America, N.A. |
USD 701 | EUR 617 | 07/06/2021 | (27 | ) | |||||||||||
| Bank of America, N.A. |
USD 400 | EUR 350 | 10/05/2021 | (14 | ) | |||||||||||
|
|
|
|||||||||||||||
| $ | (134 | ) | ||||||||||||||
|
|
|
|||||||||||||||
| Currency Abbreviations: |
| EUR - Euro |
| USD - U.S. Dollar |
The accompanying notes are part of these unaudited consolidated financial statements.
12
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of December 31, 2019
(in thousands, except share and per share amounts)
| Investment* |
Industry |
Interest Rate (+) |
Reference Rate and |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| 1st Lien/Senior Secured Debt - 134.05%# |
|
|||||||||||||||||||||||
| 3SI Security Systems, Inc.(1) |
Commercial Services & Supplies | 7.65 | % | L + 5.75%; 1.00% Floor | 06/16/2023 | $ | 2,249 | $ | 2,227 | $ | 2,227 | |||||||||||||
| Accuity Delivery Systems, LLC^ (1) (2) |
Health Care Providers & Services | 8.75 | % | L + 7.00%; 1.00% Floor | 06/13/2023 | 14,480 | 14,159 | 14,371 | ||||||||||||||||
| Acquia, Inc.(2) |
Software | 8.91 | % | L + 7.00%; 1.00% Floor | 10/31/2025 | 18,197 | 17,841 | 17,833 | ||||||||||||||||
| Acquia, Inc.(2) (3) |
Software | L + 7.00%; 1.00% Floor | 10/31/2025 | 1,946 | (38 | ) | (39 | ) | ||||||||||||||||
| Apptio, Inc.(1) (2) |
IT Services | 8.96 | % | L + 7.25%; 1.00% Floor | 01/10/2025 | 46,452 | 45,634 | 45,639 | ||||||||||||||||
| Apptio, Inc.(1) (2) (3) |
IT Services | L + 7.25%; 1.00% Floor | 01/10/2025 | 3,160 | (53 | ) | (55 | ) | ||||||||||||||||
| Associations, Inc.(1) (2) |
Real Estate Management & Development | 9.09 | % | L + 7.00% (incl. 3.00% PIK); 1.00% Floor | 07/30/2024 | 19,300 | 19,110 | 19,107 | ||||||||||||||||
| Associations, Inc.(1) (2) (3) |
Real Estate Management & Development |
9.09 | % | L + 7.00% (incl. 3.00% PIK); 1.00% Floor | 07/30/2024 | 4,247 | 2,907 | 2,905 | ||||||||||||||||
| Associations, Inc.(1) (2) (3) |
Real Estate Management & Development | L + 4.00%; 1.00% Floor | 07/30/2024 | 836 | (8 | ) | (8 | ) | ||||||||||||||||
| BJH Holdings III Corp. (dba Jack’s Family Restaurants)(1) (2) |
Hotels, Restaurants & Leisure | 7.55 | % | L + 5.75%; 1.00% Floor | 08/19/2025 | 9,097 | 9,010 | 9,006 | ||||||||||||||||
| Brillio, LLC(1) (2) |
IT Services | 6.55 | % | L + 4.75%; 1.00% Floor | 02/06/2025 | 6,567 | 6,509 | 6,501 | ||||||||||||||||
| Brillio, LLC(1) (2) (3) |
IT Services | L + 4.75%; 1.00% Floor | 02/06/2025 | 2,200 | — | (22 | ) | |||||||||||||||||
| Bullhorn, Inc.(1) (2) |
Professional Services | 7.44 | % | L + 5.50%; 1.00% Floor | 10/01/2025 | 16,109 | 15,876 | 15,868 | ||||||||||||||||
| Bullhorn, Inc.(1) (2) (3) |
Professional Services | 7.46 | % | L + 5.50%; 1.00% Floor | 10/01/2025 | 1,331 | 247 | 246 | ||||||||||||||||
| Bullhorn, Inc.(1) (2) (3) |
Professional Services | L + 5.50%; 1.00% Floor | 10/01/2025 | 799 | (11 | ) | (12 | ) | ||||||||||||||||
| Businessolver.com, Inc.(1) (2) |
Health Care Technology | 9.41 | % | L + 7.50%; 1.00% Floor | 05/15/2023 | 30,076 | 29,640 | 29,550 | ||||||||||||||||
| Businessolver.com, Inc.(1) (2) |
Health Care Technology | 9.41 | % | L + 7.50%; 1.00% Floor | 05/15/2023 | 4,511 | 4,441 | 4,432 | ||||||||||||||||
| Businessolver.com, Inc.(1) (2) (3) |
Health Care Technology | 9.98 | % | L + 7.50%; 1.00% Floor | 05/15/2023 | 3,760 | 1,452 | 1,438 | ||||||||||||||||
| CFS Management, LLC (dba Center for Sight Management)(1) (2) |
Health Care Providers & Services | 7.95 | % | L + 5.75%; 1.00% Floor | 07/01/2024 | 6,992 | 6,927 | 6,923 | ||||||||||||||||
| CFS Management, LLC (dba |
Health Care Providers & Services | L + 5.75%; 1.00% Floor | 07/01/2024 | 2,067 | (19 | ) | (21 | ) | ||||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas)(2) |
Professional Services | 7.66 | % | L + 5.75%; 1.00% Floor | 11/14/2025 | 10,300 | 10,098 | 10,094 | ||||||||||||||||
| Chronicle Bidco Inc. (dba |
Professional Services | L + 5.75%; 1.00% Floor | 11/14/2025 | 1,300 | (25 | ) | (26 | ) | ||||||||||||||||
| Chronicle Bidco Inc. (dba |
Professional Services | L + 5.75%; 1.00% Floor | 11/14/2025 | 4,330 | (42 | ) | (43 | ) | ||||||||||||||||
| Clarkson Eyecare, LLC (dba EyeCare Partners)(2) |
Health Care Providers & Services | 8.05 | % | L + 6.25%; 1.00% Floor | 04/02/2021 | 10,953 | 10,776 | 10,733 | ||||||||||||||||
| Clarkson Eyecare, LLC (dba EyeCare Partners)(2) |
Health Care Providers & Services | 8.05 | % | L + 6.25%; 1.00% Floor | 04/02/2021 | 7,241 | 7,123 | 7,097 | ||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates)^^^ (1) (2) |
Health Care Providers & Services | 8.30 | % | L + 6.50%; 1.00% Floor | 03/28/2025 | 12,700 | 12,547 | 12,478 | ||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates)^^^ (1) (2) |
Health Care Providers & Services | 8.30 | % | L + 6.50% | 03/28/2025 | 9,673 | 9,533 | 9,504 | ||||||||||||||||
| ConnectWise, LLC(2) |
IT Services | 7.94 | % | L + 6.00%; 1.00% Floor | 02/28/2025 | 19,957 | 19,564 | 19,707 | ||||||||||||||||
| ConnectWise, LLC(2) (3) |
IT Services | L + 6.00%; 1.00% Floor | 02/28/2025 | 1,524 | (30 | ) | (19 | ) | ||||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene)(1) (2) |
Real Estate Management & Development | 9.54 | % | L + 7.50%; 1.50% Floor | 08/30/2024 | 31,000 | 30,414 | 30,380 | ||||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene)(1) (2) (3) |
Real Estate Management & Development | L + 7.50%; 1.50% Floor | 08/30/2024 | 9,120 | (85 | ) | (182 | ) | ||||||||||||||||
| CorePower Yoga LLC(2) |
Diversified Consumer Services | 6.44 | % | L + 4.50% | 05/14/2025 | 12,389 | 12,219 | 12,203 | ||||||||||||||||
| CorePower Yoga LLC(2) (3) |
Diversified Consumer Services | L + 4.75% | 05/14/2025 | 1,010 | (14 | ) | (15 | ) | ||||||||||||||||
| CorePower Yoga LLC(2) (3) |
Diversified Consumer Services | L + 4.50% | 05/14/2025 | 2,692 | (36 | ) | (40 | ) | ||||||||||||||||
| CST Buyer Company (dba Intoxalock)(2) |
Diversified Consumer Services | 7.55 | % | L + 5.75%; 1.00% Floor | 10/03/2025 | 18,215 | 17,989 | 18,215 | ||||||||||||||||
| CST Buyer Company (dba Intoxalock)(2) (3) |
Diversified Consumer Services | L + 5.75%; 1.00% Floor | 10/03/2025 | 1,294 | (16 | ) | — | |||||||||||||||||
| DDS USA Holding, Inc.(1) (2) |
Health Care Equipment & Supplies | 7.22 | % | L + 5.25%; 1.00% Floor | 06/30/2022 | 5,405 | 5,386 | 5,378 | ||||||||||||||||
| DDS USA Holding, Inc.(1) (2) |
Health Care Equipment & Supplies | 7.22 | % | L + 5.25%; 1.00% Floor | 06/30/2022 | 5,112 | 5,093 | 5,086 | ||||||||||||||||
| DDS USA Holding, Inc.(1) (2) (3) |
Health Care Equipment & Supplies | 9.00 | % | P + 4.25%; 1.00% Floor | 06/30/2022 | 1,533 | 148 | 146 | ||||||||||||||||
| Diligent Corporation(1) (2) |
Professional Services | 7.42 | % | L + 5.50%; 1.00% Floor | 04/14/2022 | € | 22,822 | 26,188 | 25,344 | |||||||||||||||
| Diligent Corporation(1) (2) |
Professional Services | 7.58 | % | L + 5.50%; 1.00% Floor | 04/14/2022 | 5,460 | 5,413 | 5,406 | ||||||||||||||||
| Diligent Corporation(1) (2) |
Professional Services | 7.42 | % | L + 5.50%; 1.00% Floor | 04/14/2022 | 2,103 | 2,084 | 2,082 | ||||||||||||||||
| Diligent Corporation(1) (2) (3) |
Professional Services | 7.48 | % | L + 5.50%; 1.00% Floor | 04/14/2022 | 1,800 | 1,555 | 1,566 | ||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
13
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of December 31, 2019 (continued)
(in thousands, except share and per share amounts)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| Diligent Corporation(1) (2) |
Professional Services | 7.56 | % | L + 5.50%; 1.00% Floor | 04/14/2022 | $ | 727 | $ | 719 | $ | 719 | |||||||||||||
| Diligent Corporation(1) (2) |
Professional Services | 7.42 | % | L + 5.50%; 1.00% Floor | 04/14/2022 | 352 | 348 | 348 | ||||||||||||||||
| Diligent Corporation(1) (2) (3) |
Professional Services | L + 5.50%; 1.00% Floor | 04/14/2022 | 6,083 | (53 | ) | (61 | ) | ||||||||||||||||
| DiscoverOrg, LLC(2) |
Software | 6.30 | % | L + 4.50% | 02/02/2026 | 23,522 | 23,311 | 23,581 | ||||||||||||||||
| DocuTAP, Inc.(1) (2) |
Health Care Technology | 7.30 | % | L + 5.50%; 1.00% Floor | 05/12/2025 | 35,066 | 34,265 | 35,066 | ||||||||||||||||
| E2open, LLC(1) (2) |
Software | 7.66 | % | L + 5.75%; 1.00% Floor | 11/26/2024 | 24,239 | 24,015 | 23,997 | ||||||||||||||||
| Elemica Parent, Inc.(1) (2) |
Chemicals | 7.40 | % | L + 5.50% | 09/18/2025 | 4,257 | 4,155 | 4,151 | ||||||||||||||||
| Elemica Parent, Inc.(1) (2) (3) |
Chemicals | 7.40 | % | L + 5.50% | 09/18/2025 | 550 | 171 | 170 | ||||||||||||||||
| Elemica Parent, Inc.(1) (2) (3) |
Chemicals | L + 5.50% | 09/18/2025 | 830 | (10 | ) | (21 | ) | ||||||||||||||||
| Empirix, Inc.(1) (2) |
Diversified Telecommunication Services | 8.20 | % | L + 6.25%; 1.00% Floor | 09/25/2024 | 31,492 | 31,036 | 28,343 | ||||||||||||||||
| Empirix, Inc.(1) (2) (3) |
Diversified Telecommunication Services | L + 6.25%; 1.00% Floor | 09/25/2023 | 1,800 | (24 | ) | (180 | ) | ||||||||||||||||
| Eptam Plastics, Ltd.(2) |
Health Care Equipment & Supplies | 7.30 | % | L + 5.50%; 1.00% Floor | 12/06/2025 | 6,363 | 6,268 | 6,267 | ||||||||||||||||
| Eptam Plastics, Ltd.(2) (3) |
Health Care Equipment & Supplies | 7.30 | % | L + 5.50%; 1.00% Floor | 12/06/2025 | 1,354 | 318 | 318 | ||||||||||||||||
| Eptam Plastics, Ltd.(2) (3) |
Health Care Equipment & Supplies | L + 5.50%; 1.00% Floor | 12/06/2025 | 2,708 | (20 | ) | (20 | ) | ||||||||||||||||
| Fenergo Finance 3 Limited(1) (2) (4) |
Diversified Financial Services | 8.31 | % | L + 6.25%; 1.00% Floor | 09/05/2024 | € | 25,300 | 28,983 | 28,166 | |||||||||||||||
| Fenergo Finance 3 Limited(1) (2) (3) (4) |
Diversified Financial Services | L + 6.25%; 1.00% Floor | 09/05/2024 | 1,683 | (23 | ) | (13 | ) | ||||||||||||||||
| Fenergo Finance 3 Limited(1) (2) (3) (4) |
Diversified Financial Services | L + 6.25%; 1.00% Floor | 09/05/2024 | € | 2,200 | (35 | ) | (19 | ) | |||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) (1) |
Hotels, Restaurants & Leisure | 7.29 | % | L + 5.50%; 1.00% Floor | 08/21/2023 | 4,043 | 4,009 | 4,002 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) (1) |
Hotels, Restaurants & Leisure | 7.29 | % | L + 5.50%; 1.00% Floor | 08/21/2023 | 3,024 | 2,999 | 2,994 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) (1) (3) |
Hotels, Restaurants & Leisure | L + 5.50%; 1.00% Floor | 08/21/2023 | 3,040 | (25 | ) | (30 | ) | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 7.29 | % | L + 5.50%; 1.00% Floor | 08/21/2023 | 11,408 | 11,219 | 11,294 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 7.29 | % | L + 5.50%; 1.00% Floor | 08/21/2023 | 2,279 | 2,243 | 2,256 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) |
Hotels, Restaurants & Leisure | 7.29 | % | L + 5.50%; 1.00% Floor | 08/21/2023 | 1,441 | 1,418 | 1,427 | ||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants)(1) (3) |
Hotels, Restaurants & Leisure | 7.29 | % | L + 5.50%; 1.00% Floor | 08/21/2023 | 1,506 | 1,256 | 1,265 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) |
Health Care Providers & Services | 7.45 | % | L + 5.50%; 1.00% Floor | 09/04/2024 | 17,963 | 17,668 | 17,693 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) |
Health Care Providers & Services | 7.43 | % | L + 5.50%; 1.00% Floor | 09/04/2024 | 7,171 | 7,050 | 7,063 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) (3) |
Health Care Providers & Services | 7.40 | % | L + 5.50%; 1.00% Floor | 09/04/2024 | 6,933 | 5,769 | 5,757 | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) (3) |
Health Care Providers & Services | L + 5.50%; 1.00% Floor | 09/04/2023 | 2,900 | (43 | ) | (44 | ) | ||||||||||||||||
| Gastro Health Holdco, LLC(1) (2) (3) |
Health Care Providers & Services | L + 5.50%; 1.00% Floor | 09/04/2024 | 7,200 | (59 | ) | (108 | ) | ||||||||||||||||
| GlobalTranz Enterprises, Inc.(2) |
Road & Rail | 6.79 | % | L + 5.00% | 05/15/2026 | 11,444 | 11,230 | 10,414 | ||||||||||||||||
| GlobalTranz Enterprises, Inc.(2) (3) |
Road & Rail | L + 5.00% | 05/15/2026 | 2,968 | — | (267 | ) | |||||||||||||||||
| Granicus, Inc.(2) |
Software | 6.69 | % | L + 4.75%; 1.00% Floor | 09/07/2022 | 14,565 | 14,446 | 14,419 | ||||||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)(1) (2) |
Hotels, Restaurants & Leisure | 8.71 | % | L + 6.75%; 1.00% Floor | 07/09/2025 | 34,501 | 33,854 | 33,811 | ||||||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)(1) (2) (3) |
Hotels, Restaurants & Leisure | 8.54 | % | L + 6.75%; 1.00% Floor | 07/09/2025 | 2,805 | 369 | 365 | ||||||||||||||||
| Hygiena Borrower LLC |
Life Sciences Tools & Services | 5.94 | % | L + 4.00%; 1.00% Floor | 08/26/2022 | 5,314 | 5,261 | 5,208 | ||||||||||||||||
| Hygiena Borrower LLC(3) |
Life Sciences Tools & Services | L + 4.00%; 1.00% Floor | 08/26/2022 | 550 | (5 | ) | (11 | ) | ||||||||||||||||
| Hygiena Borrower LLC(3) |
Life Sciences Tools & Services | L + 4.00%; 1.00% Floor | 08/26/2022 | 814 | (4 | ) | (16 | ) | ||||||||||||||||
| iCIMS, Inc.(1) (2) |
Software | 8.29 | % | L + 6.50%; 1.00% Floor | 09/12/2024 | 42,594 | 41,893 | 41,849 | ||||||||||||||||
| iCIMS, Inc.(1) (2) |
Software | 8.29 | % | L + 6.50%; 1.00% Floor | 09/12/2024 | 7,844 | 7,701 | 7,707 | ||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
14
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of December 31, 2019 (continued)
(in thousands, except share and per share amounts)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| iCIMS, Inc.(1) (2) (3) |
Software | L + 6.50%; 1.00% Floor | 09/12/2024 | $ | 2,662 | $ | (42 | ) | $ | (47 | ) | |||||||||||||
| Integral Ad Science, Inc.(1) (2) |
Interactive Media & Services | 9.05 | % | L + 7.25% (incl. 1.25% PIK); 1.00% Floor | 07/19/2024 | 36,554 | 35,970 | 36,005 | ||||||||||||||||
| Integral Ad Science, Inc.(1) (2) (3) |
Interactive Media & Services | L + 6.00%; 1.00% Floor | 07/19/2023 | 2,586 | (37 | ) | (39 | ) | ||||||||||||||||
| Internet Truckstop Group, LLC (dba Truckstop)(1) (2) |
Transportation Infrastructure | 6.95 | % | L + 5.00%; 1.00% Floor | 04/02/2025 | 32,377 | 31,651 | 31,892 | ||||||||||||||||
| Internet Truckstop Group, LLC (dba |
Transportation Infrastructure | L + 5.00%; 1.00% Floor | 04/02/2025 | 2,600 | (57 | ) | (39 | ) | ||||||||||||||||
| Lithium Technologies, Inc.(1) (2) |
Interactive Media & Services | 10.04 | % | L + 8.00%; 1.00% Floor | 10/03/2022 | 50,047 | 49,285 | 49,296 | ||||||||||||||||
| Lithium Technologies, Inc.(1) (2) (3) |
Interactive Media & Services | L + 8.00%; 1.00% Floor | 10/03/2022 | 3,448 | (48 | ) | (52 | ) | ||||||||||||||||
| Mailgun Technologies, Inc.(1) (2) |
Interactive Media & Services | 6.95 | % | L + 5.00%; 1.00% Floor | 03/26/2025 | 23,170 | 22,749 | 22,765 | ||||||||||||||||
| Mailgun Technologies, Inc.(1) (2) (3) |
Interactive Media & Services | L + 5.00%; 1.00% Floor | 03/26/2025 | 1,448 | — | (25 | ) | |||||||||||||||||
| Midwest Transport, Inc.(1) (2) |
Road & Rail | 9.06 | % | L + 7.00%; 1.00% Floor | 10/02/2023 | 16,969 | 16,835 | 16,799 | ||||||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & Technology)(1) (2) |
Health Care Technology | 7.43 | % | L + 5.50%; 1.00% Floor | 11/15/2024 | 29,732 | 29,211 | 29,212 | ||||||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & Technology)(1) (2) (3) |
Health Care Technology | 7.44 | % | L + 5.50%; 1.00% Floor | 11/15/2024 | 4,525 | 1,193 | 1,188 | ||||||||||||||||
| Netvoyage Corporation (dba |
Software | 9.55 | % | L + 7.75%; 1.00% Floor | 03/22/2024 | 5,985 | 5,869 | 5,910 | ||||||||||||||||
| Netvoyage Corporation (dba |
Software | 9.55 | % | L + 7.75%; 1.00% Floor | 03/22/2024 | 7,937 | 7,831 | 7,838 | ||||||||||||||||
| Netvoyage Corporation (dba |
Software | L + 7.75%; 1.00% Floor | 03/24/2022 | 610 | (5 | ) | (8 | ) | ||||||||||||||||
| Pathway Vet Alliance LLC(1) (2) |
Health Care Providers & Services | 6.30 | % | L + 4.50% | 12/20/2024 | 6,956 | 6,896 | 6,886 | ||||||||||||||||
| Pathway Vet Alliance LLC(1) (2) |
Health Care Providers & Services | 6.30 | % | L + 4.50% | 12/20/2024 | 2,459 | 2,436 | 2,434 | ||||||||||||||||
| Picture Head Midco LLC(1) (2) |
Entertainment | 8.55 | % | L + 6.75%; 1.00% Floor | 08/31/2023 | 27,467 | 27,014 | 27,055 | ||||||||||||||||
| PlanSource Holdings, Inc.(1) (2) |
Health Care Technology | 8.15 | % | L + 6.25%; 1.00% Floor | 04/22/2025 | 33,940 | 33,324 | 33,261 | ||||||||||||||||
| PlanSource Holdings, Inc.(1) (2) (3) |
Health Care Technology | L + 6.25%; 1.00% Floor | 04/22/2025 | 4,681 | (83 | ) | (94 | ) | ||||||||||||||||
| Power Stop, LLC(2) |
Auto Components | 6.44 | % | L + 4.50% | 10/19/2025 | 10,791 | 10,768 | 10,683 | ||||||||||||||||
| Premier Imaging, LLC (dba Lucid Health)(2) |
Health Care Providers & Services | 7.49 | % | L + 5.75%; 1.00% Floor | 01/02/2025 | 17,257 | 17,001 | 16,998 | ||||||||||||||||
| PT Intermediate Holdings III, LLC (dba Parts Town)(2) |
Trading Companies & Distributors | 7.44 | % | L + 5.50%; 1.00% Floor | 10/15/2025 | 17,320 | 17,235 | 17,233 | ||||||||||||||||
| Riverpoint Medical, LLC(1) (2) |
Health Care Equipment & Supplies | 6.97 | % | L + 5.00%; 1.00% Floor | 06/21/2025 | 13,406 | 13,343 | 13,272 | ||||||||||||||||
| Riverpoint Medical, LLC(1) (2) (3) |
Health Care Equipment & Supplies | L + 5.00%; 1.00% Floor | 06/21/2025 | 2,450 | (11 | ) | (25 | ) | ||||||||||||||||
| Selectquote, Inc.(2) |
Insurance | 7.70 | % | L + 6.00%; 1.00% Floor | 11/05/2024 | 15,800 | 15,492 | 15,484 | ||||||||||||||||
| SF Home Décor, LLC (dba SureFit Home |
Household Products | 11.70 | % | L + 9.75%; 1.00% Floor | 07/13/2022 | 23,963 | 23,436 | 23,064 | ||||||||||||||||
| Shopatron, LLC (dba Kibo)(1) (2) |
Internet & Direct Marketing Retail | 9.95 | % | L + 8.00%; 1.00% Floor | 12/18/2020 | 8,947 | 8,795 | 8,812 | ||||||||||||||||
| Shopatron, LLC (dba Kibo)(1) (2) (8) |
Internet & Direct Marketing Retail | 9.95 | % | L + 8.00%; 1.00% Floor | 12/18/2020 | 2,757 | 2,729 | 2,716 | ||||||||||||||||
| SPay, Inc. (dba Stack Sports)(1) (2) |
Interactive Media & Services | 7.55 | % | L + 5.75%; 1.00% Floor | 06/17/2024 | 14,745 | 14,515 | 14,266 | ||||||||||||||||
| SPay, Inc. (dba Stack Sports)(1) (2) (3) |
Interactive Media & Services | 7.52 | % | L + 5.75%; 1.00% Floor | 06/17/2024 | 1,630 | 1,062 | 1,034 | ||||||||||||||||
| SPay, Inc. (dba Stack Sports)(1) (2) |
Interactive Media & Services | 7.76 | % | L + 5.75%; 1.00% Floor | 06/17/2024 | 543 | 539 | 526 | ||||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)(1) (2) |
Health Care Providers & Services | 7.31 | % | L + 5.25%; 1.00% Floor | 08/15/2025 | 19,578 | 19,300 | 19,236 | ||||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)(1) (2) (3) |
Health Care Providers & Services | 7.31 | % | L + 5.25%; 1.00% Floor | 08/15/2025 | 2,707 | 97 | 88 | ||||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)(1) (2) (3) |
Health Care Providers & Services | L + 5.25%; 1.00% Floor | 08/15/2025 | 6,768 | (54 | ) | (118 | ) | ||||||||||||||||
| Viant Medical Holdings, Inc.(2) |
Health Care Equipment & Supplies | 8.16 | % | L + 6.25%; 1.00% Floor | 07/02/2025 | 19,117 | 18,798 | 18,926 | ||||||||||||||||
| VRC Companies, LLC (dba Vital Records Control)(1) |
Commercial Services & Supplies | 8.30 | % | L + 6.50%; 1.00% Floor | 03/31/2023 | 10,000 | 9,925 | 9,925 | ||||||||||||||||
| VRC Companies, LLC (dba Vital Records Control)(1) (3) |
Commercial Services & Supplies | 8.60 | % | L + 6.50%; 1.00% Floor | 03/31/2022 | 249 | 136 | 136 | ||||||||||||||||
| WebPT, Inc.(1) (2) |
Health Care Technology | 8.66 | % | L + 6.75%; 1.00% Floor | 08/28/2024 | 14,933 | 14,651 | 14,635 | ||||||||||||||||
| WebPT, Inc.(1) (2) (3) |
Health Care Technology | L + 6.75%; 1.00% Floor | 08/28/2024 | 1,556 | (29 | ) | (31 | ) | ||||||||||||||||
| WebPT, Inc.(1) (2) (3) |
Health Care Technology | L + 6.75%; 1.00% Floor | 08/28/2024 | 1,867 | (17 | ) | (37 | ) | ||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
15
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of December 31, 2019 (continued)
(in thousands, except share and per share amounts)
| Investment * |
Industry |
Interest Rate (+) |
Reference Rate and |
Maturity | Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||
| Wine.com, LLC(1) (2) |
Beverages | 8.93 | % | L + 7.00%; 1.00% Floor | 11/14/2024 | $ | 9,000 | $ | 8,847 | $ | 8,820 | |||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies)(1) (2) (4) |
Real Estate Management & Development | 8.29 | % | L + 6.50%; 1.00% Floor | 06/13/2025 | 47,220 | 46,344 | 46,275 | ||||||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies)(1) (2) (3) (4) |
Real Estate Management & Development | L + 6.50%; 1.00% Floor | 06/13/2025 | 4,722 | (86 | ) | (94 | ) | ||||||||||||||||
| WorkForce Software, LLC(1) (2) |
Software | 8.41 | % | L + 6.50%; 1.00% Floor | 07/31/2025 | 12,732 | 12,491 | 12,477 | ||||||||||||||||
| WorkForce Software, LLC(1) (2) (3) |
Software | L + 6.50%; 1.00% Floor | 07/31/2025 | 1,123 | (21 | ) | (23 | ) | ||||||||||||||||
| Wrike, Inc.(1) (2) |
Professional Services | 8.55 | % | L + 6.75%; 1.00% Floor | 12/31/2024 | 32,260 | 31,670 | 31,615 | ||||||||||||||||
| Wrike, Inc.(1) (2) (3) |
Professional Services | L + 6.75%; 1.00% Floor | 12/31/2024 | 2,300 | (38 | ) | (46 | ) | ||||||||||||||||
| Xactly Corporation(1) (2) |
IT Services | 9.05 | % | L + 7.25%; 1.00% Floor | 07/29/2022 | 34,852 | 34,415 | 34,416 | ||||||||||||||||
|
Xactly |
IT Services | L + 7.25%; 1.00% Floor | 07/29/2022 | 2,177 | (23 | ) | (27 | ) | ||||||||||||||||
| Yasso, Inc.(1) (2) |
Food Products | 9.55 | % | L + 7.75%; 1.00% Floor | 03/23/2022 | 7,411 | 7,336 | 7,170 | ||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total 1st Lien/Senior Secured Debt |
|
1,272,044 | 1,266,486 | |||||||||||||||||||||
| 1st Lien/Last-Out Unitranche (5) – 10.67% |
| |||||||||||||||||||||||
| Doxim, Inc.(1) (2) |
Diversified Financial Services | 7.94 | % | L + 6.00%; 1.00% Floor | 02/28/2024 | 27,300 | 26,636 | 26,618 | ||||||||||||||||
| Doxim, Inc.(1) (2) |
Diversified Financial Services | 7.90 | % | L + 6.00%; 1.00% Floor | 02/28/2024 | 22,376 | 21,846 | 21,816 | ||||||||||||||||
| RugsUSA, LLC(1) (2) |
Household Products | 8.45 | % | L + 6.50%; 1.00% Floor | 04/30/2023 | 8,330 | 8,271 | 8,268 | ||||||||||||||||
| Smarsh, Inc.(1) (2) |
Interactive Media & Services | 9.68 | % | L + 7.88%; 1.00% Floor | 03/31/2021 | 44,429 | 44,076 | 44,095 | ||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total 1st Lien/Last-Out Unitranche |
|
100,829 | 100,797 | |||||||||||||||||||||
| 2nd Lien/Senior Secured Debt - 31.14% |
| |||||||||||||||||||||||
| American Dental Partners, Inc.(1) (2) |
Health Care Providers & Services | 10.44 | % | L + 8.50%; 1.00% Floor | 09/25/2023 | 5,333 | 5,246 | 5,239 | ||||||||||||||||
| Chase Industries, Inc. (dba Senneca Holdings)(1) (2) |
Building Products | 11.55 | % | L + 9.50% (incl. 1.50% PIK); 1.00% Floor | 05/11/2026 | 24,300 | 23,676 | 22,781 | ||||||||||||||||
| DiscoverOrg, LLC(2) |
Software | 10.19 | % | L + 8.50% | 02/01/2027 | 14,600 | 14,397 | 14,600 | ||||||||||||||||
| ERC Finance, LLC (dba Eating Recovery Center)(1) (2) |
Health Care Providers & Services | 10.02 | % | L + 8.22%; 1.00% Floor | 09/22/2025 | 25,400 | 24,948 | 24,955 | ||||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software)(1) (2) |
Diversified Financial Services | 9.60 | % | L + 7.50% | 07/31/2025 | 10,000 | 9,788 | 9,750 | ||||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software)(1) (2) (3) |
Diversified Financial Services | L + 7.50% | 07/31/2025 | 2,500 | (25 | ) | (63 | ) | ||||||||||||||||
| Hygiena Borrower LLC(1) |
Life Sciences Tools & Services | 9.69 | % | L + 7.75%; 1.00% Floor | 08/26/2023 | 2,650 | 2,610 | 2,604 | ||||||||||||||||
| Hygiena Borrower |
Life Sciences Tools & Services | 9.69 | % | L + 7.75%; 1.00% Floor | 08/26/2023 | 970 | 131 | 122 | ||||||||||||||||
| ICP Industrial, Inc.(1) (2) |
Chemicals | 10.04 | % | L + 8.25%; 1.00% Floor | 05/03/2024 | 28,900 | 28,369 | 28,322 | ||||||||||||||||
| Intelligent Medical Objects, Inc.(1) (2) |
Health Care Technology | 10.81 | % | L + 8.50%; 1.00% Floor | 12/22/2024 | 21,900 | 21,461 | 21,462 | ||||||||||||||||
| Market Track, LLC(1) (2) |
Media | 9.68 | % | L + 7.75%; 1.00% Floor | 06/05/2025 | 20,000 | 19,545 | 19,250 | ||||||||||||||||
| National Spine and Pain Centers, |
Health Care Providers & Services | 10.05 | % | L + 8.25%; 1.00% Floor | 12/02/2024 | 17,400 | 17,015 | 16,748 | ||||||||||||||||
| Odyssey Logistics & Technology Corporation(2) |
Road & Rail | 9.80 | % | L + 8.00%; 1.00% Floor | 10/12/2025 | 26,626 | 26,141 | 25,694 | ||||||||||||||||
| SMB Shipping Logistics, LLC (dba Worldwide Express)(1) (2) |
Air Freight & Logistics | 9.90 | % | L + 8.00%; 1.00% Floor | 02/03/2025 | 25,000 | 24,664 | 24,563 | ||||||||||||||||
| Spectrum Plastics Group, Inc.(2) |
Containers & Packaging | 8.80 | % | L + 7.00%; 1.00% Floor | 01/31/2026 | 6,278 | 6,252 | 4,949 | ||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners)(1) (2) |
Insurance | 10.68 | % | L + 8.75%; 1.00% Floor | 09/29/2025 | 9,700 | 9,599 | 9,603 | ||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners)(1) (2) (3) |
Insurance | 10.72 | % | L + 8.75%; 1.00% Floor | 09/29/2025 | 2,400 | 1,560 | 1,560 | ||||||||||||||||
| Xcellence, Inc. (dba Xact Data Discovery)(1) (2) |
IT Services | 10.70 | % | L + 8.75%; 1.00% Floor | 06/22/2024 | 26,100 | 25,568 | 25,708 | ||||||||||||||||
| YI, LLC (dba Young |
Health Care Equipment & Supplies | 9.69 | % | L + 7.75%; 1.00% Floor | 11/07/2025 | 21,608 | 21,088 | 21,068 | ||||||||||||||||
| Zep Inc.(2) |
Chemicals | 10.19 | % | L + 8.25%; 1.00% Floor | 08/11/2025 | 30,500 | 29,900 | 15,250 | ||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total 2nd Lien/Senior Secured Debt |
|
311,933 | 294,165 | |||||||||||||||||||||
The accompanying notes are part of these unaudited consolidated financial statements.
16
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of December 31, 2019 (continued)
(in thousands, except share and per share amounts)
| Investment * |
Industry |
Interest Rate |
Par Amount/ Shares (++) |
Cost | Fair Value |
|||||||||||||||||||
| Preferred Stock* – 1.07% |
||||||||||||||||||||||||
| Accuity Delivery Systems, LLC^ (1) (2) (6) (7) |
Health Care Providers & Services | $ | 136,589 | $ | 4,500 | $ | 7,200 | |||||||||||||||||
| Wine.com, LLC(1) (2) (6) (7) |
Beverages | 314,154 | 2,700 | 2,937 | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total Preferred Stock |
7,200 | 10,137 | ||||||||||||||||||||||
| Common Stock* – 1.22% |
||||||||||||||||||||||||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) – Class B^^^ (1) (2) (7) |
Health Care Providers & Services | 11,719 | 1,580 | 2,239 | ||||||||||||||||||||
| Collaborative Imaging Holdco, LLC (dba Texas |
Health Care Providers & Services | 11,060 | 220 | 643 | ||||||||||||||||||||
| Country Fresh Holding Company Inc.(1) (2) (6) (7) |
Food Products | 843 | 1,053 | 731 | ||||||||||||||||||||
| Elah Holdings, Inc.^ (1) (2) (6) (7) |
Capital Markets | 65,436 | 3,163 | 3,163 | ||||||||||||||||||||
| National Spine and Pain Centers, LLC(1) (2) (6) (7) |
Health Care Providers & Services | 500 | 500 | 100 | ||||||||||||||||||||
| Wrike, Inc.(1) (2) (6) (7) |
Professional Services | 4,949,520 | 3,075 | 4,266 | ||||||||||||||||||||
| Yasso, Inc.(1) (2) (6) (7) |
Food Products | 790 | 790 | 433 | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total Common Stock |
10,381 | 11,575 | ||||||||||||||||||||||
| TOTAL INVESTMENTS – 178.15% |
|
$ | 1,702,387 | $ | 1,683,160 | |||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| LIABILITIES IN EXCESS OF OTHER ASSETS – (78.15%) |
|
$ | (738,371 | ) | ||||||||||||||||||||
|
|
|
|||||||||||||||||||||||
| NET ASSETS – 100.00% |
|
$ | 944,789 | |||||||||||||||||||||
|
|
|
|||||||||||||||||||||||
| * | Assets are pledged as collateral for the Truist Revolving Credit Facility. See Note 6 “Debt”. |
| # | Percentages are based on net assets. |
| (+) | Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by reference to either LIBOR (“L”) or alternate base rate (commonly based on the Prime Rate (“P”)), at the borrower’s option, which reset periodically based on the terms of the credit agreement. L loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L rates. As of December 31, 2019, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 2.00%, 1.91%, 1.91%, 1.83%, 1.76% and 1.63%. As of December 31, 2019, P was 4.75%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at December 31, 2019. |
| (++) | The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars (“$”) unless otherwise noted, Euro (“€”). |
| ^ | As defined in the Investment Company Act of 1940, the portfolio company is deemed to be an “affiliated person” of the Company because the Company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. See Note 3 “Significant Agreements and Related Party Transactions”. |
| ^^^ | The portfolio company is otherwise deemed to be an “affiliated person” of the Company under the Investment Company Act of 1940. See Note 3 “Significant Agreements and Related Party Transactions”. |
| (1) | The fair value of the investment was determined using significant unobservable inputs. See Note 5 “Fair Value Measurement”. |
| (2) | Represent co-investments made with certain funds managed by the Investment Adviser in accordance with the terms of the exemptive relief that the Company received from the U.S. Securities and Exchange Commission. See Note 3 “Significant Agreements and Related Party Transactions”. |
| (3) | Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. See Note 8 “Commitments and Contingencies”. |
| (4) | The investment is not a qualifying asset under Section 55(a) of the Investment Company Act of 1940. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company’s total assets. As of December 31, 2019 the aggregate fair value of these securities is $74,958 or 4.39% of the Company’s total assets. |
| (5) | In exchange for the greater risk of loss, the “last-out” portion of the Company’s unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion that the Company would continue to hold. |
| (6) | Non-income producing security. |
The accompanying notes are part of these unaudited consolidated financial statements.
17
Goldman Sachs Middle Market Lending Corp.
Consolidated Schedule of Investments as of December 31, 2019 (continued)
(in thousands, except share and per share amounts)
| (7) | Securities exempt from registration under the Securities Act of 1933 (the “Securities Act”), and may be deemed to be “restricted securities” under the Securities Act. As of December 31, 2019, the aggregate fair value of these securities is $21,712 or 2.30% of the Company’s net assets. The acquisition dates of the restricted securities are as follows: |
| Investment |
Acquisition Date | |||
| Accuity Delivery Systems, LLC – Preferred Stock |
06/13/2018 | |||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) – Class B – Common Stock |
03/30/2018 | |||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) – Performance Units – Common Stock |
03/30/2018 | |||
| Country Fresh Holding Company Inc. – Common Stock |
04/29/2019 | |||
| Elah Holdings, Inc. – Common Stock |
05/09/2018 | |||
| National Spine and Pain Centers, LLC – Common Stock |
06/02/2017 | |||
| Wine.com, LLC – Preferred Stock |
11/14/2018 | |||
| Wrike, Inc. – Common Stock |
12/31/2018 | |||
| Yasso, Inc. – Common Stock |
03/23/2017 | |||
| (8) | The investment includes an exit fee that is receivable upon repayment of the loan. See Note 2 “Significant Accounting Policies”. |
PIK – Payment-In-Kind
ADDITIONAL INFORMATION
Foreign currency forward contracts
| Counterparty |
Currency Purchased |
Currency Sold |
Settlement | Unrealized Appreciation (Depreciation) |
||||||||||||
| Bank of America, N.A. |
USD 221 | EUR 200 | 01/06/2020 | $ | (3 | ) | ||||||||||
| Bank of America, N.A. |
USD 540 | EUR 446 | 01/06/2020 | 39 | ||||||||||||
| Bank of America, N.A. |
USD 337 | EUR 303 | 04/06/2020 | (6 | ) | |||||||||||
| Bank of America, N.A. |
USD 547 | EUR 448 | 04/06/2020 | 41 | ||||||||||||
| Bank of America, N.A. |
USD 321 | EUR 288 | 07/06/2020 | (6 | ) | |||||||||||
| Bank of America, N.A. |
USD 549 | EUR 446 | 07/06/2020 | 43 | ||||||||||||
| Bank of America, N.A. |
USD 729 | EUR 650 | 10/05/2020 | (13 | ) | |||||||||||
| Bank of America, N.A. |
USD 716 | EUR 635 | 01/05/2021 | (13 | ) | |||||||||||
| Bank of America, N.A. |
USD 702 | EUR 620 | 04/06/2021 | (14 | ) | |||||||||||
| Bank of America, N.A. |
USD 701 | EUR 617 | 07/06/2021 | (14 | ) | |||||||||||
| Bank of America, N.A. |
USD 400 | EUR 350 | 10/05/2021 | (8 | ) | |||||||||||
|
|
|
|||||||||||||||
| $ | 46 | |||||||||||||||
|
|
|
|||||||||||||||
Currency Abbreviations:
EUR – Euro
USD – U.S. Dollar
The accompanying notes are part of these unaudited consolidated financial statements.
18
| 1. | ORGANIZATION |
Goldman Sachs Middle Market Lending LLC (“MMLC LLC”) was formed on June 13, 2016. Effective January 30, 2017, MMLC LLC converted from a Delaware limited liability company to a Delaware corporation named Goldman Sachs Middle Market Lending Corp. (the “Company”), which, by operation of law, is deemed for purposes of Delaware law the same entity as MMLC LLC. The Company commenced operations on January 11, 2017. On January 30, 2017, the Company’s initial investors (other than the Initial Member (as defined below)) funded the initial portion of their capital commitment to purchase shares of common stock, at which time the Initial Member’s initial capital contribution to MMLC LLC was canceled. The Company has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”). In addition, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2017.
The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation. The Company will seek to achieve this objective, primarily through direct originations of secured debt, including first lien debt, unitranche loans, including last out portions of such loans, and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments.
Goldman Sachs Asset Management, L.P. (“GSAM”), a Delaware limited partnership and an affiliate of Goldman Sachs & Co. LLC (including its predecessors, “GS & Co.”), is the investment adviser (the “Investment Adviser”) of the Company. The term “Goldman Sachs” refers to The Goldman Sachs Group, Inc. (“Group Inc.”), together with GS & Co., GSAM and its other subsidiaries.
From December 29, 2016 through September 29, 2017 (the “Final Closing Date”) the Company conducted an offering pursuant to which investors made capital commitments (each, a “Commitment”) to purchase shares of the Company’s common stock pursuant to subscription agreements (“Subscription Agreements”) entered into with the Company pursuant to which each investor agreed to purchase common stock for an aggregate purchase price equal to its Commitment. Each investor is required to purchase shares of the Company’s common stock each time the Company delivers a drawdown notice at least five business days prior to the required funding date (the “Initial Drawdown Date”). The offering and sale of common stock is exempt from registration pursuant to Regulation D and Regulation S promulgated under the U.S. Securities Act of 1933, as amended, for offers and sales of securities that do not involve a public offering and for offers and sale of securities outside of the United States.
GS & Co. and Goldman Sachs International assisted the Company in conducting its private placement offering pursuant to agreements between the Company and each of GS & Co. and Goldman Sachs International.
The investment period commenced on December 29, 2016 (the “Initial Closing Date”). On August 8, 2019, our board of directors (the “Board of Directors”) extended the investment period for one additional six-month period from September 29, 2019 to March 29, 2020 (the “Investment Period”). The Investment Period expired on March 29, 2020. Following the end of the Investment Period, the Company has the right to issue drawdowns only (i) to pay, and/or establish reserves for, actual or anticipated Company expenses, liabilities, including the payment or repayment of indebtedness for borrowed money (including through the issuance of notes and other evidence of indebtedness), other indebtedness, financings or extensions of credit, or other obligations, contingent or otherwise, including the Management Fee (as defined below), whether incurred before or after the end of the investment period, (ii) to fulfill investment commitments made or approved by the investment committee of GSAM’s Private Credit Group (the “Investment Committee”) prior to the expiration of the Investment Period, (iii) to engage in hedging transactions or (iv) to make additional investments in existing portfolio companies (including transactions to hedge interest rate or currency risks related to such additional investment). Subject to the requirements of Subchapter M of the Code and the terms of any indebtedness, proceeds realized by the Company prior to the sixth anniversary of the Final Closing Date from the sale or repayment of any investment (as opposed to investment income) up to the cost of any such investment, may be retained and reinvested by the Company.
The Company will continue to operate as a private BDC reporting company, until the earlier of the following events, each referred to as an “Exit Event”: (i) any listing of the Company’s shares of common stock on a national securities exchange (a “listing”), including in connection with an initial public offering (“IPO”), (ii) merger with another entity, including an affiliated company, subject to any limitations under the Investment Company Act or (iii) the sale of all or substantially all of the assets of the Company. If the Company has not consummated an Exit Event by the sixth anniversary of the Final Closing Date, the Board of Directors (to the extent consistent with its fiduciary duties and subject to any necessary stockholder approvals and applicable requirements of the Investment Company Act and the Code) will meet to consider the Company’s potential wind down and/or liquidation and dissolution.
The Company has formed wholly owned subsidiaries, which are structured as Delaware limited liability companies, to hold certain equity or equity-like investments in portfolio companies.
19
The Merger with Goldman Sachs BDC, Inc.
On October 12, 2020, the Company completed its previously announced merger with Goldman Sachs BDC, Inc. (“GS BDC”) pursuant to the Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 11, 2020. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of the Company’s common stock was converted into the right to receive, for each share of the Company’s common stock, that number of shares of GS BDC’s common stock, par value $0.001 per share (“GS BDC Common Stock”), with a net asset value (“NAV”) equal to the NAV per share of the Company’s common stock, in each case calculated as of October 9, 2020. As a result of the Merger, GS BDC issued an aggregate of 61,037,311 shares of GS BDC Common Stock to the Company’s former stockholders. For further information, see Note 12 “Subsequent Events.”
| 2. | SIGNIFICANT ACCOUNTING POLICIES |
Basis of Presentation
The Company’s functional currency is U.S. dollars (“USD”) and these consolidated financial statements have been prepared in that currency. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to Regulation S-X. This requires the Company to make certain estimates and assumptions that may affect the amounts reported in the consolidated financial statements and accompanying notes. These consolidated financial statements reflect normal and recurring adjustments that in the opinion of the Company are necessary for the fair statement of the results for the periods presented. Actual results may differ from the estimates and assumptions included in the consolidated financial statements.
Certain financial information that is included in annual consolidated financial statements, including certain financial statement disclosures, prepared in accordance with GAAP, is not required for interim reporting purposes and has been condensed or omitted herein. These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes related thereto for the year ended December 31, 2019, included in the Company’s annual report on Form 10-K, which was filed with the SEC on February 27, 2020. The results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year, any other interim period or any future year or period.
Certain prior period information has been reclassified to conform with the current presentation. The reclassification has no effect on the Company’s consolidated financial position or the consolidated results of operations as previously reported.
As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”) issued by the Financial Accounting Standards Board (“FASB”).
Basis of Consolidation
As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the financial position and results of operations of its wholly owned subsidiaries, MMLC Blocker I, LLC (formerly known as My-On MMLC Blocker, LLC), MMLC Blocker II, LLC, MMLC Wine I, LLC, and MMLC Blocker III LLC. All significant intercompany transactions and balances have been eliminated in consolidation.
Revenue Recognition
The Company records its investment transactions on a trade date basis, which is the date when the Company assumes the risks for gains and losses related to that investment. Realized gains and losses are based on the specific identification method.
Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized, into interest income over the life of the respective investment using the effective interest method. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable. Exit fees that are receivable upon repayment of a loan or debt security are amortized into interest income over the life of the respective investment. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income, for which the Company has earned the following:
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2020 |
September 30, 2019 |
September 30, 2020 |
September 30, 2019 |
|||||||||||||
| Prepayment premiums |
$ | 661 | $ | — | $ | 807 | $ | 1,213 | ||||||||
| Accelerated amortization of upfront loan origination fees and unamortized discounts |
$ | 247 | $ | 520 | $ | 1,136 | $ | 1,747 | ||||||||
Fees received from portfolio companies (directors’ fees, consulting fees, administrative fees, tax advisory fees and other similar compensation) are paid to the Company, unless, to the extent required by applicable law or exemptive relief, if any, therefrom, the Company only receives its allocable portion of such fees when invested in the same portfolio company as another account managed by the Investment Adviser.
20
Dividend income on preferred equity investments is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity investments is recorded on the record date for private portfolio companies and on the ex-dividend date for publicly traded portfolio companies. Interest and dividend income are presented net of withholding tax, if any.
Certain investments may have contractual payment-in-kind (“PIK”) interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the principal amount or shares (if equity) of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon the investment being called by the issuer. PIK is recorded as interest or dividend income, as applicable. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends are generally reversed through interest or dividend income.
Certain structuring fees, amendment fees, syndication fees and commitment fees are recorded as other income when earned. Administrative agent fees received by the Company are recorded as other income when the services are rendered over time.
Non-Accrual Investments
Investments are placed on non-accrual status when it is probable that principal, interest or dividends will not be collected according to contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Non-accrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Company may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of September 30, 2020, the Company had certain investments held in one portfolio company on non-accrual status, which represented 0.7% and 0.0% of the total investments (excluding an investment in a money market fund managed by an affiliate of Group Inc.) at amortized cost and at fair value, respectively. As of December 31, 2019, the Company did not have any investments on non-accrual status.
Investments
The Company carries its investments in accordance with ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), issued by the FASB, which defines fair value, establishes a framework for measuring fair value and requires disclosures about fair value measurements. Fair value is generally based on quoted market prices provided by independent pricing services, broker or dealer quotations or alternative price sources. In the absence of quoted market prices, broker or dealer quotations or alternative price sources, investments are measured at fair value as determined by the Board of Directors within the meaning of the Investment Company Act.
Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material. See Note 5 “Fair Value Measurement”.
The Company generally invests in illiquid securities, including debt and equity investments, of middle-market companies. The Board of Directors has delegated to the Investment Adviser day-to-day responsibility for implementing and maintaining internal controls and procedures related to the valuation of the Company’s portfolio investments. Under valuation procedures adopted by the Board of Directors, market quotations are generally used to assess the value of the investments for which market quotations are readily available. The Investment Adviser obtains these market quotations from independent pricing services or at the bid prices obtained from at least two brokers or dealers, if available; otherwise from a principal market maker or a primary market dealer. To assess the continuing appropriateness of pricing sources and methodologies, the Investment Adviser regularly performs price verification procedures and issues challenges as necessary to independent pricing services or brokers, and any differences are reviewed in accordance with the valuation procedures. If the Board of Directors or Investment Adviser has a bona fide reason to believe any such market quotation does not reflect the fair value of an investment, it may independently value such investment in accordance with valuation procedures for investments for which market quotations are not readily available.
With respect to investments for which market quotations are not readily available, or for which market quotations are deemed not reflective of the fair value, the valuation procedures adopted by the Board of Directors contemplate a multi-step valuation process each quarter, as described below:
| (1) | The quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; |
| (2) | The Board of Directors also engages independent valuation firms (the “Independent Valuation Advisors”) to provide independent valuations of the investments for which market quotations are not readily available, or are readily available but deemed not reflective of the fair value of an investment. The Independent Valuation Advisors independently value such investments using quantitative and qualitative information provided by the investment professionals of the Investment Adviser and the portfolio companies as well as any market quotations obtained from independent pricing services, brokers, dealers or market dealers. The Independent Valuation Advisors also provide analyses to support their valuation methodology and calculations. The Independent Valuation Advisors provide an opinion on a final range of values on such investments to the Board of Directors or the Audit Committee. The Independent Valuation Advisors define fair value in accordance with ASC 820 and utilize valuation approaches including the market approach, the income approach or both. A portion of the portfolio is reviewed on a quarterly basis, and all investments in the portfolio for which market quotations are not readily available, or are readily available, but deemed not reflective of the fair value of an investment, are reviewed at least annually by an Independent Valuation Advisor; |
21
| (3) | The Independent Valuation Advisors’ preliminary valuations are reviewed by the Investment Adviser and the Valuation Oversight Group (“VOG”), a team that is part of the Controllers Department within the Finance Division of Goldman Sachs. The Independent Valuation Advisors’ valuation ranges are compared to the Investment Adviser’s valuations to ensure the Investment Adviser’s valuations are reasonable. VOG presents the valuations to the Private Investment Valuation and Side Pocket Working Group of the Investment Management Division Valuation Committee, which is comprised of representatives from GSAM who are independent of the investment decision making process; |
| (4) | The Investment Management Division Valuation Committee ratifies fair valuations and makes recommendations to the Audit Committee of the Board of Directors; |
| (5) | The Audit Committee of the Board of Directors reviews valuation information provided by the Investment Management Division Valuation Committee, the Investment Adviser and the Independent Valuation Advisors. The Audit Committee then assesses such valuation recommendations; and |
| (6) | The Board of Directors discusses the valuations and, within the meaning of the Investment Company Act, determines the fair value of the investments in good faith, based on the inputs of the Investment Adviser, the Independent Valuation Advisors and the Audit Committee. |
Money Market Funds
Investments in money market funds are valued at net asset value (“NAV”) per share. See Note 3 “Significant Agreements and Related Party Transactions.”
Cash
Cash consists of deposits held at a custodian bank. As of September 30, 2020 and December 31, 2019, the Company held an aggregate cash balance of $16,911 and $13,393. Foreign currency of $1,388 and $1,299(acquisition cost of $1,353 and $1,286) is included in cash as of September 30, 2020 and December 31, 2019.
Foreign Currency Translation
Amounts denominated in foreign currencies are translated into USD on the following basis: (i) investments and other assets and liabilities denominated in foreign currencies are translated into USD based upon currency exchange rates effective on the last business day of the period; and (ii) purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into USD based upon currency exchange rates prevailing on the transaction dates.
The Company does not isolate the portion of the results of operations resulting from changes in foreign exchange rates on investments from fluctuations arising from changes in market prices of securities held. Such fluctuations are included within the net realized and unrealized gains or losses on investments. Fluctuations arising from the translation of non-investment assets and liabilities are included with the net change in unrealized gains (losses) on foreign currency translations on the Consolidated Statements of Operations.
Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.
Derivatives
The Company may enter into foreign currency forward contracts to reduce the Company’s exposure to foreign currency exchange rate fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another, at a pre-determined price at a future date. Forward foreign currency contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts are recorded on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Notional amounts of foreign currency forward contract assets and liabilities are presented separately on the Consolidated Schedules of Investments. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date.
The Company does not utilize hedge accounting and as such, the Company recognizes its derivatives at fair value with changes in the net unrealized appreciation (depreciation) on foreign currency forward contracts recorded on the Consolidated Statements of Operations.
Income Taxes
The Company recognizes tax positions in its consolidated financial statements only when it is more likely than not that the position will be sustained upon examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more likely than not be realized upon settlement. The Company reports any interest expense related to income tax matters in income tax expense, and any income tax penalties under expenses in the Consolidated Statements of Operations.
22
The Company’s tax positions have been reviewed based on applicable statutes of limitation for tax assessments, which may vary by jurisdiction, and based on such review, the Company has concluded that no additional provision for income tax is required in the consolidated financial statements. The Company is subject to potential examination by certain taxing authorities in various jurisdictions. The Company’s tax positions are subject to ongoing interpretation of laws and regulations by taxing authorities.
The Company has elected to be treated as a RIC commencing with its taxable year ended December 31, 2017. So long as the Company maintains its status as a RIC, it will generally not be required to pay corporate-level U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. As a result, any U.S. federal income tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected in the consolidated financial statements of the Company.
To maintain its tax treatment as a RIC, the Company must meet specified source-of-income and asset diversification requirements and timely distribute to its stockholders for each taxable year at least 90% of its investment company taxable income (generally, its net ordinary income plus the excess of its realized net short-term capital gains over realized net long-term capital losses, determined without regard to the dividends paid deduction). In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income as required.
Certain of the Company’s consolidated subsidiaries are subject to U.S. federal and state corporate level income taxes. Income tax expense, if any, is included under the income category for which it applies in the Consolidated Statements of Operations.
Distributions
Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. The Company may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce a stockholder’s tax basis in its shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to paid-in capital in excess of par or distributable earnings, as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Company’s annual RIC tax return. Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a distribution is determined by the Board of Directors each quarter and is generally based upon the earnings estimated by the Investment Adviser. The Company may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Company intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and may carry forward taxable income for distribution in the following year and pay any applicable tax. The specific tax characteristics of the Company’s distributions will be reported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no assurance can be given that the Company will be able to declare such distributions in future periods.
Deferred Financing Costs
Deferred financing costs consist of fees and expenses paid in connection with the closing of and amendments to the revolving credit facility between the Company and Truist Bank (formerly known as SunTrust Bank) (the “Truist Revolving Credit Facility”). These costs are amortized using the straight-line method over the term of the Truist Revolving Credit Facility. Deferred financing costs related to the Truist Revolving Credit Facility are presented separately as an asset on the Company’s Consolidated Statements of Assets and Liabilities.
New Accounting Pronouncements
In March 2020, the FASB issued Accounting Standard Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This ASU provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The Company adopted this ASU in June 2020 and this adoption did not have a material impact on the Company’s consolidated financial statements.
23
| 3. | SIGNIFICANT AGREEMENTS AND RELATED PARTY TRANSACTIONS |
Investment Management Agreement
The Company entered into an investment management agreement effective as of January 13, 2017 (the “Investment Management Agreement”) with the Investment Adviser, pursuant to which the Investment Adviser manages the Company’s investment program and related activities.
Management Fee
The Company pays the Investment Adviser a management fee (the “Management Fee”), payable quarterly in arrears, equal to 0.375% (i.e., an annual rate of 1.50%) of the average NAV of the Company (including un-invested cash and cash equivalents) at the end of the then-current quarter and the prior calendar quarter (and, in the case of the Company’s first quarter, the NAV as of such quarter-end). The Management Fee for any partial quarter will be appropriately prorated. Following the occurrence (if any) of a listing, average gross assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) at the end of the then-current quarter and the prior calendar quarter (and, in the case of the Company’s first quarter-end following such event, the Company’s gross assets as of such quarter-end) will be used instead of average NAV to calculate the Management Fee.
For the three and nine months ended September 30, 2020, Management Fees amounted to $3,714 and $10,739. As of September 30, 2020, $3,714 remained payable. For the three and nine months ended September 30, 2019, Management Fees amounted to $3,489 and $10,145.
Incentive Fee
Pursuant to the Investment Management Agreement, the Company pays to the Investment Adviser an incentive fee (the “Incentive Fee”) as follows:
The Incentive Fee will consist of two components that are determined independently of each other, with the result that one component may be payable even if the other is not. A portion of the Incentive Fee will be based on the Company’s income and a portion will be based on the Company’s capital gains, each as described below.
i. Quarterly Incentive Fee Based on Income
For the portion of the Incentive Fee based on income, the Company’s Investment Adviser is entitled to receive the Incentive Fee based on income from the Company if the Company’s Ordinary Income (as defined below) exceeds a quarterly “hurdle rate” (as defined below) of 1.75%. For this purpose, the hurdle is computed by reference to the Company’s NAV and does not take into account changes in the market price of the Company’s common stock (if any). The Incentive Fee based on income will be determined and paid quarterly in arrears at the end of each calendar quarter by reference to the Company’s aggregate net investment income, as adjusted as described below, from the calendar quarter then ending and the eleven preceding calendar quarters (or if shorter, the number of quarters that have occurred since the Initial Drawdown Date) (in either case, the “Trailing Twelve Quarters”). However, following the occurrence (if any) of a listing, the Trailing Twelve Quarters will be “reset” so as to include, as of the end of any quarter, the calendar quarter then ending and the eleven preceding calendar quarters (or if shorter, the number of quarters that have occurred since the listing, rather than the number of quarters that have occurred since the Initial Drawdown Date).
The “hurdle amount” for the Incentive Fee based on income is determined on a quarterly basis, and is equal to 1.75% multiplied by the Company’s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for subscriptions (which shall include all issuances by the Company of shares of its common stock) and distributions that occurred during the relevant Trailing Twelve Quarters. The Incentive Fee for any partial period will be appropriately prorated. For the portion of the Incentive Fee based on income, the Company pays the Investment Adviser a quarterly Incentive Fee based on the amount by which (A) Ordinary Income in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the “Excess Income Amount.”
The Incentive Fee based on income for each quarter is determined as follows:
| • | No Incentive Fee based on income is payable to the Investment Adviser for any calendar quarter for which there is no Excess Income Amount; |
| • | 100% of the Ordinary Income (as defined below), if any, that exceeds the hurdle amount, but is less than or equal to an amount, which we refer to as the “Catch-up Amount,” determined as the sum of 2.0588% (or 2.1875% in the event of a listing) multiplied by the Company’s NAV at the beginning of each applicable calendar quarter included in the relevant Trailing Twelve Quarters is included in the calculation of the Incentive Fee based on income; and |
| • | 15% (which will be increased to 20% in the event of a listing, from the date of such listing) of the Ordinary Income that exceeds the Catch-up Amount is included in the calculation of the Incentive Fee based on income. |
The amount of the Incentive Fee based on income that will be paid to the Investment Adviser for a particular quarter will equal the excess of the Incentive Fee so calculated minus the aggregate Incentive Fees based on income that were paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters but will not exceed the Incentive Fee Cap (as described below, and will be subject to the limitations set forth in Section 205(b)(3) of the Advisers Act).
24
The Incentive Fee based on income that is paid to the Investment Adviser for a particular quarter is subject to a cap (the “Incentive Fee Cap”). The Incentive Fee Cap for any quarter is an amount equal to (a) 15% (which will be increased to 20% in the event of a listing, from the date of such listing) of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate Incentive Fees based on income that were paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters.
“Ordinary Income” means interest income, dividend income and any other income (including any accrued income that we have not yet received in cash and any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter minus our operating expenses accrued during the calendar quarter (including the Management Fee, administrative expenses and any interest expense and dividends paid on issued and outstanding preferred stock, but excluding the Incentive Fee).
“Cumulative Net Return” means (x) the Ordinary Income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters.
If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no Incentive Fee based on income to the Investment Adviser for such quarter. If, in any quarter, the Incentive Fee Cap is a positive value but is less than the Incentive Fee based on income that is payable to the Investment Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an Incentive Fee based on income to the Investment Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the Incentive Fee based on income that is payable to the Investment Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an Incentive Fee based on income to the Investment Adviser equal to the Incentive Fee calculated as described above for such quarter without regard to the Incentive Fee Cap. In certain limited circumstances, an Incentive Fee based on income will be payable to the Investment Adviser although the net income for such quarter did not exceed the hurdle rate or the Incentive Fee will be higher than it would have been if calculated based on the Company’s performance for the applicable quarter without taking into account the Trailing Twelve Quarters.
“Net Capital Loss” in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period.
ii. Annual Incentive Fee Based on Capital Gains
The portion of Incentive Fee based on capital gains is determined and paid annually in arrears at the end of each calendar year or, in the event of a listing, the date on which such event occurs. At the end of each calendar year (or the occurrence of a listing), the Company will pay the Investment Adviser an Incentive Fee equal to (A) 15% (which will be increased to 20% in the event of a listing, from the date of such listing) of the difference, if positive, of the sum of the Company’s aggregate realized capital gains, if any, computed net of the Company’s aggregate realized capital losses, if any, and the Company’s aggregate unrealized capital depreciation, in each case from the Initial Drawdown Date (or, following the occurrence (if any) of a listing, from the date on which such event occurs) until the end of such calendar year or listing, as applicable, minus (B) the cumulative amount of Incentive Fees based on capital gains previously paid to the Investment Adviser from the Initial Drawdown Date (or, following the occurrence (if any) of a listing, from the date on which such event occurs) through the end of such calendar year or listing, as applicable. For the avoidance of doubt, unrealized capital appreciation is excluded from the calculation in clause (A), above.
The Company accrues, but does not pay, a portion of the Incentive Fee based on capital gains with respect to net unrealized appreciation. Under GAAP, the Company is required to accrue an Incentive Fee based on capital gains that includes net realized capital gains and losses and net unrealized capital appreciation and depreciation on investments held at the end of each period. In calculating the accrual for the Incentive Fee based on capital gains, the Company considers the cumulative aggregate unrealized capital appreciation in the calculation, since an Incentive Fee based on capital gains would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee actually payable under the Investment Management Agreement. This accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital appreciation or depreciation. If such amount is positive at the end of a period, then the Company records a capital gains incentive fee equal to 15% (which will be increased to 20% in the event of a listing, from the date of such listing) of such amount, minus the aggregate amount of actual Incentive Fees based on capital gains paid in all prior periods (or, following the occurrence (if any) of a listing, in all prior periods beginning with the date on which such event occurs). If such amount is negative, then there is no accrual for such period. There can be no assurance that such unrealized capital appreciation will be realized in the future.
For the three and nine months ended September 30, 2020, the Company accrued an Incentive Fee based on income of $6,456 and $6,456. As of September 30, 2020, $6,456 remained payable. For the three and nine months ended September 30, 2019, the Company accrued an Incentive Fee based on income of $3,265 and $14,605.
25
Administration and Custodian Fees
The Company has entered into an administration agreement with State Street Bank and Trust Company (the “Administrator”) under which the Administrator provides various accounting and administrative services to the Company. The Company pays the Administrator fees for its services as it determines are commercially reasonable in its sole discretion. The Company also reimburses the Administrator for all reasonable expenses. To the extent that the Administrator outsources any of its functions, the Administrator pays any compensation associated with such functions. The Administrator also serves as the Company’s custodian (the “Custodian”).
For the three and nine months ended September 30, 2020, the Company incurred expenses for services provided by the Administrator and the Custodian of $297 and $897. As of September 30, 2020, $199 remained payable. For the three and nine months ended September 30, 2019, the Company incurred expenses for services provided by the Administrator and the Custodian of $287 and $824.
Transfer Agent Fees
The Company has entered into a transfer agency agreement (the “Transfer Agency Agreement”), with GS & Co. pursuant to which GS & Co. serves as the Company’s transfer agent (“Transfer Agent”), registrar and disbursing agent. The Company pays the Transfer Agent fees at an annual rate of 0.12% of the average NAV of the Company at the end of the then-current quarter and the prior calendar quarter (and, in the case of the Company’s first quarter, the Company’s NAV as of such quarter-end).
For the three and nine months ended September 30, 2020, the Company incurred expenses for services provided by the Transfer Agent of $302 and $867. As of September 30, 2020, $302 remained payable. For the three and nine months ended September 30, 2019, the Company incurred expenses for services provided by the Transfer Agent of $279 and $812.
Affiliates
The table below presents the Company’s affiliated investments:
| Beginning Fair Value Balance |
Gross Additions(2) |
Gross Reductions(3) |
Net Realized Gain (Loss) |
Net Change in Unrealized Appreciation (Depreciation) |
Ending Fair Value Balance |
Dividend, Interest and Other Income |
||||||||||||||||||||||
| For the Nine Months Ended September 30, 2020 |
||||||||||||||||||||||||||||
| Non-Controlled Affiliates |
||||||||||||||||||||||||||||
| Goldman Sachs Financial Square Government Fund(1) |
$ | — | $ | 388,506 | $ | (227,708 | ) | $ | — | $ | — | $ | 160,798 | $ | 87 | |||||||||||||
| Accuity Delivery Systems, LLC |
21,571 | 63 | — | — | 2,086 | 23,720 | 1,040 | |||||||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates) |
24,864 | 35 | — | — | (955 | ) | 23,944 | 1,371 | ||||||||||||||||||||
| Elah Holdings, Inc. |
3,163 | — | — | — | (1 | ) | 3,162 | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Total Non-Controlled Affiliates |
$ | 49,598 | $ | 388,604 | $ | (227,708 | ) | $ | — | $ | 1,130 | $ | 211,624 | $ | 2,498 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| For the Year Ended December 31, 2019 |
||||||||||||||||||||||||||||
| Non-Controlled Affiliates |
||||||||||||||||||||||||||||
| Goldman Sachs Financial Square Government Fund(1) |
$ | — | $ | 205,169 | $ | (205,169 | ) | $ | — | $ | — | $ | — | $ | 45 | |||||||||||||
| Accuity Delivery Systems, LLC |
19,482 | 75 | — | — | 2,014 | 21,571 | 1,479 | |||||||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates) |
14,594 | 9,555 | — | — | 715 | 24,864 | 1,513 | |||||||||||||||||||||
| Elah Holdings, Inc. |
3,163 | — | — | — | — | 3,163 | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Total Non-Controlled Affiliates |
$ | 37,239 | $ | 214,799 | $ | (205,169 | ) | $ | — | $ | 2,729 | $ | 49,598 | $ | 3,037 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) | Fund advised by an affiliate of Goldman Sachs. |
| (2) | Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest or dividends, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category. |
| (3) | Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category. |
Due to Affiliates
The Investment Adviser pays certain general and administrative expenses on behalf of the Company in the ordinary course of business. As of September 30, 2020 and December 31, 2019, there were $418 and $417, included within Accrued expenses and other liabilities paid by the Investment Adviser and its affiliates on behalf of the Company.
26
Co-investment Activity
In certain circumstances, negotiated co-investments by the Company and other funds managed by the Investment Adviser may be made only pursuant to an order from the SEC permitting the Company to do so. On January 4, 2017, the SEC granted exemptive relief (“Exemptive Relief”) that permits the Company (which was merged with GS BDC on October 12, 2020) to co-invest with GS BDC, Goldman Sachs Private Middle Market Credit LLC (“GS PMMC”), Goldman Sachs Private Middle Market Credit II LLC (“GS PMMC II”) and certain other funds that may be managed by GSAM, including the GSAM Credit Alternatives Team, after the date of the exemptive order, subject to certain conditions including that co-investments are made in a manner consistent with the Company’s investment objectives, positions, policies, strategies and restrictions, as well as regulatory requirements and pursuant to the conditions required by the Exemptive Relief, and are allocated fairly among participants. The GSAM Credit Alternatives Team is comprised of investment professionals dedicated to the Company’s investment strategy and other funds that share a similar investment strategy with the Company, who are responsible for identifying investment opportunities, conducting research and due diligence on prospective investments, negotiating and structuring the Company’s investments and monitoring and servicing the Company’s investments, together with investment professionals who are primarily focused on investment strategies in syndicated, liquid credit. Under the terms of the Exemptive Relief, a “required majority” (as defined in Section 57(o) of the Investment Company Act) of the Company’s independent directors must make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the proposed transaction are reasonable and fair to the Company and the Company’s stockholders and do not involve overreaching in respect of the Company or its stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of the Company’s stockholders and is consistent with the then-current investment objectives and strategies of the Company.
| 4. | INVESTMENTS |
The Company’s investments (excluding an investment in a money market fund, if any, managed by an affiliate of Group Inc.) consisted of the following:
| September 30, 2020 | December 31, 2019 | |||||||||||||||
| Investment Type |
Cost | Fair Value | Cost | Fair Value | ||||||||||||
| 1st Lien/Senior Secured Debt |
$ | 1,320,702 | $ | 1,290,854 | $ | 1,272,044 | $ | 1,266,486 | ||||||||
| 1st Lien/Last-Out Unitranche |
100,545 | 100,019 | 100,829 | 100,797 | ||||||||||||
| 2nd Lien/Senior Secured Debt |
299,557 | 267,796 | 311,933 | 294,165 | ||||||||||||
| Preferred Stock |
7,221 | 15,556 | 7,200 | 10,137 | ||||||||||||
| Common Stock |
10,381 | 14,317 | 10,381 | 11,575 | ||||||||||||
| Warrants |
1,166 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total Investments |
$ | 1,739,572 | $ | 1,688,542 | $ | 1,702,387 | $ | 1,683,160 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
27
The industry composition of the Company’s investments at fair value and net assets was as follows:
| September 30, 2020 | December 31, 2019 | |||||||||||||||
| Industry |
Fair Value | Net Assets | Fair Value | Net Assets | ||||||||||||
| Health Care Technology |
10.0 | % | 16.5 | % | 10.1 | % | 18.0 | % | ||||||||
| Interactive Media & Services |
9.8 | 16.1 | 10.0 | 17.8 | ||||||||||||
| Health Care Providers & Services |
9.5 | 15.7 | 11.5 | 20.5 | ||||||||||||
| Software |
9.4 | 15.5 | 10.1 | 18.0 | ||||||||||||
| IT Services |
7.8 | 12.9 | 7.8 | 14.0 | ||||||||||||
| Real Estate Management & Development |
7.0 | 11.5 | 5.9 | 10.4 | ||||||||||||
| Professional Services |
6.6 | 10.8 | 5.8 | 10.3 | ||||||||||||
| Diversified Financial Services |
5.3 | 8.7 | 5.1 | 9.1 | ||||||||||||
| Diversified Consumer Services |
4.9 | 8.1 | 1.8 | 3.2 | ||||||||||||
| Health Care Equipment & Supplies |
4.1 | 6.7 | 4.2 | 7.5 | ||||||||||||
| Hotels, Restaurants & Leisure |
3.8 | 6.3 | 3.9 | 7.0 | ||||||||||||
| Chemicals |
3.3 | 5.5 | 2.8 | 5.1 | ||||||||||||
| Road & Rail |
1.9 | 3.1 | 3.1 | 5.6 | ||||||||||||
| Transportation Infrastructure |
1.9 | 3.1 | 1.9 | 3.4 | ||||||||||||
| Diversified Telecommunication Services |
1.8 | 3.0 | 1.7 | 3.0 | ||||||||||||
| Household Products |
1.7 | 2.9 | 1.9 | 3.3 | ||||||||||||
| Entertainment |
1.5 | 2.4 | 1.6 | 2.9 | ||||||||||||
| Air Freight & Logistics |
1.4 | 2.3 | 1.5 | 2.6 | ||||||||||||
| Insurance |
1.3 | 2.2 | 1.6 | 2.8 | ||||||||||||
| Media |
1.1 | 1.9 | 1.1 | 2.1 | ||||||||||||
| Trading Companies & Distributors |
0.9 | 1.6 | 1.0 | 1.8 | ||||||||||||
| Beverages |
0.9 | 1.5 | 0.7 | 1.3 | ||||||||||||
| Commercial Services & Supplies |
0.7 | 1.2 | 0.7 | 1.3 | ||||||||||||
| Internet & Direct Marketing Retail |
0.7 | 1.1 | 0.7 | 1.2 | ||||||||||||
| Auto Components |
0.6 | 1.0 | 0.6 | 1.1 | ||||||||||||
| Building Products |
0.6 | 1.0 | 1.4 | 2.4 | ||||||||||||
| Food Products |
0.5 | 0.8 | 0.5 | 0.9 | ||||||||||||
| Life Sciences Tools & Services |
0.5 | 0.8 | 0.5 | 0.8 | ||||||||||||
| Containers & Packaging |
0.3 | 0.5 | 0.3 | 0.5 | ||||||||||||
| Capital Markets |
0.2 | 0.3 | 0.2 | 0.3 | ||||||||||||
| Aerospace & Defense |
— | (1) | — | (1) | — | — | ||||||||||
| Construction & Engineering |
— | (1) | — | (1) | — | — | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total |
100.0 | % | 165.0 | % | 100.0 | % | 178.2 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) | Amount rounds to 0.0%. |
The geographic composition of the Company’s investments at fair value was as follows:
| Geographic |
September 30, 2020 |
December 31, 2019 |
||||||
| United States |
95.5 | % | 95.6 | % | ||||
| Canada |
2.8 | 2.7 | ||||||
| Ireland |
1.7 | 1.7 | ||||||
|
|
|
|
|
|||||
| Total |
100.0 | % | 100.0 | % | ||||
|
|
|
|
|
|||||
| 5. | FAIR VALUE MEASUREMENT |
The fair value of a financial instrument is the amount that would be received to sell an asset or would be paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price).
28
The fair value hierarchy under ASC 820 prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:
Basis of Fair Value Measurement
Level 1 – Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.
Level 2 – Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.
Level 3 – Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include investments in privately held entities and certain over-the-counter derivatives where the fair value is based on unobservable inputs.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Note 2 “Significant Accounting Policies” should be read in conjunction with the information outlined below.
The table below presents the valuation techniques and the nature of significant inputs generally used in determining the fair value of Level 2 and Level 3 Instruments.
| Level 2 Instruments |
Valuation Techniques and Significant Inputs | |
| Equity and Fixed Income | The types of instruments that trade in markets that are not considered to be active but are valued based on quoted market prices, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency include commercial paper, most government agency obligations, most corporate debt securities, certain mortgage-backed securities, certain bank loans, less liquid publicly listed equities, certain state and municipal obligations, certain money market instruments and certain loan commitments.
Valuations of Level 2 Equity and Fixed Income instruments can be verified to quoted prices, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. Consideration is given to the nature of the quotations (e.g. indicative or firm) and the relationship of recent market activity to the prices provided from alternative pricing sources. | |
| Derivative Contracts | OTC derivatives (both centrally cleared and bilateral) are valued using market transactions and other market evidence whenever possible, including market-based inputs to models, calibration to market-clearing transactions, broker or dealer quotations, or other alternative pricing sources with reasonable levels of price transparency. Where models are used, the selection of a particular model to value an OTC derivative depends upon the contractual terms of, and specific risks inherent in, the instrument, as well as the availability of pricing information in the market. The Company generally uses similar models to value similar instruments. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, voluntary and involuntary prepayment rates, loss severity rates and correlations of such inputs. For OTC derivatives that trade in liquid markets, model inputs can generally be verified and model selection does not involve significant management judgment. OTC derivatives are classified within Level 2 of the fair value hierarchy when significant inputs are corroborated by market evidence. | |
| Level 3 Instruments |
Valuation Techniques and Significant Inputs | |
| Bank Loans, Corporate Debt, and Other Debt Obligations | Valuations are generally based on discounted cash flow techniques, for which the significant inputs are the amount and timing of expected future cash flows, market yields and recovery assumptions. The significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to credit default swaps that reference the same underlying credit risk and to other debt instruments for the same issuer for which observable prices or broker quotes are available. Other valuation methodologies are used as appropriate including market comparables, transactions in similar instruments and recovery/liquidation analysis. | |
| Equity | Recent third-party investments or pending transactions are considered to be the best evidence for any change in fair value. When these are not available, the following valuation methodologies are used, as appropriate and available (i) Transactions in similar instruments; (ii) Discounted cash flow techniques; (iii) Third party appraisals; and (iv) Industry multiples and public comparables.
Evidence includes recent or pending reorganizations (for example, merger proposals, tender offers and debt restructurings) and significant changes in financial metrics, including (i) Current financial performance as compared to projected performance; (ii) Capitalization rates and multiples; and (iii) Market yields implied by transactions of similar or related assets. | |
29
The tables below present the ranges of significant unobservable inputs used to value the Company’s Level 3 assets and liabilities as of September 30, 2020 and December 31, 2019. These ranges represent the significant unobservable inputs that were used in the valuation of each type of instrument, but they do not represent a range of values for any one instrument. For example, the lowest yield in 1st Lien/Senior Secured Debt is appropriate for valuing that specific debt investment, but may not be appropriate for valuing any other debt investments in this asset class. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Company’s Level 3 assets and liabilities.
| Level 3 Instruments |
Fair Value(1)(2) |
Valuation Techniques(3) | Significant Unobservable Inputs |
Range(4) of Significant Unobservable Inputs |
Weighted Average(5) |
|||||||||||||||
| As of September 30, 2020 |
||||||||||||||||||||
| Bank Loans, Corporate Debt, and Other Debt Obligations |
| |||||||||||||||||||
| 1st Lien/Senior Secured |
$ | 1,091,781 | Discounted cash flows | Discount Rate | 6.0% - 17.3% | 8.6% | ||||||||||||||
| 1st Lien/Last-Out Unitranche |
100,019 | Discounted cash flows | Discount Rate | 7.3% - 10.7% | 9.6% | |||||||||||||||
| 2nd Lien/Senior Secured |
206,775 | Discounted cash flows | Discount Rate | 10.0% - 12.8% | 10.7% | |||||||||||||||
| 9,933 | Comparable multiples | EV/EBITDA(6) | 7.4x - 25.1x | 10.4x | ||||||||||||||||
|
|
|
|||||||||||||||||||
| Equity |
| |||||||||||||||||||
| Preferred Stock |
$ | 8,878 | Comparable multiples | EV/EBITDA(6) | 7.9x - 26.7x | 18.7x | ||||||||||||||
| 6,657 | Comparable multiples | EV/Revenue | 1.7x - 4.4x | 1.3x | ||||||||||||||||
| Common Stock |
5,404 | Discounted cash flows | Discount Rate | 13.1% - 31.5% | 24.6% | |||||||||||||||
| 707 | Comparable multiples | EV/EBITDA(6) | 10.0x - 10.1x | 10.0x | ||||||||||||||||
| 8,206 | Comparable multiples | EV/Revenue | 0.3x - 12.5x | 12.2x | ||||||||||||||||
|
|
|
|||||||||||||||||||
| As of December 31, 2019 |
||||||||||||||||||||
| Bank Loans, Corporate Debt, and Other Debt Obligations |
| |||||||||||||||||||
| 1st Lien/Senior Secured |
$ | 1,031,569 | Discounted cash flows | Discount Rate | 6.5% - 13.3% | 8.7% | ||||||||||||||
| 1st Lien/Last-Out Unitranche |
100,797 | Discounted cash flows | Discount Rate | 8.5% - 10.1% | 9.8% | |||||||||||||||
| 2nd Lien/Senior Secured |
233,672 | Discounted cash flows | Discount Rate | 9.9% - 12.4% | 10.7% | |||||||||||||||
|
|
|
|||||||||||||||||||
| Equity |
||||||||||||||||||||
| Preferred Stock |
$ | 7,200 | Comparable multiples | EV/EBITDA(6) | 4.2x - 30.2x | 19.0x | ||||||||||||||
| 2,937 | Comparable multiples | EV/Revenue | 1.0x - 3.2x | 1.3x | ||||||||||||||||
| Common Stock |
6,045 | Discounted cash flows | Discount Rate | 13.9% - 31.0% | 23.9% | |||||||||||||||
| 1,156 | Comparable multiples | EV/EBITDA(6) | 8.5x - 12.7x | 9.7x | ||||||||||||||||
| 4,374 | Comparable multiples | EV/Revenue | 2.3x - 9.7x | 9.6x | ||||||||||||||||
|
|
|
|||||||||||||||||||
| (1) | As of September 30, 2020, included within Level 3 assets of $1,595,565 is an amount of $157,205 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $1,398,575 or 89.3% of Level 3 bank loans, corporate debt, and other debt obligations. |
| (2) | As of December 31, 2019, included within Level 3 assets of $1,579,087 is an amount of $191,337 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $1,366,038 or 87.7% of Level 3 bank loans, corporate debt, and other debt obligations. |
| (3) | The fair value of any one instrument may be determined using multiple valuation techniques. For example, market comparable and discounted cash flows may be used together to determine fair value. Therefore, the Level 3 balance encompasses both of these techniques. |
| (4) | The range for an asset category consisting of a single investment represents the relevant market data considered in determining the fair value of the investment. |
| (5) | Weighted average for an asset category consisting of multiple investments is calculated by weighting the significant unobservable input by the relative fair value of the investment. Weighted average for an asset category consisting of a single investment represents the significant unobservable input used in the fair value of the investment. |
| (6) | Enterprise value of portfolio company as a multiple of earnings before interest, taxes, depreciation and amortization (“EBITDA”). |
As noted above, the income and market approaches were used in the determination of fair value of certain Level 3 assets as of September 30, 2020 and December 31, 2019. The significant unobservable inputs used in the income approach are the discount rate or market yield used to discount the estimated future cash flows expected to be received from the underlying investment, which include both future principal and interest payments. An increase in the discount rate or market yield would result in a decrease in the fair value. Included in the consideration and selection of discount rates is risk of default, rating of the investment, call provisions and comparable company investments. The significant unobservable inputs used in the market approach are based on market comparable transactions and market multiples of publicly traded comparable companies. Increases or decreases in market comparable transactions or market multiples would result in an increase or decrease, in the fair value.
30
The following is a summary of the Company’s assets categorized within the fair value hierarchy:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||||||||
| Assets |
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||
| 1st Lien/Senior Secured Debt |
$ | — | $ | 41,889 | $ | 1,248,965 | $ | 1,290,854 | $ | — | $ | 58,830 | $ | 1,207,656 | $ | 1,266,486 | ||||||||||||||||
| 1st Lien/Last-Out Unitranche |
— | — | 100,019 | 100,019 | — | — | 100,797 | 100,797 | ||||||||||||||||||||||||
| 2nd Lien/Senior Secured Debt |
— | 51,088 | 216,708 | 267,796 | — | 45,243 | 248,922 | 294,165 | ||||||||||||||||||||||||
| Preferred Stock |
— | — | 15,556 | 15,556 | — | — | 10,137 | 10,137 | ||||||||||||||||||||||||
| Common Stock |
— | — | 14,317 | 14,317 | — | — | 11,575 | 11,575 | ||||||||||||||||||||||||
| Warrants |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
| Affiliated Money Market Fund |
160,798 | — | — | 160,798 | — | — | — | — | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total assets |
$ | 160,798 | $ | 92,977 | $ | 1,595,565 | $ | 1,849,340 | $ | — | $ | 104,073 | $ | 1,579,087 | $ | 1,683,160 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Foreign currency forward contracts - asset (liability)(1) |
$ | — | $ | (134 | ) | $ | — | $ | (134 | ) | $ | — | $ | 46 | $ | — | $ | 46 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| (1) | Amounts represent the unrealized appreciation (depreciation) on the foreign currency forward contracts. |
The below table presents a summary of changes in fair value of Level 3 assets by investment type:
| Beginning Balance |
Purchases(1) | Net Realized Gain (Loss) |
Net Change in Unrealized Appreciation (Depreciation) |
Sales and Settlements(1) |
Net Amortization of Premium/ Discount |
Transfers In |
Transfers Out(2) |
Ending Balance |
Net Change in Unrealized Appreciation (Depreciation) for assets still held |
|||||||||||||||||||||||||||||||
| For the Nine Months Ended September 30, 2020 |
|
|||||||||||||||||||||||||||||||||||||||
| 1st Lien/Senior Secured Debt |
$ | 1,207,656 | $ | 156,242 | $ | 220 | $ | (22,416 | ) | $ | (87,632 | ) | $ | 3,901 | $ | — | $ | (9,006 | ) | $ | 1,248,965 | $ | (22,658 | ) | ||||||||||||||||
| 1st Lien/Last-Out Unitranche |
100,797 | — | — | (494 | ) | (695 | ) | 411 | — | — | 100,019 | (494 | ) | |||||||||||||||||||||||||||
| 2nd Lien/Senior Secured Debt |
248,922 | 13,155 | — | (18,871 | ) | (11,852 | ) | 604 | — | (15,250 | ) | 216,708 | (18,870 | ) | ||||||||||||||||||||||||||
| Preferred Stock |
10,137 | 21 | — | 5,398 | — | — | — | — | 15,556 | 5,398 | ||||||||||||||||||||||||||||||
| Common Stock |
11,575 | — | — | 2,742 | — | — | — | — | 14,317 | 2,742 | ||||||||||||||||||||||||||||||
| Warrants |
— | 2,333 | — | (1,166 | ) | (1,167 | ) | — | — | — | — | (1,166 | ) | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Total assets |
$ | 1,579,087 | $ | 171,751 | $ | 220 | $ | (34,807 | ) | $ | (101,346 | ) | $ | 4,916 | $ | — | $ | (24,256 | ) | $ | 1,595,565 | $ | (35,048 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| For the Nine Months Ended September 30, 2019 |
|
|||||||||||||||||||||||||||||||||||||||
| 1st Lien/Senior Secured Debt |
$ | 644,913 | $ | 559,371 | $ | (21 | ) | $ | (3,437 | ) | $ | (114,031 | ) | $ | 3,558 | $ | — | $ | — | $ | 1,090,353 | $ | (2,981 | ) | ||||||||||||||||
| 1st Lien/Last-Out Unitranche |
90,582 | 10,294 | — | (124 | ) | (339 | ) | 372 | — | — | 100,785 | (124 | ) | |||||||||||||||||||||||||||
| 2nd Lien/Senior Secured Debt |
300,116 | 24,522 | (10,553 | ) | 1,181 | (32,795 | ) | 987 | — | (17,504 | ) | 265,954 | (816 | ) | ||||||||||||||||||||||||||
| Preferred Stock |
8,100 | — | — | 1,393 | — | — | — | — | 9,493 | 1,393 | ||||||||||||||||||||||||||||||
| Common Stock |
9,825 | 1,054 | — | 2,755 | — | — | — | — | 13,634 | 2,755 | ||||||||||||||||||||||||||||||
| Warrants |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Total assets |
$ | 1,053,536 | $ | 595,241 | $ | (10,574 | ) | $ | 1,768 | $ | (147,165 | ) | $ | 4,917 | $ | — | $ | (17,504 | ) | $ | 1,480,219 | $ | 227 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| (1) | Purchases may include PIK and securities received in corporate actions and restructurings. Sales and Settlements may include securities delivered in corporate actions and restructuring of investments. |
| (2) | Transfers out were primarily due to increased price transparency. |
Debt Not Carried at Fair Value
The fair value of the Company’s debt, which would have been categorized as Level 3 within the fair value hierarchy as of September 30, 2020 and December 31, 2019, approximates its carrying value because the Truist Revolving Credit Facility has variable interest based on selected short term rates.
31
| 6. | DEBT |
In accordance with the Investment Company Act, with certain exceptions, the Company is currently allowed to borrow amounts such that its asset coverage ratio, as defined in the Investment Company Act, is at least 200% after such borrowing (or 150% if certain requirements are met). As of September 30, 2020 and December 31, 2019, the Company’s asset coverage ratio based on the aggregate amount outstanding of senior securities was 221% and 228%.
The Company’s outstanding debt was as follows:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||
| Aggregate Borrowing Amount Committed |
Amount Available |
Carrying Value |
Aggregate Borrowing Amount Committed |
Amount Available |
Carrying Value |
|||||||||||||||||||
| Truist Revolving Credit Facility(1)(2) |
$ | 850,000 | $ | 7,171 | $ | 843,219 | $ | 850,000 | $ | 120,648 | $ | 729,986 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total Debt |
$ | 850,000 | $ | 7,171 | $ | 843,219 | $ | 850,000 | $ | 120,648 | $ | 729,986 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) | The Company may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of September 30, 2020, the Company had outstanding borrowings denominated in USD of $787,000 and in Euros (EUR) of 47,950. As of December 31, 2019, the Company had outstanding borrowings denominated in USD of $676,200 and in EUR of 47,950. |
| (2) | Provides, under certain circumstances, a total borrowing capacity of $900,000. |
The weighted average interest rates of the aggregate borrowings outstanding for the nine months ended September 30, 2020 and for the year ended December 31, 2019 were 2.97% and 4.27%.
Truist Revolving Credit Facility
On September 11, 2017, the Company entered into the Truist Revolving Credit Facility, a multicurrency facility, with various lenders. Truist Bank serves as administrative agent and Bank of America, N.A. serves as syndication agent. The Company amended the Truist Revolving Credit Facility on September 17, 2018, July 10, 2019 and February 25, 2020.
The total commitments under the Truist Revolving Credit Facility is $850,000. The accordion feature of the Truist Revolving Credit Facility allows the Company, subject to the satisfaction of various conditions, to bring total commitments under the Truist Revolving Credit Facility to $900,000.
Borrowings under the Truist Revolving Credit Facility, including amounts drawn in respect of letters of credit, bear interest (at the Company’s election) of either the Adjusted LIBO Rate (as defined in the Truist Revolving Credit Facility) plus the Applicable Margin (as defined in the Truist Revolving Credit Facility) or the Applicable Margin plus the higher of the Prime Rate (as defined in the Truist Revolving Credit Facility), Federal Funds Effective Rate (as defined in the Truist Revolving Credit Facility) plus 0.5% or overnight London Interbank Offered Rate (“LIBOR”) plus 1.0%. Interest is payable quarterly in arrears or as defined in the Truist Revolving Credit Facility. The Company pays a fee of 0.375% per annum on committed but undrawn amounts under the Truist Revolving Credit Facility, payable quarterly in arrears. Any amounts borrowed under the Truist Revolving Credit Facility will mature, and all accrued and unpaid interest will be due and payable, on March 11, 2022.
The Truist Revolving Credit Facility may be guaranteed by certain of the Company’s subsidiaries that are formed or acquired by the Company in the future (collectively, the “Guarantors”). Proceeds from borrowings may be used for general corporate purposes, including the funding of portfolio investments.
The Company’s obligations to the lenders under the Truist Revolving Credit Facility are secured by a first priority security interest in substantially all of the Company’s portfolio of investments and cash, with certain exceptions. The Truist Revolving Credit Facility contains certain customary covenants, including: (i) maintaining a minimum shareholder’s equity, (ii) maintaining an asset coverage ratio of at least 2 to 1, (iii) maintaining a minimum liquidity test of at least 15% of the “covered debt amount” during any period when the “adjusted covered debt balance” is greater than 85% of the “adjusted borrowing base,” as such quoted terms are defined in the Truist Revolving Credit Facility and (iv) restrictions on industry concentrations in the Company’s investment portfolio.
The Truist Revolving Credit Facility also includes customary representations and warranties, conditions precedent to funding of draws and events of default (including a change in control event of default trigger).
Costs of $5,626 were incurred in connection with obtaining and amending the Truist Revolving Credit Facility and exercising its right under the accordion feature, which have been recorded as deferred financing costs on the Consolidated Statements of Assets and Liabilities and are being amortized over the life of the Truist Revolving Credit Facility using the straight-line method. As of September 30, 2020 and December 31, 2019, outstanding deferred financing costs were $1,988 and $2,617.
The below table presents the summary information of the Truist Revolving Credit Facility:
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2020 |
September 30, 2019 |
September 30, 2020 |
September 30, 2019 |
|||||||||||||
| Borrowing interest expense |
$ | 5,195 | $ | 6,399 | $ | 17,937 | $ | 14,810 | ||||||||
| Facility fees |
20 | 228 | 166 | 685 | ||||||||||||
| Amortization of financing costs |
347 | 374 | 1,059 | 974 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total |
$ | 5,562 | $ | 7,001 | $ | 19,162 | $ | 16,469 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Weighted average interest rate |
2.45 | % | 4.34 | % | 2.97 | % | 4.40 | % | ||||||||
| Average outstanding balance |
$ | 843,045 | $ | 584,493 | $ | 805,444 | $ | 450,012 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
32
| 7. | DERIVATIVES |
The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies.
In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or a similar agreement with its derivative counterparties. An ISDA Master Agreement is a bilateral agreement between the Company and a counterparty that governs OTC derivatives, including foreign currency forward contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default (close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.
For financial reporting purposes, cash collateral that has been pledged to cover obligations of the Company and cash collateral received from the counterparty, if any, is included in the Consolidated Statements of Assets and Liabilities as due to/due from a broker. The Company minimizes counterparty credit risk by only entering into agreements with counterparties that they believe to be in good standing and by monitoring the financial stability of those counterparties.
For the three and nine months ended September 30, 2020, the Company’s average USD notional exposure to foreign currency forward contracts were $3,465 and $4,286. For the three and nine months ended September 30, 2019, the Company’s average USD notional exposure to foreign currency forward contracts were $2,963 and $3,855.
The Company’s net exposure to foreign currency forward contracts by counterparty that are subject to ISDA Master Agreements or similar agreements presented on the Consolidated Statements of Assets and Liabilities was as follows:
| Gross Amount of Assets |
Gross Amount of (Liabilities) |
Net Amount of Assets or (Liabilities) |
Collateral (Received) Pledged (1) |
Net Amounts (2) | ||||||||||||||||
| September 30, 2020 |
||||||||||||||||||||
| Bank of America, N.A. |
$ | — | $ | (134 | ) | $ | (134 | ) | $ | — | $ | (134 | ) | |||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| December 31, 2019 |
||||||||||||||||||||
| Bank of America, N.A. |
$ | 46 | $ | — | $ | 46 | $ | — | $ | 46 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (1) | Amount excludes excess cash collateral paid. |
| (2) | Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights under the agreement. Net amount excludes any over-collateralized amounts. |
The effect of transactions in derivative instruments to the Consolidated Statements of Operations was as follows:
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2020 |
September 30, 2019 |
September 30, 2020 |
September 30, 2019 |
|||||||||||||
| Net realized gain (loss) on foreign currency forward contracts |
$ | 40 | $ | 53 | $ | 150 | $ | 65 | ||||||||
| Net change in unrealized appreciation (depreciation) on foreign currency forward contracts |
(179 | ) | 78 | (180 | ) | 123 | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total net realized and unrealized gains (losses) on foreign currency forward contracts |
$ | (139 | ) | $ | 131 | $ | (30 | ) | $ | 188 | ||||||
|
|
|
|
|
|
|
|
|
|||||||||
| 8. | COMMITMENTS AND CONTINGENCIES |
Capital Commitments
The Company had aggregate capital commitments and undrawn capital commitments from investors as follows:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||
| Capital Commitments |
Unfunded Capital Commitments |
% of Capital Commitments Funded |
Capital Commitments |
Unfunded Capital Commitments |
% of Capital Commitments Funded |
|||||||||||||||||||
| Common Stock |
$ | 1,034,646 | $ | — | 100 | % | $ | 1,034,992 | $ | 62,152 | 94 | % | ||||||||||||
33
Portfolio Company Commitments
The Company may enter into investment commitments to fund investments through signed commitment letters which in certain circumstances may be disclosed by the Company. In many circumstances, borrower acceptance and final terms are subject to transaction-related contingencies. These are disclosed as commitments upon execution of a final agreement. As of September 30, 2020, the Company believed that it had adequate financial resources to satisfy its unfunded commitments. The Company had the following unfunded commitments by investment types:
| Unfunded Commitment Balances(2) |
Fair Value(3) | |||||||||||||||||||
| Commitment Expiration Date(1) |
September 30, 2020 |
December 31, 2019 |
September 30, 2020 |
December 31, 2019 |
||||||||||||||||
| 1st Lien/Senior Secured Debt |
||||||||||||||||||||
| Brillio, LLC |
2/6/2021 | $ | 1,100 | $ | 2,200 | $ | (25 | ) | $ | (22 | ) | |||||||||
| Associations, Inc. |
7/30/2021 | 63 | 1,299 | (3 | ) | (13 | ) | |||||||||||||
| WebPT, Inc. |
8/28/2021 | 1,867 | 1,867 | (75 | ) | (37 | ) | |||||||||||||
| Elemica Parent, Inc. |
9/18/2021 | 830 | 830 | (58 | ) | (21 | ) | |||||||||||||
| Bullhorn, Inc. |
10/1/2021 | 732 | 1,065 | (11 | ) | (16 | ) | |||||||||||||
| Eptam Plastics, Ltd. |
12/6/2021 | 2,708 | 2,708 | (74 | ) | (20 | ) | |||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
12/20/2021 | 96 | — | (3 | ) | — | ||||||||||||||
| MRI Software LLC |
2/10/2022 | 565 | — | (20 | ) | — | ||||||||||||||
| Netvoyage Corporation (dba NetDocuments) |
3/24/2022 | 610 | 610 | (20 | ) | (8 | ) | |||||||||||||
| VRC Companies, LLC (dba Vital Records Control) |
3/31/2022 | 249 | 111 | (2 | ) | (1 | ) | |||||||||||||
| DDS USA Holding, Inc. |
6/30/2022 | 766 | 1,380 | (8 | ) | (7 | ) | |||||||||||||
| Xactly Corporation |
7/29/2022 | 2,177 | 2,177 | (38 | ) | (27 | ) | |||||||||||||
| Purfoods, LLC |
8/12/2022 | 200 | — | (3 | ) | — | ||||||||||||||
| Hygiena Borrower LLC |
8/26/2022 | 550 | 550 | (11 | ) | (11 | ) | |||||||||||||
| Lithium Technologies, Inc. |
10/3/2022 | 2,873 | 3,448 | (122 | ) | (52 | ) | |||||||||||||
| Businessolver.com, Inc. |
5/15/2023 | 3,760 | 2,256 | (94 | ) | (39 | ) | |||||||||||||
| Integral Ad Science, Inc. |
7/19/2023 | 2,586 | 2,586 | (97 | ) | (39 | ) | |||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
8/21/2023 | 1,506 | 226 | (53 | ) | (2 | ) | |||||||||||||
| Gastro Health Holdco, LLC |
9/4/2023 | 2,900 | 2,900 | (123 | ) | (44 | ) | |||||||||||||
| Empirix, Inc. |
9/25/2023 | 1,800 | 1,800 | (54 | ) | (180 | ) | |||||||||||||
| WebPT, Inc. |
8/28/2024 | 778 | 1,556 | (31 | ) | (31 | ) | |||||||||||||
| Fenergo Finance 3 Limited |
9/5/2024 | 2,579 | 2,468 | (32 | ) | (19 | ) | |||||||||||||
| Fenergo Finance 3 Limited |
9/5/2024 | 1,683 | 1,683 | (21 | ) | (13 | ) | |||||||||||||
| iCIMS, Inc. |
9/12/2024 | 2,662 | 2,662 | (47 | ) | (47 | ) | |||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & Technology) |
11/15/2024 | 1,810 | 3,258 | (27 | ) | (57 | ) | |||||||||||||
| Wrike, Inc. |
12/31/2024 | 2,300 | 2,300 | — | (46 | ) | ||||||||||||||
| Apptio, Inc. |
1/10/2025 | 3,160 | 3,160 | (47 | ) | (55 | ) | |||||||||||||
| ConnectWise, LLC |
2/28/2025 | 1,524 | 1,524 | (15 | ) | (19 | ) | |||||||||||||
| Villa Bidco Inc (dba Authority Brands) |
3/21/2025 | 1,118 | — | (22 | ) | — | ||||||||||||||
| Mailgun Technologies, Inc. |
3/26/2025 | 1,448 | 1,448 | — | (25 | ) | ||||||||||||||
| Internet Truckstop Group, LLC (dba Truckstop) |
4/2/2025 | 2,600 | 2,600 | (52 | ) | (39 | ) | |||||||||||||
| PlanSource Holdings, Inc. |
4/22/2025 | 4,681 | 4,681 | (164 | ) | (94 | ) | |||||||||||||
| CorePower Yoga LLC |
5/14/2025 | 807 | 1,009 | (121 | ) | (15 | ) | |||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies) |
6/13/2025 | 4,722 | 4,722 | (47 | ) | (94 | ) | |||||||||||||
| Riverpoint Medical, LLC |
6/21/2025 | 2,450 | 2,450 | (92 | ) | (25 | ) | |||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) |
7/9/2025 | 2,805 | 2,384 | (203 | ) | (48 | ) | |||||||||||||
| WorkForce Software, LLC |
7/31/2025 | 1,123 | 1,123 | (28 | ) | (23 | ) | |||||||||||||
| Diligent Corporation |
8/4/2025 | 1,800 | 216 | (45 | ) | (2 | ) | |||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) |
8/15/2025 | 2,707 | 2,572 | (95 | ) | (45 | ) | |||||||||||||
| Elemica Parent, Inc. |
9/18/2025 | 132 | 366 | (9 | ) | (9 | ) | |||||||||||||
| CST Buyer Company (dba Intoxalock) |
10/3/2025 | 1,294 | 1,294 | — | — | |||||||||||||||
| Acquia, Inc. |
10/31/2025 | 1,946 | 1,946 | (58 | ) | (39 | ) | |||||||||||||
| Chronicle Bidco Inc. (dba Lexitas) |
11/14/2025 | 1,300 | 1,300 | (39 | ) | (26 | ) | |||||||||||||
| Governmentjobs.com, Inc. (dba NeoGov) |
2/5/2026 | 3,595 | — | (63 | ) | — | ||||||||||||||
| MRI Software LLC |
2/10/2026 | 990 | — | (35 | ) | — | ||||||||||||||
| Instructure Holdings |
3/24/2026 | 3,000 | — | (30 | ) | — | ||||||||||||||
| Project Eagle Holdings, LLC |
7/6/2026 | 37 | — | (1 | ) | — | ||||||||||||||
| Granicus, Inc. |
8/21/2026 | 929 | — | (23 | ) | — | ||||||||||||||
| Foundation Software |
8/31/2026 | 61 | — | (2 | ) | — | ||||||||||||||
| Bullhorn, Inc. |
9/30/2026 | 799 | 799 | (12 | ) | (12 | ) | |||||||||||||
| MedeAnalytics, Inc. |
10/9/2026 | 465 | — | — | — | |||||||||||||||
| Gastro Health Holdco, LLC |
4/13/2020 | — | 1,072 | — | (16 | ) | ||||||||||||||
| GlobalTranz Enterprises, Inc. |
5/15/2020 | — | 2,968 | — | (267 | ) | ||||||||||||||
| Hygiena Borrower LLC |
6/29/2020 | — | 814 | — | (16 | ) | ||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene) |
8/30/2020 | — | 9,120 | — | (182 | ) | ||||||||||||||
| Diligent Corporation |
12/19/2020 | — | 6,083 | — | (61 | ) | ||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
2/28/2021 | — | 3,040 | — | (30 | ) | ||||||||||||||
| CorePower Yoga LLC |
5/14/2021 | — | 2,692 | — | (40 | ) | ||||||||||||||
| CFS Management, LLC (dba Center for Sight Management) |
7/1/2021 | — | 2,067 | — | (21 | ) | ||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) |
8/15/2021 | — | 6,768 | — | (118 | ) | ||||||||||||||
| Gastro Health Holdco, LLC |
9/13/2021 | — | 7,200 | — | (108 | ) | ||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas) |
11/14/2021 | — | 4,330 | — | (43 | ) | ||||||||||||||
| SPay, Inc. (dba Stack Sports) |
6/17/2024 | — | 543 | — | (18 | ) | ||||||||||||||
| Associations, Inc. |
7/30/2024 | — | 836 | — | (8 | ) | ||||||||||||||
| Eptam Plastics, Ltd. |
12/6/2025 | — | 1,015 | — | (15 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total 1st Lien/Senior Secured Debt |
$ | 85,243 | $ | 124,082 | $ | (2,255 | ) | $ | (2,265 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| 2nd Lien/Senior Secured Debt |
||||||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners) |
3/29/2020 | — | $ | 816 | — | $ | (8 | ) | ||||||||||||
| Hygiena Borrower LLC |
6/29/2020 | — | 831 | — | (15 | ) | ||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software) |
7/31/2020 | — | 2,500 | — | (63 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total 2nd Lien/Senior Secured Debt |
$ | — | $ | 4,147 | $ | — | $ | (86 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total |
$ | 85,243 | $ | 128,229 | $ | (2,255 | ) | $ | (2,351 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) | Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity. |
| (2) | Unfunded commitments denominated in currencies other than USD have been converted to USD using the exchange rate as of the applicable reporting date. |
| (3) | The fair value is reflected as investments, at fair value on the Consolidated Statements of Assets and Liabilities. |
34
Contingencies
In the normal course of business, the Company enters into contracts that provide a variety of general indemnifications. Any exposure to the Company under these arrangements could involve future claims that may be made against the Company. Currently, no such claims exist or are expected to arise and, accordingly, the Company has not accrued any liability in connection with such indemnifications.
| 9. | NET ASSETS |
Capital Drawdowns
The following table summarizes the total shares issued and proceeds received related to capital drawdowns:
| Share Issue Date |
Shares Issued | Proceeds Received | ||||||
| For the Nine Months Ended September 30, 2020 |
||||||||
| February 24, 2020 |
3,282,464 | $ | 61,806 | |||||
|
|
|
|
|
|||||
| Total capital drawdowns |
3,282,464 | $ | 61,806 | |||||
|
|
|
|
|
|||||
| For the Nine Months Ended September 30, 2019 |
||||||||
| March 25, 2019 |
4,286,182 | $ | 82,610 | |||||
| June 27, 2019 |
2,179,196 | 41,545 | ||||||
|
|
|
|
|
|||||
| Total capital drawdowns |
6,465,378 | $ | 124,155 | |||||
|
|
|
|
|
|||||
Distributions
The following table reflects the distributions declared on shares of the Company’s common stock:
| Date Declared |
Record Date | Payment Date | Amount Per Share | |||||
|
For the Nine Months Ended September 30, 2020 |
||||||||
| February 27, 2020 |
March 16, 2020 | April 30, 2020 | $ | 0.43 | ||||
| For the Nine Months Ended September 30, 2019 |
||||||||
| February 28, 2019 |
March 15, 2019 | April 30, 2019 | $ | 0.43 | ||||
| May 9, 2019 |
June 14, 2019 | July 31, 2019 | $ | 0.43 | ||||
| August 8, 2019 |
September 13, 2019 | October 31, 2019 | $ | 0.43 | ||||
| 10. | EARNINGS PER SHARE |
The following information sets forth the computation of basic and diluted earnings per share:
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2020 |
September 30, 2019 |
September 30, 2020 |
September 30, 2019 |
|||||||||||||
| Net increase (decrease) in net assets from operations |
$ | 45,735 | $ | 18,500 | $ | 39,658 | $ | 41,479 | ||||||||
| Weighted average shares outstanding |
53,844,947 | 49,470,258 | 53,198,038 | 46,754,248 | ||||||||||||
| Basic and diluted earnings per share |
$ | 0.85 | $ | 0.37 | $ | 0.75 | $ | 0.89 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
Diluted earnings per share equal basic earnings per share because there were no common share equivalents outstanding during the period presented.
35
| 11. | FINANCIAL HIGHLIGHTS |
The below table presents the schedule of financial highlights of the Company:
| Nine Months Ended September 30, 2020 |
Nine Months Ended September 30, 2019 |
|||||||
| Per Share Data:(1) |
||||||||
| NAV, beginning of period |
$ | 18.69 | $ | 19.07 | ||||
| Net investment income (loss) |
1.39 | 1.27 | ||||||
| Net realized and unrealized gains (losses)(2) |
(0.65 | ) | (0.32 | ) | ||||
| Income tax provision, realized and unrealized gains |
0.00 | (6) | (0.01 | ) | ||||
|
|
|
|
|
|||||
| Net increase (decrease) in net assets from operations(2) |
0.74 | 0.94 | ||||||
|
|
|
|
|
|||||
| Distributions declared: |
||||||||
| From net investment income |
(0.43 | ) | (1.29 | ) | ||||
|
|
|
|
|
|||||
| Distributions declared from net investment income |
(0.43 | ) | (1.29 | ) | ||||
|
|
|
|
|
|||||
| Total increase (decrease) in net assets |
0.31 | (0.35 | ) | |||||
|
|
|
|
|
|||||
| NAV, end of period |
$ | 19.00 | $ | 18.72 | ||||
|
|
|
|
|
|||||
| Shares outstanding, end of period |
53,844,947 | 49,470,258 | ||||||
| Weighted average shares outstanding |
53,198,038 | 46,754,248 | ||||||
| Total return based on NAV(3) |
3.96 | % | 4.93 | % | ||||
| Supplemental Data/Ratio(4) (all amounts in thousands except ratios): |
||||||||
| Net assets, end of period |
$ | 1,023,100 | $ | 925,959 | ||||
| Ratio of net expenses to average net assets |
5.87 | % | 6.85 | % | ||||
| Ratio of expenses (without incentive fees and interest and other debt expenses) to net assets |
2.30 | % | 2.13 | % | ||||
| Ratio of interest and other debt expenses to average net assets |
2.67 | % | 2.50 | % | ||||
| Ratio of incentive fees to average net assets |
0.90 | % | 2.22 | % | ||||
| Ratio of total expenses to average net assets |
5.87 | % | 6.85 | % | ||||
| Ratio of net investment income (loss) to average net assets |
10.36 | % | 9.04 | % | ||||
| Average debt outstanding |
$ | 805,444 | $ | 450,012 | ||||
| Average debt per share(5) |
$ | 15.14 | $ | 9.63 | ||||
| Portfolio turnover |
9 | % | 11 | % | ||||
| (1) | The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared, which reflects the actual amount of distributions declared per share for the applicable period. |
| (2) | The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the distribution. |
| (3) | Calculated as the change in NAV per share during the period plus dividends declared per share, divided by the beginning NAV per share. |
| (4) | Ratios are annualized except for certain operating expenses, as applicable. |
| (5) | Calculated as average debt outstanding divided by the weighted average shares outstanding during the applicable period. |
| (6) | Amount rounds to less than $0.00. |
| 12. | SUBSEQUENT EVENTS |
Subsequent events after the date of the Consolidated Statements of Assets and Liabilities have been evaluated through the date the unaudited consolidated financial statements were issued. Other than items discussed below, the Company has concluded that there is no impact requiring adjustment or disclosure in the consolidated financial statements.
Prior to consummation of the Merger, and as previously announced, on October 3, 2020, the Board of Directors declared a special distribution of $75,000, or $1.39 per share, payable on October 30, 2020 to shareholders of record as of October 9, 2020.
On October 12, 2020, the Company completed its previously announced merger with GS BDC pursuant to the Merger Agreement, dated as of June 11, 2020. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of the Company’s common stock was converted into the right to receive, for each share of the Company’s common stock, that number of shares of GS BDC Common Stock with a NAV equal to the NAV per share of the Company’s common stock, in each case calculated as of October 9, 2020. As a result of the Merger, GS BDC issued an aggregate of 61,037,311 shares of GS BDC Common Stock to the Company’s former stockholders. Upon consummation of the Merger, the separate corporate existence of the Company ended. For more information about the Merger, see the Company’s Current Report on Form 8-K filed on October 13, 2020, the Company’s Form N-54C filed on October 13, 2020, and the Company’s Form 15 filed on October 13, 2020.
With the consummation of the Merger, the Truist Revolving Credit facility was terminated.
36
Exhibit 99.2
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The following unaudited pro forma condensed consolidated financial information and explanatory notes illustrate the effect of the Merger (as defined below) on the financial position and results of operations of Goldman Sachs BDC, Inc. (“GSBD”) based upon the respective historical financial positions and results of operations of GSBD and Goldman Sachs Middle Market Lending Corp. (“MMLC”) under the asset acquisition method of accounting with GSBD treated as the acquirer. The unaudited pro forma condensed consolidated financial information has been derived from and should be read in conjunction with the historical consolidated financial statements and the related notes of GSBD, which are included in GSBD’s quarterly report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 5, 2020, and MMLC, which are included as Exhibit 99.1 hereto.
GSBD entered into the Agreement and Plan of Merger (the “Original Merger Agreement”), with MMLC, Evergreen Merger Sub Inc., a wholly owned subsidiary of GSBD (“Merger Sub”) and Goldman Sachs Asset Management, L.P., the investment adviser to each of GSBD and MMLC (“GSAM,” and together with GSBD, MMLC and Merger Sub, the “Parties”). The Parties amended and restated the Original Merger Agreement in its entirety (as amended and restated, the “Amended and Restated Merger Agreement”). Pursuant to and subject to the terms and conditions of the Amended and Restated Merger Agreement, Merger Sub will merge with and into MMLC, with MMLC continuing as the surviving company and as a wholly-owned subsidiary of GSBD (the “Initial Merger”) and, immediately thereafter, MMLC will merge with and into GSBD, with GSBD continuing as the surviving company (the “Second Merger” and, together with the Initial Merger, the “Merger”).
The unaudited pro forma condensed consolidated financial information includes the unaudited pro forma condensed consolidated Statement of Assets and Liabilities as of September 30, 2020 assuming the Merger had been completed on September 30, 2020. The unaudited pro forma condensed consolidated Statement of Operations for the nine months ended September 30, 2020, and for the year ended December 31, 2019 were prepared assuming the Merger had been completed on January 1, 2019. Additionally, the unaudited pro forma condensed consolidated financial information for the year ended December 31, 2019 includes the following events that occurred in February 2020: (i) GSBD’s issuance of $360.0 million of 2025 Notes, (ii) the amendment of the GSBD Credit Facility, and (iii) MMLC’s capital drawdowns of $61.8 million. Such unaudited pro forma condensed consolidated financial statements are based on the historical financial statements of GSBD and MMLC from publicly available information and certain assumptions and adjustments as discussed in Note 2 “Preliminary Pro Forma Adjustments” of the accompanying notes to the unaudited pro forma condensed consolidated financial statements in this section.
The Amended and Restated Merger Agreement provides that each MMLC stockholder will be entitled to receive, for each share of MMLC common stock, par value $0.001 per share (“MMLC Common Stock”), that number of shares of GSBD common stock, par value $0.001 per share (“GSBD Common Stock”) with a net asset value (“NAV”) equal to the NAV per share of MMLC Common Stock, in each case calculated as of the same date within 48 hours (excluding Sundays and holidays) prior to the closing of the Merger.
Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain “non-qualifying” assets (for example cash) and does not give rise to goodwill. GSBD will be the accounting survivor of the Merger. GSBD believes that the acquisition of MMLC should be accounted for as an asset acquisition based on the nature of its pre-acquisition operations and other factors outlined in ASC 805-50—Business Combinations—Related Issues, with the fair value of total consideration paid in conjunction with the Merger allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Merger. See the section entitled “Accounting Treatment of the Merger” in GSBD’s joint proxy statement and prospectus that forms a part of a registration statement on Form N-14 filed with the SEC on August 4, 2020 for additional information.
The unaudited pro forma condensed consolidated financial information is presented for illustrative purposes only and does not necessarily indicate the results of operations or the combined financial position that would have resulted had the Merger been completed at the beginning of the applicable period presented, nor the impact of expense efficiencies, asset dispositions, share repurchases and other factors. In addition, as explained in more detail in the accompanying notes to the unaudited pro forma condensed consolidated financial information, the allocation of the pro forma purchase price reflected in the unaudited pro forma condensed consolidated financial information involves estimates, is subject to adjustment and may vary significantly from the actual purchase price allocation that will be recorded upon completion of the Merger.
See notes to unaudited pro forma condensed consolidated financial statements.
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Statement of Assets and Liabilities
As of September 30, 2020
Unaudited
(In thousands, except share and per share data)
| Actual | Actual | Pro Forma | ||||||||||||||||||
| Goldman Sachs | Goldman Sachs BDC, |
|||||||||||||||||||
| Goldman Sachs BDC, Inc. |
Middle Market Lending Corp. |
Pro Forma Adjustments |
Inc. Combined |
|||||||||||||||||
| Assets and Liabilities Data: |
||||||||||||||||||||
| Investments, at fair value |
$ | 1,431,195 | $ | 1,688,542 | $ | — | (A) | $ | 3,119,737 | |||||||||||
| Cash and cash equivalents, and foreign currencies |
114,810 | 177,709 | — | 292,519 | ||||||||||||||||
| Deferred financing costs |
8,144 | 1,988 | 1,812 | (B) | 11,944 | |||||||||||||||
| Other assets |
15,303 | 12,746 | 4,033 | (C) | 32,082 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total assets |
1,569,452 | 1,880,985 | 5,845 | 3,456,282 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Liabilities & Net Assets |
||||||||||||||||||||
| Debt (net of debt issuance cost associated with GSBD) |
911,685 | 843,219 | — | (B) | 1,754,904 | |||||||||||||||
| Other liabilities |
31,344 | 14,666 | 85,800 | (B)(C)(D) | 131,810 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total liabilities |
943,029 | 857,885 | 85,800 | 1,886,714 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total Net Assets |
626,423 | 1,023,100 | (79,955) | 1,569,568 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total liabilities and net assets |
$ | 1,569,452 | $ | 1,880,985 | $ | 5,845 | $ | 3,456,282 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Number of shares of common stock outstanding |
40,448,044 | 53,844,947 | 7,617,827 | (E) | 101,910,818 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net asset value per share |
$ | 15.49 | $ | 19.00 | $ | 15.40 | ||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
See notes to unaudited pro forma condensed consolidated financial statements.
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Statement of Operations
For the Nine Months Ended September 30, 2020
Unaudited
(In thousands, except share and per share data)
| Actual | Actual | Pro Forma | ||||||||||||||||||
| Goldman Sachs BDC, Inc. |
Goldman Sachs Middle Market Lending Corp. |
Pro Forma Adjustments |
Goldman Sachs BDC, Inc. Combined |
|||||||||||||||||
| Performance Data: |
||||||||||||||||||||
| Interest and dividend income |
$ | 92,332 | $ | 114,331 | $ | 12,518 | (A) | $ | 219,181 | |||||||||||
| Other income |
1,695 | 2,186 | — | 3,881 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total investment income |
94,027 | 116,517 | 12,518 | 223,062 | ||||||||||||||||
| Interest and other debt expenses |
26,897 | 19,162 | (2,180 | ) | (B) | 43,879 | ||||||||||||||
| Management fees |
10,901 | 10,739 | 2,088 | (F) | 23,728 | |||||||||||||||
| Incentive fees |
737 | 6,456 | 3,449 | (F) | 10,642 | |||||||||||||||
| Other expenses |
5,479 | 6,431 | (2,790 | ) | (C)(G) | 9,120 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total expenses |
44,014 | 42,788 | 567 | 87,369 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Incentive fees waiver |
(737 | ) | — | 737 | (F) | — | ||||||||||||||
| Management fees waiver |
(3,807 | ) | — | 3,807 | (F) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net investment income |
54,557 | 73,729 | 7,407 | 135,693 | ||||||||||||||||
| Net realized gain (loss) |
(47,389 | ) | 396 | — | (46,993 | ) | ||||||||||||||
| Net change in unrealized appreciation (depreciation) |
(3,782 | ) | (34,394 | ) | (12,518 | ) | (A) | (50,694 | ) | |||||||||||
| Total net realized and unrealized gains (losses) |
(51,171 | ) | (33,998 | ) | (12,518 | ) | (97,687 | ) | ||||||||||||
| (Provision) benefit for taxes |
92 | (73 | ) | — | 19 | |||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
| Net increase (decrease) in net assets resulting from operations |
3,478 | 39,658 | (5,111 | ) | 38,025 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Per Common Share Data |
||||||||||||||||||||
| Weighted average shares outstanding(1) |
40,413,082 | 53,198,038 | 8,264,736 | 101,875,856 | ||||||||||||||||
| Net investment income per share (basic and diluted) |
$ | 1.35 | $ | 1.39 | $ | 1.33 | ||||||||||||||
| Earnings per share (basic and diluted) |
$ | 0.09 | $ | 0.75 | $ | 0.37 | ||||||||||||||
| (1) | Basic and diluted weighted average shares outstanding for Pro Forma Goldman Sachs BDC, Inc. is estimated by adding estimated share issuance to MMLC stockholders of 61,462,774 shares to weighted average shares outstanding for GSBD for the nine months ended September 30, 2020. |
See notes to unaudited pro forma condensed consolidated financial statements.
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2019
Unaudited
(In thousands, except share and per share data)
| Actual | Actual | Pro Forma | ||||||||||||||||
| Goldman Sachs BDC, Inc. |
Goldman Sachs Middle Market Lending Corp. |
Pro Forma Adjustments |
Goldman Sachs BDC, Inc. Combined |
|||||||||||||||
| Performance Data: |
||||||||||||||||||
| Interest and dividend income |
$ | 144,685 | $ | 143,781 | $ | 16,691 | (A) | $ | 305,157 | |||||||||
| Other income |
2,576 | 1,962 | — | 4,538 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total investment income |
147,261 | 145,743 | 16,691 | 309,695 | ||||||||||||||
| Interest and other debt expenses |
36,313 | 24,076 | 553 | (B) | 60,942 | |||||||||||||
| Management fees |
14,696 | 13,665 | 3,360 | (F) | 31,721 | |||||||||||||
| Incentive fees |
9,220 | 18,024 | (2,710 | ) | (F) | 24,534 | ||||||||||||
| Other expenses |
7,707 | 7,133 | (2,455 | ) | (C)(G) | 12,385 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total expenses |
67,936 | 62,898 | (1,252 | ) | 129,582 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Incentive fees waiver |
(394 | ) | — | 394 | (F) | — | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net investment income |
79,719 | 82,845 | 17,549 | 180,113 | ||||||||||||||
| Net realized gain (loss) |
(39,029 | ) | (8,750 | ) | — | (47,779 | ) | |||||||||||
| Net change in unrealized appreciation (depreciation) |
(4,715 | ) | (12,269 | ) | (16,691 | ) | (A) | (33,675 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total net realized and unrealized gains (losses) |
(43,744 | ) | (21,019 | ) | (16,691 | ) | (81,454 | ) | ||||||||||
| (Provision) benefit for taxes |
173 | (694 | ) | — | (521 | ) | ||||||||||||
|
|
|
|
|
|
|
|||||||||||||
| Net increase (decrease) in net assets resulting from operations |
36,148 | 61,132 | 858 | 98,138 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Per Common Share Data |
||||||||||||||||||
| Weighted average shares outstanding(1) |
40,313,662 | 47,453,793 | 14,008,981 | 101,776,436 | ||||||||||||||
| Net investment income per share (basic and diluted) |
$ | 1.98 | $ | 1.75 | $ | 1.77 | ||||||||||||
| Earnings per share (basic and diluted) |
$ | 0.90 | $ | 1.29 | $ | 0.96 | ||||||||||||
| (1) | Basic and diluted weighted average shares outstanding for Pro Forma Goldman Sachs BDC, Inc. is estimated by adding estimated share issuance to MMLC stockholders of 61,462,774 shares to weighted average shares outstanding for GSBD for the year ended December 31, 2019. |
See notes to unaudited pro forma condensed consolidated financial statements.
1. BASIS OF PRO FORMA PRESENTATION
The unaudited pro forma condensed consolidated financial information related to the Merger is included as of and for the nine months ended September 30, 2020, and for the year ended December 31, 2019. On December 9, 2019, GSBD and MMLC entered into the Initial Merger Agreement, which was amended and restated in its entirety on June 11, 2020 by the Amended and Restated Merger Agreement. For the purposes of the pro forma condensed consolidated financial statements, the cost of the acquisition is based on the closing price of GSBD Common Stock as of September 30, 2020, adjusted to include a discount to reflect the impact of transfer restrictions applicable to the shares of GSBD Common Stock issued to MMLC stockholders pursuant to the terms of the Merger and the impact of $3.5 million in estimated transaction costs expected to be incurred by GSBD (the “Pro Forma Accounting Purchase Price”). The Pro Forma Accounting Purchase Price is approximately $863.2 million in stock consideration which is based upon a price of $15.04 per share of GSBD Common Stock as of September 30, 2020 and an implied value per share of MMLC Common Stock of $15.97. The pro forma adjustments included herein reflect the conversion of MMLC Common Stock into GSBD Common Stock using an exchange ratio of 1.1415 of a share of GSBD Common Stock, for each of the 53,844,947 shares of MMLC Common Stock outstanding as of September 30, 2020.
The Merger is accounted for as an asset acquisition of MMLC by GSBD in accordance with the asset acquisition method of accounting as detailed in ASC 805-50, Business Combinations—Related Issues. In applying the asset acquisition method of accounting, GSBD is using a cost approach to allocate the cost of the assets purchased against the assets being acquired. The cost of the acquisition is determined to be the fair value of the consideration given or the fair value of the assets acquired, whichever is more clearly evident. On a pro forma basis, the Pro Forma Accounting Purchase Price was used as a preliminary estimate of purchase price for accounting purposes. The fair value of the Merger Consideration paid by GSBD is allocated to assets acquired and liabilities assumed based on their relative fair values as of the date of acquisition and will not give rise to goodwill. Preliminary purchase accounting allocations are detailed in Note 2 “Preliminary Purchase Accounting Allocations”.
GSBD’s financial statements include its accounts and the accounts of all its consolidated subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates: The preparation of the unaudited pro forma condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Many of the amounts have been rounded, and all amounts are in thousands, except share and per share amounts.
Valuation of Portfolio Investments: The valuation processes and oversight are identical for GSBD and MMLC. As BDCs, GSBD and MMLC conduct the valuation of their assets, pursuant to which their NAV is determined, consistent with GAAP and the 1940 Act. The GSBD Board and MMLC Board, with the assistance of the GSBD Audit Committee and the MMLC Audit Committee, respectively, determines the fair value of each fund’s assets within the meaning of the 1940 Act, on at least a quarterly basis, in accordance with the terms of Financial Accounting Standards Board ASC Topic 820, Fair Value Measurement and Disclosures (“ASC 820”).
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is a market-based measurement, not an entity-specific measurement. For some assets and liabilities, observable market transactions or market information might be available. For other assets and liabilities, observable market transactions and market information might not be available. However, the objective of a fair value measurement in both cases is the same – to estimate the price when an orderly transaction to sell the asset or transfer the liability would take place between market participants at the measurement date under current market conditions (that is, an exit price at the measurement date from the perspective of a market participant that holds the asset or owes the liability).
ASC 820 establishes a hierarchal disclosure framework which ranks the observability of inputs used in measuring financial instruments at fair value. The observability of inputs is impacted by a number of factors, including the type of financial instruments and their specific characteristics. Financial instruments with readily available quoted prices, or for which fair value can be measured from quoted prices in active markets, generally will have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three-level hierarchy for fair value measurement is defined as follows:
Level 1—inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.
Level 2—inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The type of financial instruments in this category includes less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities, and certain over-the-counter derivatives where the fair value is based on observable inputs.
Level 3—inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include investments in privately held entities and certain over-the-counter derivatives where the fair value is based on unobservable inputs.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given financial instrument is based on the lowest level of input that is significant to the fair value measurement. Each of GSBD’s and MMLC’s assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the financial instrument.
With respect to investments for which market quotations are not readily available, or for which market quotations are deemed not reflective of the fair value, the valuation procedures adopted by the GSBD Board and MMLC Board contemplates a multi-step valuation process each quarter, as described below:
| (1) | The quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of Investment Adviser responsible for the portfolio investment; |
| (2) | The GSBD Board and MMLC Board also engage Independent Valuation Advisors to provide independent valuations of the investments for which market quotations are not readily available, or are readily available but deemed not reflective of the fair value of an investment. The Independent Valuation Advisors independently value such investments using quantitative and qualitative information provided by the investment professionals of the Investment Adviser as well as any market quotations obtained from independent pricing services, brokers, dealers or market dealers. The Independent Valuation Advisors also provide analyses to support their valuation methodology and calculations. The Independent Valuation Advisors provide an opinion on a final range of values on such investments to the GSBD Board or the GSBD Audit Committee or the MMLC Board or the MMLC Audit Committee. The Independent Valuation Advisors define fair value in accordance with ASC 820 and utilize valuation approaches including the market approach, the income approach or both. A portion of the portfolio is reviewed on a quarterly basis, and all investments in the portfolio for which market quotations are not readily available, or are readily available, but deemed not reflective of the fair value of an investment, are reviewed at least annually by an Independent Valuation Advisor; |
| (3) | The Independent Valuation Advisors’ preliminary valuations are reviewed by GSAM and the Valuation Oversight Group (“VOG”), a team that is part of the Controllers Department within the Finance Division of Goldman Sachs. The Independent Valuation Advisors’ ranges are compared to GSAM’s valuations to ensure GSAM’s valuations are reasonable. VOG presents the valuations to the Private Investment Valuation and Side Pocket Working Group of the Investment Management Division Valuation Committee, which is comprised of representatives from GSAM who are independent of the investment making decision process; |
| (4) | The Investment Management Division Valuation Committee ratifies fair valuations and makes recommendations to the GSBD Audit Committee or the MMLC Audit Committee; |
| (5) | The Audit Committee of each of the GSBD Board or the MMLC Board, as applicable, reviews valuation information provided by the Investment Management Division Valuation Committee, GSAM and the Independent Valuation Advisors. The relevant Audit Committee then assesses such valuation recommendations; and |
| (6) | Each of the GSBD Board and the MMLC Board discusses the valuations and, within the meaning of the 1940 Act, determines the fair value of investments in good faith, based on the input of GSAM, the Independent Valuation Advisors and the relevant Audit Committee. |
Income Taxes: GSBD has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. As a RIC, GSBD generally will not be required to pay corporate-level U.S. federal income taxes on any net ordinary income or capital gains that GSBD timely distributes to its stockholders as dividends. To maintain its RIC status, GSBD must meet specified source-of-income and asset diversification requirements and timely distribute to stockholders at least 90% of GSBD’s investment company taxable income for each year. Depending upon the level of taxable income earned in a year, GSBD may choose to carry forward taxable income for distribution in the following year and pay any applicable tax. GSBD generally will be required to pay a U.S. federal excise tax if GSBD’s distributions during a calendar year do not exceed the sum of (1) 98% of GSBD’s net ordinary income (taking into account certain deferrals and elections) for the calendar year, (2) 98.2% of GSBD’s capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (3) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years.
Transaction Costs: Both GSBD and MMLC incur direct transaction costs resulting from the Merger. GSBD, as the acquirer in an asset acquisition, will capitalize its transaction costs and such costs will be reflected as an adjustment to the purchase price of MMLC. MMLC will expense its transaction costs as incurred. In the event the Merger is consummated, GSAM shall reimburse each of MMLC and GSBD, in each case in an amount of up to $4.0 million for all fees and expenses incurred and payable by MMLC or on its behalf, on the one hand, and GSBD or on its behalf, on the other hand, in connection with or related to the Merger, the Amended and Restated Merger Agreement and the related transactions (including all documented fees and expenses of counsel, accountants, experts and consultants to MMLC or the MMLC Special Committee, on the one hand, or GSBD or the GSBD Special Committee, on the other hand).
GSBD expects to incur approximately $3.5 million in estimated transaction costs net of GSAM reimbursement, which will be capitalized for the purposes of the purchase price accounting. MMLC expects to incur approximately $3.1 million in estimated transaction costs net of GSAM reimbursement.
2. PRELIMINARY PURCHASE ACCOUNTING ALLOCATIONS
The unaudited pro forma condensed consolidated financial information includes the unaudited Pro Forma Condensed Consolidated Statement of Assets and Liabilities as of September 30, 2020 assuming the Merger had been completed on September 30, 2020. The unaudited Pro Forma Condensed Consolidated Statements of Operations for the nine months ended September 30, 2020 and for the year ended December 31, 2019 were prepared assuming the Merger had been completed on January 1, 2019.
For purposes of the pro forma condensed consolidated financial statements, the cost of the acquisition is based on the Pro Forma Accounting Purchase Price. The Pro Forma Accounting Purchase Price is approximately $863.2 million in stock consideration which is based upon a price of $15.04 per share of GSBD Common Stock as of September 30, 2020. The unaudited Pro Forma Condensed Consolidated Statement of Assets and Liabilities reflects the issuance of 61,462,774 shares of GSBD Common Stock pursuant to the Amended and Restated Merger Agreement.
If the closing stock price of GSBD common stock were to increase or decrease by 5%, the Pro Forma Accounting Purchase Price would be approximately $906 million and $820 million, respectively.
The Merger will be accounted for using the asset acquisition method of accounting. Accordingly, the fair value of the consideration paid by GSBD in connection with the Merger will be allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of acquisition and will not give rise to goodwill.
The Merger closed in the fourth quarter of 2020. The prevailing market price of GSBD Common Stock at closing may differ from the price of GSBD Common Stock on which we have based the Pro Forma Accounting Purchase Price. To the extent that the closing sales price of GSBD Common Stock as of immediately prior to closing, adjusted to include a discount to reflect the impact of transfer restrictions applicable to the shares of GSBD Common Stock issued to MMLC stockholders pursuant to the terms of the Merger and the impact of estimated transaction costs expected to be incurred by GSBD (the “Accounting Purchase Price”) does not closely approximate the NAV of GSBD Common Stock at such time, the difference between the Accounting Purchase Price and the fair value of MMLC’s net assets acquired, would result in a purchase premium or discount (henceforth referred to as the “purchase premium (or discount)”). The purchase premium (or discount) will be allocated to the acquired assets and assumed liabilities of MMLC based on their relative fair values as of the closing date. Immediately following the Merger, GSBD will record its investments, including former MMLC investments, at their respective fair values and, as a result, the purchase premium (or discount) allocated to the cost basis of the investments acquired from MMLC will be recognized as unrealized depreciation (or appreciation). The purchase premium (or discount) allocated to the acquired MMLC investments in loans would amortize over the life of the loans through interest income with a corresponding reversal of the initial unrealized depreciation (or appreciation) on the acquired MMLC loans through their ultimate disposition. The purchase premium (or discount) allocated to the acquired MMLC investments in equity securities would not amortize over the life of the equity securities through interest income and, assuming no subsequent change to the fair value of the acquired MMLC equity securities and disposition of such equity securities at fair value, would be recognized as realized loss (or gain) with a corresponding reversal of the unrealized depreciation (or appreciation) upon disposition of such equity securities.
The following table summarizes the calculation of pro forma purchase price and adjustments to assets acquired and the liabilities assumed based on MMLC’s estimate of relative fair values:
| Goldman Sachs Middle Market Lending Corp. |
Pro Forma Adjustments (1) |
Pro Forma September 30, 2020 |
||||||||||
| Common stock issued |
$ | 863,159 | ||||||||||
|
|
|
|||||||||||
| Total purchase price |
863,159 | |||||||||||
|
|
|
|||||||||||
| Investments, at fair value |
$ | 1,688,542 | $ | — | $ | 1,688,542 | ||||||
| Cash and cash equivalents |
177,709 | — | 177,709 | |||||||||
| Deferred financing costs |
1,988 | (1,988 | ) | — | ||||||||
| Other assets |
12,746 | 4,000 | 16,746 | |||||||||
|
|
|
|
|
|
|
|||||||
| Total assets acquired |
1,880,985 | 2,012 | 1,882,997 | |||||||||
| Debt |
843,219 | — | 843,219 | |||||||||
|
|
|
|
|
|||||||||
| Other liabilities assumed (including transaction costs) |
14,666 | 78,500 | 93,166 | |||||||||
|
|
|
|
|
|
|
|||||||
| Total liabilities |
857,885 | 78,500 | 936,385 | |||||||||
|
|
|
|
|
|
|
|||||||
| Net assets acquired |
$ | 1,023,100 | $ | (76,488 | ) | $ | 946,612 | |||||
|
|
|
|
|
|
|
|||||||
| Purchase discount (2) |
$ | (83,453) | ||||||||||
|
|
|
|||||||||||
| (1) | Pro Forma adjustments are detailed in Note 3 “Preliminary Pro Forma Adjustments.” |
| (2) | Purchase discount is allocated to cost of investments acquired after initial recognition of cost at fair value of assets acquired, illustrated in the table below. |
| Pro Forma Adjustments | ||||||||||||||||
| Goldman Sachs Middle Market Lending Corp. September 30, 2020 |
Recognition of Cost at Fair Value of Assets Acquired |
Purchase Discount |
Pro Forma September 30, 2020 |
|||||||||||||
| Investments, at fair value: |
||||||||||||||||
| Amortized Cost |
$ | 1,739,572 | $ | (51,030 | ) | $ | (83,453 | ) | $ | 1,605,089 | ||||||
| Unrealized appreciation (depreciation) on investments |
(51,030 | ) | 51,030 | 83,453 | 83,453 | |||||||||||
|
|
|
|
|
|||||||||||||
| $ | 1,688,542 | $ | 1,688,542 | |||||||||||||
3. PRELIMINARY PURCHASE ACCOUNTING ALLOCATIONS
(A) The pro forma adjustment to investments at fair value reflects the initial recognition by GSBD of MMLC investments at fair value, a decrease in cost of investments equal to the calculated pro forma purchase discount and a corresponding increase to unrealized appreciation (depreciation) on investments. The pro forma adjustment to interest and dividend income reflects the amortization of the purchase discount resulting from the purchase discount paid in the Merger allocated to the investments in loan securities acquired from MMLC over a period of five years (represents the average remaining term of loan securities acquired) and the corresponding reversal of the unrealized appreciation, described in the preceding sentence, on the loans acquired from MMLC. The adjustment assumes the estimated purchase discount calculated as of September 30, 2020 of $83.5 million equates to the purchase discount if the Merger had occurred on January 1, 2019. Based on these assumptions, Pro Forma Condensed Consolidated Statements of Operations reflect increases to interest income and corresponding reversals of unrealized appreciation.
(B) The pro forma adjustment to deferred financing costs on the Pro Forma Condensed Consolidated Statement of Assets and Liabilities reflects the elimination of $2.0 million of unamortized deferred financing costs associated with the extinguishment of MMLC’s revolving credit facility debt balance on the Pro Forma Condensed Consolidated Statement of Assets and Liabilities, which is offset by the anticipated increase in capacity and amount outstanding under the GSBD existing credit facility (the “GSBD Credit Facility”) following the consummation of the Merger, as discussed below.
In addition, the pro forma adjustment reflects approximately $3.8 million in fees and expenses to be capitalized to deferred financing costs on the Pro Forma Condensed Consolidated Statement of Assets and Liabilities and the corresponding liability to be recorded in other liabilities for the fees and expenses incurred in connection with increasing the borrowing capacity of the GSBD Credit Facility upon consummation of the Merger.
The adjustment of $2.2 million to interest and other debt expenses on the Pro Forma Condensed Consolidated Statement of Operations for the nine months ended September 30, 2020 includes (i) the elimination of unamortized deferred financing costs associated with MMLC’s revolving credit facility that will not be acquired as part of the Merger; (ii) amortization of deferred financing costs associated with the aforementioned increase of borrowing capacity to the GSBD Credit Facility; and (iii) a recalculation of the interest expense related to MMLC’s outstanding debt balance utilizing the weighted average interest rate of 2.69% as of September 30, 2020 for the GSBD Credit Facility that will remain in place following the consummation of the Merger.
The adjustment of $0.6 million to interest and other debt expenses on the Pro Forma Condensed Consolidated Statement of Operations for the year ended December 31, 2019, includes (i) the elimination of unamortized deferred financing costs associated with MMLC’s revolving credit facility that will not be acquired as part of the Merger; (ii) amortization of deferred financing costs associated with the February 25, 2020 amendment to the GSBD Credit Facility and the aforementioned increase in capacity to the GSBD Credit Facility; (iii) amortization of debt issuance costs associated with the 2025 Notes issuance and the corresponding interest expense; and (iv) a recalculation of the interest expense related to the estimated weighted average debt outstanding of $900.0 million utilizing the weighted average interest rate of 3.64% under the amended terms for the GSBD Credit Facility that will remain in place following the consummation of the Merger.
(C) In the event the Merger is consummated, GSAM shall reimburse each of MMLC and GSBD, in each case in an amount of up to $4.0 million for all fees and expenses incurred and payable by MMLC or on its behalf, on the one hand, and GSBD or on its behalf, on the other hand, in connection with or related to the Merger, the Amended and Restated Merger Agreement and the related transactions (including all documented fees and expenses of counsel, accountants, experts and consultants to MMLC or the MMLC Special Committee, on the one hand, or GSBD or the GSBD Special Committee, on the other hand). An asset equal to the aggregate reimbursement amount of $8.0 million was added to the Pro Forma Condensed Consolidated Statement of Assets and Liabilities.
GSBD’s estimated transaction costs are $7.5 million, for which $1.0 million was capitalized for the year ended December 31, 2019 and an incremental $3.0 million was capitalized for the nine months ended September 30, 2020. Transaction expenses for GSBD are included in other assets on GSBD’s Consolidated Statement of Assets and Liabilities and have been removed as the transaction costs are capitalized in the purchase price. The remaining estimated outstanding transaction costs of $3.5 million were added to the Pro Forma Condensed Consolidated Statements of Assets and Liabilities, within other liabilities. Estimated transaction costs are $ 3.5 million net of GSAM reimbursement, which have been capitalized, as well as utilized for purposes of calculating the exchange ratio.
MMLC’s estimated transaction costs are $7.1 million, for which $1.5 million was expensed for the year ended December 31, 2019 and an incremental $2.1 million was expensed for the nine months ended September 30, 2020. The remaining estimated outstanding transaction costs of $3.5 million were added to the Pro Forma Condensed Consolidated Statements of Assets and Liabilities, within other liabilities. Transaction expenses for MMLC are included in other expenses on MMLC’s Consolidated Statement of Operations and have been removed from the Pro-Forma Condensed Statement of Operations as these are non-recurring expenses.
(D) In addition to the pro forma adjustment made in footnotes (B) and (C), the pro forma adjustment reflects the estimated distribution of approximately $75.0 million to MMLC stockholders relating to the pre-closing period that the MMLC Board will declare prior to the closing, subject to MMLC’s compliance with all applicable regulatory requirements and covenants contained in debt agreements to which MMLC is party or subject.
(E) This pro forma adjustment reflects shares of GSBD Common Stock issued to MMLC stockholders based on an exchange ratio of 1.1415 shares of GSBD Common Stock for each share of MMLC Common Stock held as of September 30, 2020. For purposes of calculating the exchange ratio, the NAV of MMLC as of September 30, 2020 was adjusted by (i) elimination of unamortized deferred financing discussed in footnote (B), (ii) estimated net transaction costs discussed in footnote (C); and (iii) the distribution to MMLC stockholders discussed in footnote (D). New shares of GSBD Common Stock issued equal the adjusted NAV per share of MMLC Common Stock of $17.58 divided by the adjusted NAV per share of GSBD Common Stock as of September 30, 2020 of $15.40. This resulted in an increase in total combined shares outstanding of 7,617,827.
(F) After the Merger, MMLC’s assets will be subject to the Second Amended and Restated Investment Management Agreement, dated June 15, 2018, by and between GSBD and GSAM (the “GSBD Investment Management Agreement”). The adjustments included in the Pro Forma Condensed Consolidated Statements of Operations are to account for differences in the calculation of management and incentive fees between the Investment Management Agreement, dated January 13, 2017, by and between MMLC and GSAM (the “MMLC Investment Management Agreement”) and the GSBD Investment Management Agreement.
In addition, the voluntary management fee waiver for GSBD has been removed from the Pro-Forma Condensed Statement of Operations as this was a non-recurring waiver.
In addition, in connection with the Merger, GSAM has agreed to waive a portion of its incentive fee for nine quarters, commencing with the quarter ending December 31, 2019 through and including the quarter ending December 31, 2021, otherwise payable by GSBD under the GSBD Investment Management Agreement, for each such quarter in an amount sufficient to ensure that GSBD’s net investment income per weighted share outstanding for such quarter is at least $0.48 per share. Because the Incentive Fee Waiver is temporary and short-term, the calculation of incentive fees presented in the Pro Forma Condensed Consolidated Statements of Operations for the nine months ended September 30, 2020 and the year ended December 31, 2019 do not take into account the Incentive Fee Waiver and has been removed from the Pro-Forma Condensed Statement of Operations.
(G) In addition to the pro forma adjustment made to other expenses in footnote (C) for MMLC transaction expenses, which are included in other expenses on MMLC’s Consolidated Statement of Operations and have been removed from the Pro Forma Condensed Statement of Operations as these are non-recurring expenses, the pro forma adjustment to other expenses reflects the impact of the Merger on professional fees and general and administrative expenses representing cost savings attributable to the Merger.
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Schedule of Investments
Unaudited
As of September 30, 2020
(In thousands)
| Actual | Actual | |||||||||||||||||||||||||||||||||||
| Goldman Sachs BDC, Inc. |
Goldman Sachs Middle Market Lending Corp. |
Pro Forma Combined |
||||||||||||||||||||||||||||||||||
| Investment* |
Industry | Interest |
Reference Rate |
Maturity Date |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Footnotes | |||||||||||||||||||||||||
| 1st Lien Senior Secured Debt |
||||||||||||||||||||||||||||||||||||
| 3SI Security Systems, Inc. |
Commercial Services & Supplies |
6.75% | L + 5.75%; 1.00% Floor | 6/16/2023 | 14,419 | 14,228 | — | — | 14,419 | 14,228 | (1) | |||||||||||||||||||||||||
| 3SI Security Systems, Inc. |
Commercial Services & Supplies |
6.75% | L + 5.75%; 1.00% Floor | 6/16/2023 | — | — | 2,193 | 2,166 | 2,193 | 2,166 | (1) | |||||||||||||||||||||||||
| A Place For Mom, Inc. |
Diversified Consumer Services |
4.75% | L + 3.75%; 1.00% Floor | 8/10/2024 | 8,769 | 7,897 | — | — | 8,769 | 7,897 | ||||||||||||||||||||||||||
| Accuity Delivery Systems, LLC |
Health Care Providers & Services |
8.00% | L + 7.00%; 1.00% Floor | 6/13/2023 | 9,989 | 10,424 | 14,222 | 14,842 | 24,211 | 25,266 | ^ (1) (2) | |||||||||||||||||||||||||
| Acquia, Inc. |
Software | 8.00% | L + 7.00%; 1.00% Floor | 10/31/2025 | 12,147 | 11,993 | 17,877 | 17,651 | 30,024 | 29,644 | (1) (2) | |||||||||||||||||||||||||
| Acquia, Inc. |
Software | L + 7.00%; 1.00% Floor | 10/31/2025 | (22 | ) | (40 | ) | (33 | ) | (58 | ) | (55 | ) | (98 | ) | (1) (2) (3) | ||||||||||||||||||||
| Ansira Partners, Inc. |
Professional Services |
7.50% | L + 6.50% PIK; 1.00% Floor | 12/20/2024 | 4,634 | 3,865 | — | — | 4,634 | 3,865 | ||||||||||||||||||||||||||
| Ansira Partners, Inc. |
Professional Services |
7.50% | L + 6.50% PIK; 1.00% Floor | 12/20/2024 | 285 | 238 | — | — | 285 | 238 | ||||||||||||||||||||||||||
| Apptio, Inc. |
IT Services | 8.25% | L + 7.25%; 1.00% Floor | 1/10/2025 | 32,198 | 32,212 | 45,735 | 45,755 | 77,933 | 77,967 | (1) (2) | |||||||||||||||||||||||||
| Apptio, Inc. |
IT Services | L + 7.25%; 1.00% Floor | 1/10/2025 | (32 | ) | (33 | ) | (45 | ) | (47 | ) | (77 | ) | (80 | ) | (1) (2) (3) | ||||||||||||||||||||
| Associations, Inc. |
Real Estate Management & Development |
8.00% | L + 7.00% (incl. 3.00% PIK); 1.00% Floor |
7/30/2024 | 13,744 | 13,303 | 19,582 | 18,954 | 33,326 | 32,257 | (1) (2) | |||||||||||||||||||||||||
| Associations, Inc. |
Real Estate Management & Development |
8.23% | L + 7.00% (incl. 3.00% PIK); 1.00% Floor | 7/30/2024 | 2,965 | 2,868 | 4,224 | 4,086 | 7,189 | 6,954 | (1) (2) (3) | |||||||||||||||||||||||||
| Associations, Inc. |
Real Estate Management & Development |
7.00% | L + 6.00%; 1.00% Floor | 7/30/2024 | 582 | 563 | 829 | 802 | 1,411 | 1,365 | (1) (2) | |||||||||||||||||||||||||
| ATX Networks Corp. |
Communications Equipment |
8.75% | L + 7.75% (incl. 1.50% PIK); 1.00% Floor | 12/31/2023 | 7,208 | 6,352 | — | — | 7,208 | 6,352 | ||||||||||||||||||||||||||
| ATX Networks Corp. |
Communications Equipment |
8.75% | L + 7.75% (incl. 1.50% PIK); 1.00% Floor | 12/31/2023 | 457 | 404 | — | — | 457 | 404 | ||||||||||||||||||||||||||
| Badger Sportswear, Inc. |
Textiles, Apparel & Luxury Goods |
6.25% | L + 5.00%; 1.00% Floor | 9/11/2023 | 7,102 | 5,363 | — | — | 7,102 | 5,363 | ||||||||||||||||||||||||||
| Barbri, Inc. |
Diversified Consumer Services |
5.33% | L + 4.25%; 1.00% Floor | 12/1/2023 | 6,225 | 5,681 | — | — | 6,225 | 5,681 | ||||||||||||||||||||||||||
| BJH Holdings III Corp. (dba Jack’s Family Restaurants) |
Hotels, Restaurants & Leisure |
6.50% | L + 5.50%; 1.00% Floor | 8/19/2025 | 6,110 | 5,916 | 8,952 | 8,667 | 15,062 | 14,583 | (2) | |||||||||||||||||||||||||
| Brillio, LLC |
IT Services | 5.75% | L + 4.75%; 1.00% Floor | 2/6/2025 | 4,429 | 4,363 | 6,468 | 6,371 | 10,897 | 10,734 | (1) (2) | |||||||||||||||||||||||||
| Brillio, LLC |
IT Services | 5.75% | L + 4.75%; 1.00% Floor | 2/6/2025 | 755 | 721 | 1,100 | 1,050 | 1,855 | 1,771 | (1) (2) (3) | |||||||||||||||||||||||||
| Bullhorn, Inc. |
Professional Services |
6.75% | L + 5.75%; 1.00% Floor | 9/30/2026 | 10,717 | 10,748 | 15,702 | 15,749 | 26,419 | 26,497 | (2) | |||||||||||||||||||||||||
| Bullhorn, Inc. |
Professional Services |
6.75% | L + 5.75%; 1.00% Floor | 9/30/2026 | 222 | 223 | 326 | 327 | 548 | 550 | (2) | |||||||||||||||||||||||||
| Bullhorn, Inc. |
Professional Services |
6.75% | L + 5.75%; 1.00% Floor | 9/30/2026 | 177 | 178 | 260 | 260 | 437 | 438 | (2) | |||||||||||||||||||||||||
| Bullhorn, Inc. |
Professional Services |
L + 5.75%; 1.00% Floor | 9/30/2026 | (9 | ) | (7 | ) | (13 | ) | (11 | ) | (22 | ) | (18 | ) | (2) (3) | ||||||||||||||||||||
| Bullhorn, Inc. |
Professional Services |
L + 5.75%; 1.00% Floor | 9/30/2026 | (10 | ) | (8 | ) | (14 | ) | (12 | ) | (24 | ) | (20 | ) | (2) (3) | ||||||||||||||||||||
| Businessolver.com, Inc. |
Health Care Technology |
8.50% | L + 7.50%; 1.00% Floor | 5/15/2023 | 12,403 | 12,235 | 29,726 | 29,324 | 42,129 | 41,559 | (1) (2) | |||||||||||||||||||||||||
| Businessolver.com, Inc. |
Health Care Technology |
8.50% | L + 7.50%; 1.00% Floor | 5/15/2023 | 10,986 | 10,896 | — | — | 10,986 | 10,896 | (1) (2) | |||||||||||||||||||||||||
| Businessolver.com, Inc. |
Health Care Technology |
8.50% | L + 7.50%; 1.00% Floor | 5/15/2023 | 1,859 | 1,835 | 4,455 | 4,399 | 6,314 | 6,234 | (1) (2) | |||||||||||||||||||||||||
| Businessolver.com, Inc. |
Health Care Technology |
L + 7.50%; 1.00% Floor | 5/15/2023 | (17 | ) | (39 | ) | (40 | ) | (94 | ) | (57 | ) | (133 | ) | (1) (2) (3) | ||||||||||||||||||||
| CFS Management, LLC (dba Center for Sight Management) |
Health Care Providers & Services |
6.75% | L + 5.75%; 1.00% Floor | 7/1/2024 | 4,723 | 4,595 | 6,884 | 6,697 | 11,607 | 11,292 | (1) (2) | |||||||||||||||||||||||||
| CFS Management, LLC (dba Center for Sight Management) |
Health Care Providers & Services |
6.75% | L + 5.75%; 1.00% Floor | 7/1/2024 | 1,407 | 1,368 | 2,051 | 1,995 | 3,458 | 3,363 | (1) (2) | |||||||||||||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas) |
Professional Services |
6.75% | L + 5.75%; 1.00% Floor | 11/14/2025 | 6,825 | 6,739 | 10,043 | 9,916 | 16,868 | 16,655 | (1) (2) | |||||||||||||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas) |
Professional Services |
6.75% | L + 5.75%; 1.00% Floor | 11/14/2025 | 2,872 | 2,837 | 4,230 | 4,178 | 7,102 | 7,015 | (1) (2) | |||||||||||||||||||||||||
| Chronicle Bidco Inc. (dba Lexitas) |
Professional Services |
L + 5.75%; 1.00% Floor | 11/14/2025 | (15 | ) | (26 | ) | (22 | ) | (39 | ) | (37 | ) | (65 | ) | (1) (2) (3) | ||||||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates) |
Health Care Providers & Services |
7.50% | L + 6.50%; 1.00% Floor | 3/28/2025 | 8,806 | 8,633 | 12,566 | 12,319 | 21,372 | 20,952 | ^^^ (1) (2) | |||||||||||||||||||||||||
| Collaborative Imaging, LLC (dba Texas Radiology Associates) |
Health Care Providers & Services |
7.50% | L + 6.50%; 1.00% Floor | 3/28/2025 | 6,518 | 6,404 | 9,550 | 9,383 | 16,068 | 15,787 | ^^^ (1) (2) | |||||||||||||||||||||||||
| ConnectWise, LLC |
IT Services | 7.00% | L + 6.00%; 1.00% Floor | 2/28/2025 | 13,231 | 13,329 | 19,464 | 19,608 | 32,695 | 32,937 | (1) (2) | |||||||||||||||||||||||||
| ConnectWise, LLC |
IT Services | L + 6.00%; 1.00% Floor | 2/28/2025 | (17 | ) | (10 | ) | (26 | ) | (15 | ) | (43 | ) | (25 | ) | (1) (2) (3) | ||||||||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene) |
Real Estate Management & Development |
9.00% | L + 7.50%; 1.50% Floor | 8/30/2024 | 20,852 | 18,020 | 30,492 | 26,350 | 51,344 | 44,370 | (1) (2) | |||||||||||||||||||||||||
| Convene 237 Park Avenue, LLC (dba Convene) |
Real Estate Management & Development |
9.00% | L + 7.50%; 1.50% Floor | 8/30/2024 | 6,113 | 5,287 | 8,962 | 7,752 | 15,075 | 13,039 | (1) (2) | |||||||||||||||||||||||||
| CorePower Yoga LLC |
Diversified Consumer Services |
7.00% | L + 6.00% (incl. 1.25% PIK); 1.00% Floor | 5/14/2025 | 9,541 | 8,215 | 14,214 | 12,240 | 23,755 | 20,455 | (2) | |||||||||||||||||||||||||
| CorePower Yoga LLC |
Diversified Consumer Services |
7.00% | L + 6.00% (incl. 1.25% PIK); 1.00% Floor | 5/14/2025 | 127 | 34 | 189 | 50 | 316 | 84 | (2) (3) | |||||||||||||||||||||||||
| CST Buyer Company (dba Intoxalock) |
Diversified Consumer Services |
6.25% | L + 5.25%; 1.00% Floor | 10/3/2025 | 11,304 | 11,430 | 16,684 | 16,870 | 27,988 | 28,300 | (1) (2) | |||||||||||||||||||||||||
| CST Buyer Company (dba Intoxalock) |
Diversified Consumer Services |
L + 5.25%; 1.00% Floor | 10/3/2025 | (9 | ) | — | (14 | ) | — | (23 | ) | — | (1) (2) (3) | |||||||||||||||||||||||
| DDS USA Holding, Inc. |
Health Care Equipment & Supplies |
6.75% | L + 5.75%; 1.00% Floor | 6/30/2022 | 3,766 | 3,738 | 5,350 | 5,310 | 9,116 | 9,048 | (1) (2) | |||||||||||||||||||||||||
| DDS USA Holding, Inc. |
Health Care Equipment & Supplies |
6.75% | L + 5.75%; 1.00% Floor | 6/30/2022 | 3,560 | 3,533 | 5,056 | 5,018 | 8,616 | 8,551 | (1) (2) | |||||||||||||||||||||||||
| DDS USA Holding, Inc. |
Health Care Equipment & Supplies |
6.75% | L + 5.75%; 1.00% Floor | 6/30/2022 | 537 | 529 | 763 | 751 | 1,300 | 1,280 | (1) (2) (3) | |||||||||||||||||||||||||
| Diligent Corporation |
Professional Services |
7.25% | L + 6.25%; 1.00% Floor | 8/4/2025 | 18,147 | 18,170 | 25,860 | 25,892 | 44,007 | 44,062 | (2) | |||||||||||||||||||||||||
| Diligent Corporation |
Professional Services |
7.25% | L + 6.25%; 1.00% Floor | 8/4/2025 | 10,124 | 10,012 | 14,438 | 14,279 | 24,562 | 24,291 | (2) | |||||||||||||||||||||||||
| Diligent Corporation |
Professional Services |
L + 6.25%; 1.00% Floor | 8/4/2025 | (25 | ) | (33 | ) | (34 | ) | (45 | ) | (59 | ) | (78 | ) | (2) (3) | ||||||||||||||||||||
| DocuTAP, Inc. |
Health Care Technology |
6.50% | L + 5.50%; 1.00% Floor | 5/12/2025 | 23,431 | 23,255 | 34,102 | 33,845 | 57,533 | 57,100 | (1) (2) | |||||||||||||||||||||||||
| E2open, LLC |
Software | 6.75% | L + 5.75%; 1.00% Floor | 11/26/2024 | 16,007 | 15,492 | 23,864 | 23,095 | 39,871 | 38,587 | (2) | |||||||||||||||||||||||||
| Elemica Parent, Inc. |
Chemicals | 5.73% | L + 5.50% | 9/18/2025 | 2,822 | 2,682 | 4,135 | 3,930 | 6,957 | 6,612 | (1) (2) | |||||||||||||||||||||||||
| Elemica Parent, Inc. |
Chemicals | 5.72% | L + 5.50% | 9/18/2025 | 281 | 262 | 406 | 379 | 687 | 641 | (1) (2) (3) | |||||||||||||||||||||||||
| Elemica Parent, Inc. |
Chemicals | L + 5.50% | 9/18/2025 | (6 | ) | (39 | ) | (9 | ) | (58 | ) | (15 | ) | (97 | ) | (1) (2) (3) | ||||||||||||||||||||
| Empirix, Inc. |
Diversified Telecommunication Services |
7.25% | L + 6.25%; 1.00% Floor | 9/25/2024 | 21,647 | 21,265 | 30,870 | 30,323 | 52,517 | 51,588 | (1) (2) | |||||||||||||||||||||||||
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Schedule of Investments (continued)
Unaudited
As of September 30, 2020
(In thousands)
| Actual | Actual | |||||||||||||||||||||||||||||||||||
| Goldman Sachs BDC, Inc. |
Goldman Sachs Middle Market Lending Corp. |
Pro Forma Combined |
||||||||||||||||||||||||||||||||||
| Investment* |
Industry | Interest |
Reference Rate |
Maturity Date |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Footnotes | |||||||||||||||||||||||||
| Empirix, Inc. |
Diversified Telecommunication Services |
L + 6.25%; 1.00% Floor | 9/25/2023 | (14 | ) | (39 | ) | (19 | ) | (54 | ) | (33 | ) | (93 | ) | (1) (2) (3) | ||||||||||||||||||||
| Eptam Plastics, Ltd. |
Health Care Equipment & Supplies |
6.50% | L + 5.50%; 1.00% Floor | 12/6/2025 | 4,221 | 4,160 | 6,247 | 6,157 | 10,468 | 10,317 | (1) (2) | |||||||||||||||||||||||||
| Eptam Plastics, Ltd. |
Health Care Equipment & Supplies |
6.50% | L + 5.50%; 1.00% Floor | 12/6/2025 | 903 | 890 | 1,336 | 1,317 | 2,239 | 2,207 | (1) (2) | |||||||||||||||||||||||||
| Eptam Plastics, Ltd. |
Health Care Equipment & Supplies |
L + 5.50%; 1.00% Floor | 12/6/2025 | (12 | ) | (50 | ) | (18 | ) | (74 | ) | (30 | ) | (124 | ) | (1) (2) (3) | ||||||||||||||||||||
| Fenergo Finance 3 Limited |
Diversified Financial Services |
7.00% | L + 6.00%; 1.00% Floor | 9/5/2024 | 20,431 | 20,609 | 29,040 | 29,292 | 49,471 | 49,901 | (1) (2) (4) | |||||||||||||||||||||||||
| Fenergo Finance 3 Limited |
Diversified Financial Services |
L + 6.00%; 1.00% Floor | 9/5/2024 | (14 | ) | (15 | ) | (19 | ) | (21 | ) | (33 | ) | (36 | ) | (1) (2) (3) (4) | ||||||||||||||||||||
| Fenergo Finance 3 Limited |
Diversified Financial Services |
L + 6.00%; 1.00% Floor | 9/5/2024 | (20 | ) | (22 | ) | (30 | ) | (32 | ) | (50 | ) | (54 | ) | (1) (2) (3) (4) | ||||||||||||||||||||
| Foundation Software |
Construction & Engineering |
10.25% | P + 7.00%; 2.00% Floor | 8/31/2027 | 418 | 418 | 418 | 418 | 836 | 836 | (2) | |||||||||||||||||||||||||
| Foundation Software |
Construction & Engineering |
P + 7.00%; 2.00% Floor | 8/31/2026 | (2 | ) | (2 | ) | (2 | ) | (2 | ) | (4 | ) | (4 | ) | (2) (3) | ||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | — | (1 | ) | — | (3 | ) | — | (4 | ) | (1) (3) | |||||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
8.00% | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | 4,347 | 4,252 | 11,145 | 10,901 | 15,492 | 15,153 | (1) | |||||||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
8.00% | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | 869 | 850 | 2,228 | 2,178 | 3,097 | 3,028 | (1) | |||||||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
8.00% | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | 549 | 537 | 1,408 | 1,377 | 1,957 | 1,914 | (1) | |||||||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | (7 | ) | (21 | ) | (19 | ) | (53 | ) | (26 | ) | (74 | ) | (1) (3) | ||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
8.00% | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | — | — | 3,977 | 3,864 | 3,977 | 3,864 | (1) | |||||||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
8.00% | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | — | — | 2,991 | 2,905 | 2,991 | 2,905 | (1) | |||||||||||||||||||||||||
| FWR Holding Corporation (dba First Watch Restaurants) |
Hotels, Restaurants & Leisure |
8.00% | L + 7.00% (incl. 1.50% PIK); 1.00% Floor | 8/21/2023 | — | — | 2,975 | 2,891 | 2,975 | 2,891 | (1) | |||||||||||||||||||||||||
| Gastro Health Holdco, LLC |
Health Care Providers & Services |
7.02% | L + 6.00%; 1.00% Floor | 9/4/2024 | 9,542 | 9,268 | 13,600 | 13,209 | 23,142 | 22,477 | (1) (2) | |||||||||||||||||||||||||
| Gastro Health Holdco, LLC |
Health Care Providers & Services |
7.00% | L + 6.00%; 1.00% Floor | 9/4/2024 | 4,973 | 4,831 | 7,020 | 6,820 | 11,993 | 11,651 | (1) (2) | |||||||||||||||||||||||||
| Gastro Health Holdco, LLC |
Health Care Providers & Services |
7.01% | L + 6.00%; 1.00% Floor | 9/4/2024 | 4,783 | 4,637 | 6,801 | 6,593 | 11,584 | 11,230 | (1) (2) | |||||||||||||||||||||||||
| Gastro Health Holdco, LLC |
Health Care Providers & Services |
L + 6.00%; 1.00% Floor | 9/4/2023 | (24 | ) | (85 | ) | (34 | ) | (123 | ) | (58 | ) | (208 | ) | (1) (2) (3) | ||||||||||||||||||||
| GH Holding Company (dba Grace Hill) |
Real Estate Management & Development |
4.65% | L + 4.50% | 2/28/2023 | 7,294 | 7,166 | — | — | 7,294 | 7,166 | (1) | |||||||||||||||||||||||||
| GI Revelation Acquisition LLC (dba Consilio) |
IT Services | 5.15% | L + 5.00% | 4/16/2025 | 4,630 | 4,460 | — | — | 4,630 | 4,460 | ||||||||||||||||||||||||||
| GK Holdings, Inc. (dba Global Knowledge) |
IT Services | 9.00% | L + 8.00%; 1.00% Floor | 1/20/2021 | 8,479 | 4,510 | — | — | 8,479 | 4,510 | ||||||||||||||||||||||||||
| GlobalTranz Enterprises, Inc. |
Road & Rail | 5.16% | L + 5.00% | 5/15/2026 | 7,495 | 6,423 | 11,167 | 9,569 | 18,662 | 15,992 | (2) | |||||||||||||||||||||||||
| Governmentjobs.com, Inc. (dba NeoGov) |
Software | 7.50% | L + 6.50%; 1.00% Floor | 2/5/2026 | 17,971 | 17,984 | 28,621 | 28,643 | 46,592 | 46,627 | (1) (2) | |||||||||||||||||||||||||
| Governmentjobs.com, Inc. (dba NeoGov) |
Software | 7.50% | L + 6.50%; 1.00% Floor | 2/5/2026 | 139 | 140 | 222 | 224 | 361 | 364 | (1) (2) (3) | |||||||||||||||||||||||||
| Granicus, Inc. |
Software | 8.00% | L + 7.00%; 1.00% Floor | 8/21/2026 | 9,032 | 9,029 | 13,226 | 13,221 | 22,258 | 22,250 | (2) | |||||||||||||||||||||||||
| Granicus, Inc. |
Software | L + 7.00%; 1.00% Floor | 8/21/2026 | (16 | ) | (16 | ) | (23 | ) | (23 | ) | (39 | ) | (39 | ) | (2) (3) | ||||||||||||||||||||
| Halo Branded Solutions, Inc. |
Commercial Services & Supplies |
5.50% | L + 4.50%; 1.00% Floor | 6/30/2025 | 6,393 | 5,797 | — | — | 6,393 | 5,797 | ||||||||||||||||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) |
Hotels, Restaurants & Leisure |
7.75% | L + 6.75%; 1.00% Floor | 7/9/2025 | 22,869 | 21,478 | 34,072 | 32,000 | 56,941 | 53,478 | (1) (2) | |||||||||||||||||||||||||
| HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) |
Hotels, Restaurants & Leisure |
L + 6.75%; 1.00% Floor | 7/9/2025 | (23 | ) | (136 | ) | (34 | ) | (203 | ) | (57 | ) | (339 | ) | (1) (2) (3) | ||||||||||||||||||||
| Hygiena Borrower LLC |
Life Sciences Tools & Services |
5.00% | L + 4.00%; 1.00% Floor | 8/26/2022 | 12,006 | 11,828 | 5,084 | 5,019 | 17,090 | 16,847 | ||||||||||||||||||||||||||
| Hygiena Borrower LLC |
Life Sciences Tools & Services |
L + 4.00%; 1.00% Floor | 8/26/2022 | (8 | ) | (26 | ) | (4 | ) | (11 | ) | (12 | ) | (37 | ) | (3) | ||||||||||||||||||||
| iCIMS, Inc. |
Software | 7.50% | L + 6.50%; 1.00% Floor | 9/12/2024 | 29,470 | 29,372 | 41,988 | 41,849 | 71,458 | 71,221 | (1) (2) | |||||||||||||||||||||||||
| iCIMS, Inc. |
Software | 7.50% | L + 6.50%; 1.00% Floor | 9/12/2024 | 5,419 | 5,409 | 7,720 | 7,707 | 13,139 | 13,116 | (1) (2) | |||||||||||||||||||||||||
| iCIMS, Inc. |
Software | L + 6.50%; 1.00% Floor | 9/12/2024 | (25 | ) | (33 | ) | (35 | ) | (47 | ) | (60 | ) | (80 | ) | (1) (2) (3) | ||||||||||||||||||||
| Infinity Sales Group |
Media | 11.50% | L + 10.50%; 1.00% Floor | 11/23/2022 | 25,579 | 25,898 | — | — | 25,579 | 25,898 | (1) | |||||||||||||||||||||||||
| Instructure Holdings |
Diversified Consumer Services |
8.00% | L + 7.00%; 1.00% Floor | 3/24/2026 | 25,435 | 25,477 | 38,142 | 38,206 | 63,577 | 63,683 | (1) (2) | |||||||||||||||||||||||||
| Instructure Holdings |
Diversified Consumer Services |
L + 7.00%; 1.00% Floor | 3/24/2026 | (23 | ) | (20 | ) | (34 | ) | (30 | ) | (57 | ) | (50 | ) | (1) (2) (3) | ||||||||||||||||||||
| Integral Ad Science, Inc. |
Interactive Media & Services |
8.25% | L + 7.25% (incl. 1.25% PIK); 1.00% Floor | 7/19/2024 | 25,548 | 24,927 | 36,403 | 35,519 | 61,951 | 60,446 | (1) (2) | |||||||||||||||||||||||||
| Integral Ad Science, Inc. |
Interactive Media & Services |
L + 6.00%; 1.00% Floor | 7/19/2023 | (21 | ) | (68 | ) | (29 | ) | (97 | ) | (50 | ) | (165 | ) | (1) (2) (3) | ||||||||||||||||||||
| Internet Truckstop Group, LLC (dba Truckstop) |
Transportation Infrastructure |
6.50% | L + 5.50%; 1.00% Floor | 4/2/2025 | 21,607 | 21,600 | 31,500 | 31,491 | 53,107 | 53,091 | (1) (2) | |||||||||||||||||||||||||
| Internet Truckstop Group, LLC (dba Truckstop) |
Transportation Infrastructure |
L + 5.50%; 1.00% Floor | 4/2/2025 | (34 | ) | (36 | ) | (49 | ) | (52 | ) | (83 | ) | (88 | ) | (1) (2) (3) | ||||||||||||||||||||
| Iracore International Holdings, Inc. |
Energy Equipment & Services |
10.00% | L + 9.00%; 1.00% Floor | 4/12/2021 | 2,917 | 2,910 | — | — | 2,917 | 2,910 | ^ (1) | |||||||||||||||||||||||||
| Jill Acquisition LLC (dba J. Jill) |
Specialty Retail | 6.00% | L + 5.00%; 1.00% Floor | 5/8/2024 | 6,569 | 4,476 | — | — | 6,569 | 4,476 | ||||||||||||||||||||||||||
| Kawa Solar Holdings Limited |
Construction & Engineering |
12/31/2020 | 3,603 | 3,181 | — | — | 3,603 | 3,181 | ^ (1) (4) (5) | |||||||||||||||||||||||||||
| Kawa Solar Holdings Limited |
Construction & Engineering |
12/31/2020 | 2,683 | — | — | — | 2,683 | — | ^ (1) (4) (5) | |||||||||||||||||||||||||||
| Lithium Technologies, Inc. |
Interactive Media & Services |
9.00% | L + 8.00%; 1.00% Floor | 10/3/2022 | 38,519 | 37,310 | 49,473 | 47,920 | 87,992 | 85,230 | (1) (2) | |||||||||||||||||||||||||
| Lithium Technologies, Inc. |
Interactive Media & Services |
9.21% | L + 8.00%; 1.00% Floor | 10/3/2022 | 420 | 333 | 539 | 428 | 959 | 761 | (1) (2) (3) | |||||||||||||||||||||||||
| Mailgun Technologies, Inc. |
Interactive Media & Services |
6.00% | L + 5.00%; 1.00% Floor | 3/26/2025 | 15,525 | 15,776 | 22,628 | 22,995 | 38,153 | 38,771 | (1) (2) | |||||||||||||||||||||||||
| Mailgun Technologies, Inc. |
Interactive Media & Services |
L + 5.00%; 1.00% Floor | 3/26/2025 | — | — | — | — | — | — | (1) (2) (3) | ||||||||||||||||||||||||||
| MedeAnalytics, Inc. |
Health Care Technology |
L + 6.50%; 1.00% Floor | 10/9/2026 | — | — | — | — | — | — | (2) (3) | ||||||||||||||||||||||||||
| Mervin Manufacturing, Inc. |
Leisure Products | 8.50% | L + 7.50%; 1.00% Floor | 9/30/2022 | 10,830 | 10,236 | — | — | 10,830 | 10,236 | (1) | |||||||||||||||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & Technology) |
Health Care Technology |
6.50% | L + 5.50%; 1.00% Floor | 11/15/2024 | 20,244 | 20,248 | 29,059 | 29,064 | 49,303 | 49,312 | (1) (2) | |||||||||||||||||||||||||
| MMIT Holdings, LLC (dba Managed Markets Insight & Technology) |
Health Care Technology |
6.50% | L + 5.50%; 1.00% Floor | 11/15/2024 | 1,867 | 1,865 | 2,651 | 2,647 | 4,518 | 4,512 | (1) (2) (3) | |||||||||||||||||||||||||
| MRI Software LLC |
Real Estate Management & Development |
6.50% | L + 5.50%; 1.00% Floor | 2/10/2026 | 8,728 | 8,498 | 13,901 | 13,534 | 22,629 | 22,032 | ||||||||||||||||||||||||||
| MRI Software LLC |
Real Estate Management & Development |
L + 5.50%; 1.00% Floor | 2/10/2026 | (5 | ) | (12 | ) | (7 | ) | (20 | ) | (12 | ) | (32 | ) | (3) | ||||||||||||||||||||
| MRI Software LLC |
Real Estate Management & Development |
L + 5.50%; 1.00% Floor | 2/10/2026 | (6 | ) | (22 | ) | (9 | ) | (35 | ) | (15 | ) | (57 | ) | (3) | ||||||||||||||||||||
| Netvoyage Corporation (dba NetDocuments) |
Software | 8.75% | L + 7.75%; 1.00% Floor | 3/22/2024 | 8,354 | 8,175 | 7,787 | 7,620 | 16,141 | 15,795 | (1) (2) | |||||||||||||||||||||||||
| Netvoyage Corporation (dba NetDocuments) |
Software | 8.75% | L + 7.75%; 1.00% Floor | 3/22/2024 | 3,895 | 3,831 | 5,842 | 5,747 | 9,737 | 9,578 | (1) (2) | |||||||||||||||||||||||||
| Netvoyage Corporation (dba NetDocuments) |
Software | 8.75% | L + 7.75%; 1.00% Floor | 3/22/2024 | 785 | 771 | 867 | 851 | 1,652 | 1,622 | (1) (2) | |||||||||||||||||||||||||
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Schedule of Investments (continued)
Unaudited
As of September 30, 2020
(In thousands)
| Actual | Actual | |||||||||||||||||||||||||||||||||||
| Goldman Sachs BDC, Inc. |
Goldman Sachs Middle Market Lending Corp. |
Pro Forma Combined |
||||||||||||||||||||||||||||||||||
| Investment* |
Industry | Interest |
Reference Rate |
Maturity Date |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Footnotes | |||||||||||||||||||||||||
| Netvoyage Corporation (dba NetDocuments) |
Software | L + 7.75%; 1.00% Floor | 3/24/2022 | (4 | ) | (21 | ) | (4 | ) | (20 | ) | (8 | ) | (41 | ) | (1) (2) (3) | ||||||||||||||||||||
| Output Services Group, Inc. |
Diversified Consumer Services |
4.69% | L + 4.50%; 1.00% Floor | 3/27/2024 | 3,900 | 2,803 | — | — | 3,900 | 2,803 | ||||||||||||||||||||||||||
| Pharmalogic Holdings Corp. |
Health Care Equipment & Supplies |
4.15% | L + 4.00% | 6/11/2023 | 3,209 | 3,053 | — | — | 3,209 | 3,053 | (1) | |||||||||||||||||||||||||
| Pharmalogic Holdings Corp. |
Health Care Equipment & Supplies |
4.15% | L + 4.00% | 6/11/2023 | 1,744 | 1,659 | — | — | 1,744 | 1,659 | (1) | |||||||||||||||||||||||||
| Pharmalogic Holdings Corp. |
Health Care Equipment & Supplies |
4.15% | L + 4.00% | 6/11/2023 | 1,710 | 1,630 | — | — | 1,710 | 1,630 | (1) | |||||||||||||||||||||||||
| Pharmalogic Holdings Corp. |
Health Care Equipment & Supplies |
4.15% | L + 4.00% | 6/11/2023 | 921 | 877 | — | — | 921 | 877 | (1) | |||||||||||||||||||||||||
| Picture Head Midco LLC |
Entertainment | 8.25% | L + 7.25% (incl. 0.5% PIK); 1.00% Floor | 8/31/2023 | 18,132 | 16,778 | 27,004 | 24,995 | 45,136 | 41,773 | (1) (2) | |||||||||||||||||||||||||
| PlanSource Holdings, Inc. |
Health Care Technology |
7.25% | L + 6.25%; 1.00% Floor | 4/22/2025 | 22,415 | 21,983 | 33,396 | 32,752 | 55,811 | 54,735 | (1) (2) | |||||||||||||||||||||||||
| PlanSource Holdings, Inc. |
Health Care Technology |
L + 6.25%; 1.00% Floor | 4/22/2025 | (48 | ) | (110 | ) | (72 | ) | (164 | ) | (120 | ) | (274 | ) | (1) (2) (3) | ||||||||||||||||||||
| Power Stop, LLC |
Auto Components |
4.65% | L + 4.50% | 10/19/2025 | 7,453 | 7,094 | 10,689 | 10,174 | 18,142 | 17,268 | (2) | |||||||||||||||||||||||||
| Premier Imaging, LLC (dba Lucid Health) |
Health Care Providers & Services |
6.75% | L + 5.75%; 1.00% Floor | 1/2/2025 | 11,531 | 11,156 | 16,906 | 16,356 | 28,437 | 27,512 | (1) (2) | |||||||||||||||||||||||||
| Professional Physical Therapy |
Health Care Providers & Services |
9.58% | L + 8.50% (incl. 2.50% PIK); 1.00% Floor | 12/16/2022 | 5,328 | 5,155 | — | — | 5,328 | 5,155 | (1) | |||||||||||||||||||||||||
| Project Eagle Holdings, LLC |
Aerospace & Defense |
9.25% | L + 8.25%; 1.00% Floor | 7/6/2026 | 441 | 441 | 441 | 441 | 882 | 882 | (2) | |||||||||||||||||||||||||
| Project Eagle Holdings, LLC |
Aerospace & Defense |
L + 8.25%; 1.00% Floor | 7/6/2026 | (1 | ) | (1 | ) | (1 | ) | (1 | ) | (2 | ) | (2 | ) | (2) (3) | ||||||||||||||||||||
| PT Intermediate Holdings III, LLC (dba Parts Town) |
Trading Companies & Distributors |
6.50% | L + 5.50%; 1.00% Floor | 10/15/2025 | 11,621 | 10,796 | 17,115 | 15,901 | 28,736 | 26,697 | (2) | |||||||||||||||||||||||||
| Purfoods, LLC |
Health Care Providers & Services |
7.25% | L + 6.25%; 1.00% Floor | 8/12/2026 | 293 | 293 | 293 | 293 | 586 | 586 | (2) | |||||||||||||||||||||||||
| Purfoods, LLC |
Health Care Providers & Services |
L + 6.25%; 1.00% Floor | 8/12/2026 | (2 | ) | (3 | ) | (2 | ) | (3 | ) | (4 | ) | (6 | ) | (2) (3) | ||||||||||||||||||||
| Riverpoint Medical, LLC |
Health Care Equipment & Supplies |
5.50% | L + 4.50%; 1.00% Floor | 6/21/2025 | 8,893 | 8,595 | 13,250 | 12,806 | 22,143 | 21,401 | (1) (2) | |||||||||||||||||||||||||
| Riverpoint Medical, LLC |
Health Care Equipment & Supplies |
L + 4.50%; 1.00% Floor | 6/21/2025 | (7 | ) | (62 | ) | (10 | ) | (92 | ) | (17 | ) | (154 | ) | (1) (2) (3) | ||||||||||||||||||||
| Selectquote, Inc. |
Insurance | 7.00% | L + 6.00%; 1.00% Floor | 11/5/2024 | 8,044 | 8,182 | 11,878 | 12,082 | 19,922 | 20,264 | (2) | |||||||||||||||||||||||||
| SF Home Décor, LLC (dba SureFit Home Décor) |
Household Products |
10.75% | L + 9.75%; 1.00% Floor | 7/13/2022 | 18,342 | 16,822 | 23,142 | 21,224 | 41,484 | 38,046 | (1) (2) | |||||||||||||||||||||||||
| Shopatron, LLC (dba Kibo) |
Internet & Direct Marketing Retail |
9.00% | L + 8.00%; 1.00% Floor | 12/18/2020 | 5,943 | 5,921 | 8,845 | 8,813 | 14,788 | 14,734 | (1) (2) | |||||||||||||||||||||||||
| Shopatron, LLC (dba Kibo) |
Internet & Direct Marketing Retail |
9.00% | L + 8.00%; 1.00% Floor | 12/18/2020 | 1,843 | 1,833 | 2,743 | 2,729 | 4,586 | 4,562 | (1) (2) (6) | |||||||||||||||||||||||||
| SMS Systems Maintenance Services, Inc. |
IT Services | 6.00% | L + 5.00%; 1.00% Floor | 10/30/2023 | 3,231 | 2,537 | — | — | 3,231 | 2,537 | ||||||||||||||||||||||||||
| SPay, Inc. (dba Stack Sports) |
Interactive Media & Services |
8.75% | L + 7.75% (incl. 2.00% PIK); 1.00% Floor | 6/17/2024 | 10,475 | 9,339 | 14,950 | 13,329 | 25,425 | 22,668 | (1) (2) | |||||||||||||||||||||||||
| SPay, Inc. (dba Stack Sports) |
Interactive Media & Services |
8.84% | L + 7.75% (incl. 2.00% PIK); 1.00% Floor | 6/17/2024 | 760 | 677 | 1,087 | 969 | 1,847 | 1,646 | (1) (2) | |||||||||||||||||||||||||
| SPay, Inc. (dba Stack Sports) |
Interactive Media & Services |
8.97% | L + 7.75% (incl. 2.00% PIK); 1.00% Floor | 6/17/2024 | 384 | 340 | 546 | 484 | 930 | 824 | (1) (2) | |||||||||||||||||||||||||
| Syntellis Performance Solutions, LLC |
Health Care Technology |
9.00% | L + 8.00%; 1.00% Floor | 8/2/2027 | 407 | 407 | 407 | 407 | 814 | 814 | (1) (2) | |||||||||||||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) |
Health Care Providers & Services |
6.25% | L + 5.25%; 1.00% Floor | 8/15/2025 | 10,713 | 10,470 | 15,615 | 15,261 | 26,328 | 25,731 | (1) (2) | |||||||||||||||||||||||||
| The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) |
Health Care Providers & Services |
L + 5.25%; 1.00% Floor | 8/15/2025 | (23 | ) | (65 | ) | (33 | ) | (95 | ) | (56 | ) | (160 | ) | (1) (2) (3) | ||||||||||||||||||||
| Tronair Parent Inc. |
Air Freight & Logistics |
5.75% | L + 4.75%; 1.00% Floor | 9/8/2023 | 6,689 | 5,242 | — | — | 6,689 | 5,242 | ||||||||||||||||||||||||||
| U.S. Acute Care Solutions, LLC |
Health Care Providers & Services |
7.00% | L + 6.00%; 1.00% Floor | 5/17/2021 | 6,277 | 5,722 | — | — | 6,277 | 5,722 | ||||||||||||||||||||||||||
| US Med Acquisition, Inc. |
Health Care Equipment & Supplies |
9.00% | L + 8.00%; 1.00% Floor | 8/13/2021 | 29,303 | 28,823 | — | — | 29,303 | 28,823 | (1) | |||||||||||||||||||||||||
| Viant Medical Holdings, Inc. |
Health Care Equipment & Supplies |
7.25% | L + 6.25%; 1.00% Floor | 7/2/2025 | 12,701 | 12,247 | 18,693 | 18,025 | 31,394 | 30,272 | (2) | |||||||||||||||||||||||||
| Villa Bidco Inc (dba Authority Brands) |
Diversified Consumer Services |
6.75% | L + 5.75%; 1.00% Floor | 3/21/2025 | 10,512 | 10,516 | 15,764 | 15,770 | 26,276 | 26,286 | (1) (2) | |||||||||||||||||||||||||
| Villa Bidco Inc (dba Authority Brands) |
Diversified Consumer Services |
8.00% | P + 4.75%; 2.00% Floor | 3/21/2025 | 102 | 102 | 153 | 153 | 255 | 255 | (1) (2) (3) | |||||||||||||||||||||||||
| VRC Companies, LLC (dba Vital Records Control) |
Commercial Services & Supplies |
7.50% | L + 6.50%; 1.00% Floor | 3/31/2023 | 18,395 | 18,411 | 9,867 | 9,851 | 28,262 | 28,262 | (1) | |||||||||||||||||||||||||
| VRC Companies, LLC (dba Vital Records Control) |
Commercial Services & Supplies |
L + 6.50%; 1.00% Floor | 3/31/2022 | (6 | ) | (7 | ) | (1 | ) | (2 | ) | (7 | ) | (9 | ) | (1) (3) | ||||||||||||||||||||
| WebPT, Inc. |
Health Care Technology |
7.75% | L + 6.75%; 1.00% Floor | 8/28/2024 | 10,026 | 9,784 | 14,690 | 14,336 | 24,716 | 24,120 | (1) (2) | |||||||||||||||||||||||||
| WebPT, Inc. |
Health Care Technology |
7.75% | L + 6.75%; 1.00% Floor | 8/28/2024 | 514 | 488 | 753 | 716 | 1,267 | 1,204 | (1) (2) (3) | |||||||||||||||||||||||||
| WebPT, Inc. |
Health Care Technology |
L + 6.75%; 1.00% Floor | 8/28/2024 | (10 | ) | (51 | ) | (15 | ) | (75 | ) | (25 | ) | (126 | ) | (1) (2) (3) | ||||||||||||||||||||
| Wine.com, LLC |
Beverages | 8.00% | L + 7.00%; 1.00% Floor | 11/14/2024 | 6,305 | 6,384 | 8,866 | 8,977 | 15,171 | 15,361 | (1) (2) | |||||||||||||||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies) |
Real Estate Management & Development |
7.00% | L + 6.00%; 1.00% Floor | 6/13/2025 | 31,174 | 31,377 | 46,445 | 46,748 | 77,619 | 78,125 | (1) (2) (4) | |||||||||||||||||||||||||
| Wolfpack IP Co. (dba Lone Wolf Technologies) |
Real Estate Management & Development |
L + 6.00%; 1.00% Floor | 6/13/2025 | (50 | ) | (32 | ) | (74 | ) | (47 | ) | (124 | ) | (79 | ) | (1) (2) (3) (4) | ||||||||||||||||||||
| WorkForce Software, LLC |
Software | 7.50% | L + 6.50%; 1.00% Floor | 7/31/2025 | 8,632 | 8,560 | 12,582 | 12,477 | 21,214 | 21,037 | (1) (2) | |||||||||||||||||||||||||
| WorkForce Software, LLC |
Software | L + 6.50%; 1.00% Floor | 7/31/2025 | (12 | ) | (19 | ) | (18 | ) | (28 | ) | (30 | ) | (47 | ) | (1) (2) (3) | ||||||||||||||||||||
| Wrike, Inc. |
Professional Services |
7.75% | L + 6.75%; 1.00% Floor | 12/31/2024 | 22,341 | 22,704 | 31,744 | 32,260 | 54,085 | 54,964 | (1) (2) | |||||||||||||||||||||||||
| Wrike, Inc. |
Professional Services |
L + 6.75%; 1.00% Floor | 12/31/2024 | (23 | ) | — | (33 | ) | — | (56 | ) | — | (1) (2) (3) | |||||||||||||||||||||||
| Xactly Corporation |
IT Services | 8.25% | L + 7.25%; 1.00% Floor | 7/29/2022 | 26,925 | 26,698 | 34,533 | 34,242 | 61,458 | 60,940 | (1) (2) | |||||||||||||||||||||||||
| Xactly Corporation |
IT Services | L + 7.25%; 1.00% Floor | 7/29/2022 | (13 | ) | (30 | ) | (16 | ) | (38 | ) | (29 | ) | (68 | ) | (1) (2) (3) | ||||||||||||||||||||
| Yasso, Inc. |
Food Products | 8.75% | L + 7.75%; 1.00% Floor | 3/23/2022 | 7,905 | 7,960 | 7,297 | 7,348 | 15,202 | 15,308 | (1) (2) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL FIRST LIEN SENIOR SECURED |
1,121,283 | 1,080,514 | 1,320,702 | 1,290,854 | 2,441,985 | 2,371,368 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| 1st Lien/Last-Out Unitranche |
||||||||||||||||||||||||||||||||||||
| Doxim, Inc. |
Diversified Financial Services |
7.00% | L + 6.00%; 1.00% Floor | 2/28/2024 | 11,656 | 11,603 | 26,741 | 26,618 | 38,397 | 38,221 | (1) (2) | |||||||||||||||||||||||||
| Doxim, Inc. |
Diversified Financial Services |
7.00% | L + 6.00%; 1.00% Floor | 2/28/2024 | 612 | 609 | 21,930 | 21,816 | 22,542 | 22,425 | (1) (2) | |||||||||||||||||||||||||
| RugsUSA, LLC |
Household Products |
7.00% | L + 6.00%; 1.00% Floor | 4/30/2023 | 5,796 | 5,799 | 8,267 | 8,272 | 14,063 | 14,071 | (1) (2) | |||||||||||||||||||||||||
| Smarsh, Inc. |
Interactive Media & Services |
8.88% | L + 7.88%; 1.00% Floor | 3/31/2021 | 17,090 | 16,964 | 43,607 | 43,313 | 60,697 | 60,277 | (1) (2) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL FIRST LIEN/LAST-OUT UNITRANCHE(7) |
35,154 | 34,975 | 100,545 | 100,019 | 135,699 | 134,994 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| 2nd Lien Senior Secured Debt |
||||||||||||||||||||||||||||||||||||
| American Dental Partners, Inc. |
Health Care Providers & Services |
9.50% | L + 8.50%; 1.00% Floor | 9/25/2023 | 5,660 | 5,279 | 5,261 | 4,906 | 10,921 | 10,185 | (1) (2) | |||||||||||||||||||||||||
| ASC Acquisition Holdings, LLC |
Distributors | 7.00% | L + 7.00% PIK | 11/14/2025 | 7,754 | 7,364 | — | — | 7,754 | 7,364 | ^ (1) | |||||||||||||||||||||||||
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Schedule of Investments (continued)
Unaudited
As of September 30, 2020
(In thousands)
| Actual | Actual | |||||||||||||||||||||||||||||||||||
| Goldman Sachs BDC, Inc. |
Goldman Sachs Middle Market Lending Corp. |
Pro Forma Combined |
||||||||||||||||||||||||||||||||||
| Investment* |
Industry | Interest |
Reference Rate |
Maturity Date |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
Footnotes | |||||||||||||||||||||||||
| Bolttech Mannings, Inc. |
Commercial Services & Supplies |
8.25% | L + 8.00% PIK | 11/20/2022 | 12,820 | 12,763 | — | — | 12,820 | 12,763 | ^^ (1) | |||||||||||||||||||||||||
| Chase Industries, Inc. (dba Senneca Holdings) |
Building Products | 11.00% PIK | 5/11/2026 | — | — | 11,847 | — | 11,847 | — | (1) (2) (8) | ||||||||||||||||||||||||||
| Chase Industries, Inc. (dba Senneca Holdings) |
Building Products | 10.00% PIK | 10.00% PIK | 11/11/2025 | — | — | 10,750 | 9,933 | 10,750 | 9,933 | (1) (2) | |||||||||||||||||||||||||
| ERC Finance, LLC (dba Eating Recovery Center) |
Health Care Providers & Services |
9.22% | L + 8.22%; 1.00% Floor | 9/22/2025 | 19,484 | 19,107 | 24,994 | 24,511 | 44,478 | 43,618 | (1) (2) | |||||||||||||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software) |
Diversified Financial Services |
7.80% | L + 7.50% | 7/31/2025 | 6,868 | 6,335 | 9,811 | 9,050 | 16,679 | 15,385 | (1) (2) | |||||||||||||||||||||||||
| Genesis Acquisition Co. (dba ProCare Software) |
Diversified Financial Services |
7.80% | L + 7.50% | 7/31/2025 | 1,763 | 1,629 | 2,448 | 2,263 | 4,211 | 3,892 | (1) (2) | |||||||||||||||||||||||||
| GK Holdings, Inc. (dba Global Knowledge) |
IT Services | L + 12.25%; 1.00% Floor | 1/20/2022 | 2,977 | 750 | — | — | 2,977 | 750 | (8) | ||||||||||||||||||||||||||
| Hygiena Borrower LLC |
Life Sciences Tools & Services |
8.75% | L + 7.75%; 1.00% Floor | 8/26/2023 | 1,837 | 1,795 | 2,617 | 2,557 | 4,454 | 4,352 | (1) | |||||||||||||||||||||||||
| Hygiena Borrower LLC |
Life Sciences Tools & Services |
8.75% | L + 7.75%; 1.00% Floor | 8/26/2023 | 96 | 94 | 137 | 134 | 233 | 228 | (1) | |||||||||||||||||||||||||
| ICP Industrial, Inc. |
Chemicals | 9.25% | L + 8.25%; 1.00% Floor | 5/3/2024 | 20,080 | 19,686 | 28,447 | 27,888 | 48,527 | 47,574 | (1) (2) | |||||||||||||||||||||||||
| IHS Intermediate Inc. (dba Interactive Health Solutions) |
Health Care Providers & Services |
L + 8.25%; 1.00% Floor | 7/20/2022 | 9,902 | — | — | — | 9,902 | — | (1) (8) | ||||||||||||||||||||||||||
| Intelligent Medical Objects, Inc. |
Health Care Technology |
9.50% | L + 8.50%; 1.00% Floor | 12/22/2024 | — | — | 21,514 | 21,298 | 21,514 | 21,298 | (1) (2) | |||||||||||||||||||||||||
| Market Track, LLC |
Media | 8.75% | L + 7.75%; 1.00% Floor | 6/5/2025 | 21,751 | 21,201 | 19,595 | 19,100 | 41,346 | 40,301 | (1) (2) | |||||||||||||||||||||||||
| MPI Engineered Technologies, LLC |
Auto Components |
12.00% PIK | 12.00% PIK | 7/15/2025 | 13,580 | 12,154 | — | — | 13,580 | 12,154 | (1) | |||||||||||||||||||||||||
| MPI Products LLC |
Auto Components |
7/15/2025 | — | — | — | — | — | — | (1) (5) | |||||||||||||||||||||||||||
| National Spine and Pain Centers, LLC |
Health Care Providers & Services |
9.25% | L + 8.25%; 1.00% Floor | 12/2/2024 | 18,730 | 18,288 | 17,063 | 16,660 | 35,793 | 34,948 | (1) (2) | |||||||||||||||||||||||||
| Odyssey Logistics & Technology Corporation |
Road & Rail | 9.00% | L + 8.00%; 1.00% Floor | 10/12/2025 | 18,416 | 15,539 | 26,191 | 22,100 | 44,607 | 37,639 | (2) | |||||||||||||||||||||||||
| SMB Shipping Logistics, LLC (dba Worldwide Express) |
Air Freight & Logistics |
9.00% | L + 8.00%; 1.00% Floor | 2/3/2025 | 41,174 | 39,062 | 24,704 | 23,437 | 65,878 | 62,499 | (1) (2) | |||||||||||||||||||||||||
| Spectrum Plastics Group, Inc. |
Containers & Packaging |
8.00% | L + 7.00%; 1.00% Floor | 1/31/2026 | 6,225 | 5,135 | 6,255 | 5,160 | 12,480 | 10,295 | (2) | |||||||||||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners) |
Insurance | 9.75% | L + 8.75%; 1.00% Floor | 9/29/2025 | — | — | 9,609 | 9,166 | 9,609 | 9,166 | (1) (2) | |||||||||||||||||||||||||
| USRP Holdings, Inc. (dba U.S. Retirement Partners) |
Insurance | 9.75% | L + 8.75%; 1.00% Floor | 9/29/2025 | — | — | 1,570 | 1,497 | 1,570 | 1,497 | (1) (2) | |||||||||||||||||||||||||
| Xcellence, Inc. (dba Xact Data Discovery) |
IT Services | 9.75% | L + 8.75%; 1.00% Floor | 6/22/2024 | — | — | 25,641 | 24,860 | 25,641 | 24,860 | (1) (2) | |||||||||||||||||||||||||
| YI, LLC (dba Young Innovations) |
Health Care Equipment & Supplies |
8.75% | L + 7.75%; 1.00% Floor | 11/7/2025 | 14,905 | 13,712 | 21,140 | 19,448 | 36,045 | 33,160 | (1) (2) | |||||||||||||||||||||||||
| Zep Inc. |
Chemicals | 9.25% | L + 8.25%; 1.00% Floor | 8/11/2025 | 23,381 | 18,594 | 29,963 | 23,828 | 53,344 | 42,422 | (2) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL SECOND LIEN |
247,403 | 218,487 | 299,557 | 267,796 | 546,960 | 486,283 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Unsecured Debt |
||||||||||||||||||||||||||||||||||||
| CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) |
Aerospace & Defense |
12.00% PIK | 3/6/2021 | 4,327 | 4,327 | — | — | 4,327 | 4,327 | ^ (1) | ||||||||||||||||||||||||||
| CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) |
Aerospace & Defense |
12.00% PIK | 3/6/2021 | 1,888 | 1,888 | — | — | 1,888 | 1,888 | ^ (1) | ||||||||||||||||||||||||||
| Conergy Asia & ME Pte. LTD. |
Construction & Engineering |
6/30/2021 | 1,119 | 996 | — | — | 1,119 | 996 | ^ (1) (4) (5) | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL UNSECURED DEBT |
7,334 | 7,211 | — | — | 7,334 | 7,211 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Preferred Stock |
||||||||||||||||||||||||||||||||||||
| Accuity Delivery Systems, LLC |
Health Care Providers & Services |
3,200 | 6,313 | 4,500 | 8,878 | 7,700 | 15,191 | ^ (1) (2) (5) (9) | ||||||||||||||||||||||||||||
| CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) |
Aerospace & Defense |
10,186 | 30,125 | — | — | 10,186 | 30,125 | ^ (1) (5) (9) | ||||||||||||||||||||||||||||
| Conergy Asia Holdings, Ltd. |
Construction & Engineering |
600 | — | — | — | 600 | — | ^ (1) (4) (5) (9) | ||||||||||||||||||||||||||||
| Exostar LLC - Class A |
Aerospace & Defense |
10 | 10 | 10 | 10 | 20 | 20 | (2) (5) (9) | ||||||||||||||||||||||||||||
| Foundation Software |
Construction & Engineering |
11 | 11 | 11 | 11 | 22 | 22 | (2) (5) (9) | ||||||||||||||||||||||||||||
| Kawa Solar Holdings Limited |
Construction & Engineering |
8.00% PIK | 778 | — | — | — | 778 | — | ^ (1) (4) (8) (9) | |||||||||||||||||||||||||||
| Wine.com, LLC |
Beverages | 1,900 | 4,685 | 2,700 | 6,657 | 4,600 | 11,342 | (1) (2) (5) (9) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL PREFERRED STOCK |
16,685 | 41,144 | 7,221 | 15,556 | 23,906 | 56,700 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Common Stock |
||||||||||||||||||||||||||||||||||||
| ASC Acquisition Holdings, LLC |
Distributors | 125 | 209 | — | — | 125 | 209 | ^ (1) (5) (9) | ||||||||||||||||||||||||||||
| ASC Acquisition Holdings, LLC |
Distributors | 13,745 | 10,083 | — | — | 13,745 | 10,083 | ^ (1) (5) (9) | ||||||||||||||||||||||||||||
| Bolttech Mannings, Inc. |
Commercial Services & Supplies |
14,885 | 6,656 | — | — | 14,885 | 6,656 | ^^ (1) (5) (9) | ||||||||||||||||||||||||||||
| CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) |
Aerospace & Defense |
2,393 | 12,314 | — | — | 2,393 | 12,314 | ^ (1) (5) (9) | ||||||||||||||||||||||||||||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B |
Health Care Providers & Services |
1,141 | 1,349 | 1,580 | 1,868 | 2,721 | 3,217 | ^^^ (1) (2) (9) | ||||||||||||||||||||||||||||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units |
Health Care Providers & Services |
159 | 270 | 220 | 374 | 379 | 644 | ^^^ (1) (2) (4) (5) (9) | ||||||||||||||||||||||||||||
| Conergy Asia Holdings, Ltd. |
Construction & Engineering |
4,700 | — | — | — | 4,700 | — | ^ (1) (4) (5) (9) | ||||||||||||||||||||||||||||
| Country Fresh Holding Company Inc. |
Food Products | 839 | 41 | 1,053 | 52 | 1,892 | 93 | (1) (2) (5) (9) | ||||||||||||||||||||||||||||
| Elah Holdings, Inc. |
Capital Markets | 2,234 | 2,234 | 3,163 | 3,162 | 5,397 | 5,396 | ^ (1) (2) (5) (9) | ||||||||||||||||||||||||||||
| Exostar LLC - Class B |
Aerospace & Defense |
— | — | — | — | — | — | (2) (5) (9) | ||||||||||||||||||||||||||||
| Foundation Software - Class B |
Construction & Engineering |
— | — | — | — | — | — | (2) (5) (9) | ||||||||||||||||||||||||||||
| Iracore International Holdings, Inc. |
Energy Equipment & Services |
7,003 | 7,824 | — | — | 7,003 | 7,824 | ^ (1) (5) (9) | ||||||||||||||||||||||||||||
| Jill Acquisition LLC (dba J. Jill) |
Specialty Retail | 56 | 51 | — | — | 56 | 51 | (5) (9) | ||||||||||||||||||||||||||||
| Kawa Solar Holdings Limited |
Construction & Engineering |
— | — | — | — | — | — | ^ (1) (4) (5) (9) | ||||||||||||||||||||||||||||
| National Spine and Pain Centers, LLC |
Health Care Providers & Services |
600 | 358 | 500 | 298 | 1,100 | 656 | (1) (2) (5) (9) | ||||||||||||||||||||||||||||
| Prairie Provident Resources, Inc. |
Oil, Gas & Consumable Fuels |
9,237 | 40 | — | — | 9,237 | 40 | ^^^ (4) (5) | ||||||||||||||||||||||||||||
| Wrike, Inc. |
Professional Services |
2,165 | 5,645 | 3,075 | 8,018 | 5,240 | 13,663 | (1) (2) (5) (9) | ||||||||||||||||||||||||||||
| Yasso, Inc. |
Food Products | 850 | 586 | 790 | 545 | 1,640 | 1,131 | (1) (2) (5) (9) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL COMMON STOCK |
60,132 | 47,660 | 10,381 | 14,317 | 70,513 | 61,977 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| ASC Acquisition Holdings, LLC |
Distributors | 756 | 1,204 | — | — | 756 | 1,204 | ^ (1) (9) | ||||||||||||||||||||||||||||
| KDOR Holdings Inc. (dba Senneca Holdings) |
Building Products | — | — | 1,036 | — | 1,036 | — | (1) (2) (9) | ||||||||||||||||||||||||||||
| KDOR Holdings Inc. (dba Senneca Holdings) |
Building Products | — | — | 108 | — | 108 | — | (1) (2) (9) | ||||||||||||||||||||||||||||
| KDOR Holdings Inc. (dba Senneca Holdings) |
Building Products | — | — | 22 | — | 22 | — | (1) (2) (9) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| TOTAL WARRANTS |
756 | 1,204 | 1,166 | 0 | 1,922 | 1,204 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total investment before Pro Forma Adjustments |
1,488,747 | 1,431,195 | 1,739,572 | 1,688,542 | 3,228,319 | 3,119,737 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Estimated Purchase Price Allocation Adjustment Before Purchase Discount |
(51,030 | ) | ||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||
| Estimated Purchase Discount Adjustment |
(83,453 | ) | ||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||
| TOTAL INVESTMENTS (10) |
3,093,836 | |||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||
Goldman Sachs BDC, Inc.
Pro Forma Condensed Consolidated Schedule of Investments (continued)
Unaudited
As of September 30, 2020
(In thousands)
| * | Assets are pledged as collateral for the GSBD Credit Facility. |
| (+) | The Pro Forma Condensed Schedule of Investments discloses the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR (“L”) or alternate base rate (commonly based on the Prime Rate (“P”)), at the borrower’s option, which reset periodically based on the terms of the credit agreement. L loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L rates. As of September 30, 2020, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 0.36%, 0.26%, 0.23%, 0.19%, 0.15% and 0.10%, respectively. As of September 30, 2020, P was 3.25%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at September 30, 2020. |
| ^ | As defined in the 1940 Act, the investment is deemed to be an “affiliated person” of the combined company because the combined company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. |
| ^^ | As defined in the 1940 Act, the investment is deemed to be a “controlled affiliated person” of the combined company because the combined company owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. |
| ^^^ | The portfolio company is otherwise deemed to be an “affiliated person” of the combined company under the 1940 Act. |
| (1) | The fair value of the investment was determined using significant unobservable inputs. |
| (2) | Represent co-investments made with the combined company’s affiliates in accordance with the terms of the exemptive relief that the combined company received from the SEC. |
| (3) | Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. |
| (4) | The investment is not a qualifying asset under Section 55(a) of the 1940 Act. The combined company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the combined company’s total assets. |
| (5) | Non-income producing security. |
| (6) | The investment includes an exit fee that is receivable upon repayment of the loan. |
| (7) | In exchange for the greater risk of loss, the “last-out” portion of the combined company’s unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion that the combined company would continue to hold. |
| (8) | The investment is on non-accrual status as of September 30, 2020. |
| (9) | Securities exempt from registration under the Securities Act, and may be deemed to be “restricted securities” under the Securities Act. The acquisition dates of the restricted securities are as follows: |
| Investment |
Acquisition Date | |||
| ASC Acquisition Holdings, LLC - Warrants |
08/14/2020 | |||
| ASC Acquisition Holdings, LLC - Common Stock |
08/14/2020 | |||
| ASC Acquisition Holdings, LLC - Common Stock |
08/14/2020 | |||
| Accuity Delivery Systems, LLC - Preferred Stock |
06/13/2018 | |||
| Bolttech Mannings, Inc. - Common Stock |
12/22/2017 | |||
| CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) - Preferred Stock |
07/01/2016 | |||
| CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) - Common Stock |
07/01/2016 | |||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B - Common Stock |
03/30/2018 | |||
| Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units - Common Stock |
03/30/2018 | |||
| Conergy Asia Holdings, Ltd. - Common Stock |
07/31/2017 | |||
| Conergy Asia Holdings, Ltd. - Preferred Stock |
08/23/2017 | |||
| Country Fresh Holding Company Inc. - Common Stock |
04/29/2019 | |||
| Elah Holdings, Inc. - Common Stock |
05/09/2018 | |||
| Exostar LLC - Class A - Preferred Stock |
07/06/2020 | |||
| Exostar LLC - Class B - Common Stock |
07/06/2020 | |||
| Foundation Software - Preferred Stock |
08/31/2020 | |||
| Foundation Software - Class B - Common Stock |
08/31/2020 | |||
| Iracore International Holdings, Inc. - Common Stock |
04/13/2017 | |||
| Jill Acquisition LLC (dba J. Jill) - Common Stock |
09/30/2020 | |||
| Kawa Solar Holdings Limited - Common Stock |
08/17/2016 | |||
| Kawa Solar Holdings Limited - Preferred Stock |
10/25/2016 | |||
| KDOR Holdings Inc. (dba Senneca Holdings) - Warrants |
05/29/2020 | |||
| KDOR Holdings Inc. (dba Senneca Holdings) - Warrants |
05/29/2020 | |||
| KDOR Holdings Inc. (dba Senneca Holdings) – Warrants |
06/22/2020 | |||
| National Spine and Pain Centers, LLC - Common Stock |
06/02/2017 | |||
| Wine.com, LLC - Preferred Stock |
11/14/2018 | |||
| Wrike, Inc. - Common Stock |
12/31/2018 | |||
| Yasso, Inc. - Common Stock |
03/23/2017 | |||
| (10) | Total investments excludes investment in a money market fund, if any, managed by an affiliate of Group Inc. As of September 30, 2020, the combined company’s investment in an affiliated Money Market Fund is $258,030. The annualized seven-day yield as of September 30, 2020 is 0.00%. |
PIK – Payment-In-Kind